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Université Bourgogne Franche-Comté 
ϯϮ, avenue de l’Observatoire 
25000 Besançon 
Titre : Mécanismes de perception gustative des lipides alimentaires : cross-talk avec les récepteurs 
du goût amer et des endocannabinoïdes. 
Mots clés : Goût du gras, amer, endocannabinoïdes, cellules gustatives, HTC-8, CB1R 
Introduction. L'obésité constitue l'un des principaux problèmes de santé publique en ce début du 
21ème siècle. Sa prévalence augmente régulièrement, en particulier chez les enfants. Ce constat n'est 
pas anodin car l'obésité est généralement associée à diverses pathologies graves (diabète de type 2, 
hypertension et cancer,…). Ainsi, des investigations sur les mécanismes impliqués dans la 
perception gustative des lipides alimentaires pourraient éclairer leurs rôles dans  l’incidence de 
l’obésité.  
Buts et objectifs. Plusieurs études ont démontré le rôle des endocannabinoïdes et des aliments amers 
dans l’obésité. Ainsi, nous avons étudié l’interaction (cross-talk) des récepteurs cannabinoïdes et du 
goût amer avec le goût lipidique. Cette thèse comporte ainsi deux volets : les récepteurs 
cannabinoïdes (CB1R), le goût amer et leurs interactions avec les récepteurs lipidiques. 
Résultats et discussion. Dans la première partie, nous avons étudié le rôle régulateur de CB1R. 
Ainsi, des tests comportementaux sur des souris CB1R-/- et des souris de type sauvage (WT) ont 
montré que l'invalidation du gène Cb1r était associée à une faible préférence pour les solutions contenant de l'huile de colza ou un acide gras à longue chaîne (AGLC) tel que l’acide linoléique 
(LA). L'administration de rimonabant, un agoniste-inverse de CB1R, chez la souris a également 
entraîné une faible préférence pour les acides gras alimentaires. Aucune différence dans l'expression 
des protéines CD36 et GPR120 n'a été observée dans les cellules des papilles gustatives des souris 
WT et CB1R-/-. La signalisation calcique via CD36 dans les cellules des papilles gustatives des souris 
CB1R-/- diminue de façon significative par rapport à celle observée dans les cellules gustatives des 
souris WT. Les cellules des papilles gustatives des souris CB1R-/- présentent également une 
diminution significative de l'ARNm de Pro-glucagon et de Glp-1r et un faible niveau basal de GLP-
1. Nous rapportons que CB1R est impliqué dans la perception du goût du gras via la signalisation 
calcique et la sécrétion de GLP-1.  
Résultats et discussion. Dans la seconde partie, nous avons d’abord caractérisé le phénotype de 
cellules fongiformes humaines (HTC-8). En effet, le projet de ma thèse comprend la caractérisation à 
l’échelle moléculaire des récepteurs amers et lipidiques et leur cross-talk dans ces cellules 
(collaboration BRAIN, Allemagne). Nous avons démontré que les cellules HTC-8 expriment PLCβ2 
et l’α-gustducin à l’échelle des ARNm et des protéines. Elles expriment également TAS2R16 et 
TAS2R38 et ces mêmes cellules co-expriment CD36 et GPR120. Puis, nous avons étudié la 
signalisation via ces récepteurs en utilisant  l’acide linoléique, un agoniste de CD36 et GPR120, la 
sinigrin, agoniste de TAS2R16 et TAS2R38, la salicin, agoniste du récepteur TAS2R16 et le 
phénylthiocarbamide, agoniste du récepteur TAS2R38. De plus, les études du signal calcique ont 
démontré que la signalisation en aval du goût gras partage une voie commune avec la signalisation 
en aval du goût amer, mettant en évidence un cross-talk entre ces deux modalités gustatives.  
Bien que nous ayons montré le cross-talk entre les modalités gustatives amère et lipidique, il nous 
reste à étudier ces phénomènes à l’échelle de l’organisme. Ces résultats, d’ores et déjà, montrent que 
le goût amer et le récepteur cannabinoïde-1 sont liés à la sensibilité au goût du gras et doivent être 
pris en compte pour la gestion de l'obésité. 
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Title : Mechanisms of gustatory perception of dietary lipids: cross-talk with bitter taste and 
endocannabinoid receptors. 
Keywords : fat taste, bitter taste, endocannabinoids, taste cells, HTC-8, CB1R 
Introduction. Obesity is one of the major public health problems at the beginning of the 21st 
century. Its prevalence is increasing steadily, especially among children. This observation is very 
important because obesity is generally associated with various serious pathologies (type 2 diabetes, 
hypertension and cancer, etc.). Thus, investigations into the mechanisms involved in the taste 
perception of dietary lipids could shed light on their roles in the incidence of obesity. 
Aims and objectives. Several studies have demonstrated the role of endocannabinoids and bitter 
foods in obesity. Thus, we studied the cross-talk of cannabinoid receptors and bitter taste with lipid 
taste. This thesis consists of two components: cannabinoid (CB1R) and bitter taste receptors and their 
interactions with lipid receptors.  
Results and discussion. In the first part, we studied the regulatory role of CB1R. The behavioural 
tests on CB1R-/- and wild-type (WT) showed that the invalidation of the Cb1r gene was associated 
with low preference for solutions containing rapeseed oil or a long chain fatty acid (LCFA) such as 
linoleic acid (LA). Administration of rimonabant, a CB1R inverse agonist, in mice also resulted in a 
low preference for dietary fatty acids. No differences in the expression of CD36 and GPR120 
proteins were observed in the taste buds cells of WT and CB1R-/- mice. Calcium signalling via CD36 
in the taste bud cells of CB1R-/- mice decreased significantly compared with those observed in the 
taste cells of WT mice. The taste bud cells of CB1R-/- mice also show a significant decrease in Pro-
glucagon and Glp-1r mRNA and a low basal level of GLP-1. We report that CB1R is involved in the 
perception of fat taste via calcium signalling and secretion of GLP-1.  
Results and discussion. In the second part, we first characterized the phenotype of human fungiform 
cells (HTC-8). Indeed, the project of my thesis includes molecular characterization of bitter and lipid 
receptors and their cross-talk in these cells (collaboration BRAIN, Germany). We have demonstrated 
that HTC-8 cells express PLCβ2 and α-gustducin at mRNA and protein levels. They also express 
TAS2R16 and TAS2R38 and the same cells co-express CD36 and GPR120. Then, we studied 
signalling via these receptors using linoleic acid, a CD36 and GPR120 agonist, sinigrin, TAS2R16 
agonist and TAS2R38, salicin, TAS2R16 receptor agonist, and phenylthiocarbamide, TAS2R38 
receptor agonist. In addition, calcium signal studies have shown that downstream fatty signalling 
shares a common path with downstream bitter taste signalling, highlighting a cross-talk between 
these two taste modalities.  
Although we have shown the cross-talk between bitter and lipid taste modalities, we still have to 
study these phenomena at the level of the organism. These resultsshow that the bitter taste and the 
cannabinoid-1 receptor are related to the taste sensitivity of fat and must be taken into account for the 
management of obesity 
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Introduction 
Due to increasing abundance of food, the Western diet is constituted of almost 45% of fat (i.e. 
10% beyond the nutritional recommandations), greatly contributing to the prevalence of 
obesity. In France, the obesity rate is increased from 8% in 1997 (first survey) to 15% in 2012 
according to the last ObEpi report (OMS, 2012), involving serious diseases such as type II 
diabetes, atherosclerosis and hypertension. The epidemic of obesity is consequently 
considered as a major public health problem. 
The availability of highly palatable foods rich in energy, fat and sugar has been associated 
with the risk for obesity (Erlanson-Albertsson, 2005). The hedonic property of this type of 
food is a driving force, promoting its preferential consumption. Mela and Sacchetti (1991) 
observed that obese subjects had a higher spontaneous preference for dietary lipids than 
normal subjects (Drewnowski et al., 1985). This suggests the existence of selective detection 
of these caloric / lipidic foods operating from the oral cavity. 
Taste is one of the components that enables orosensory perception of foods and their 
composition. This plays a crucial role in food choices. Humans have a highly selective taste 
system that allows them to distinguish between nutritive and potentially toxic foods (Jyotaki 
et al., 2010). The perception of taste provides with the information on the quality of food 
ingested by the organism. The signals generated in the oral cavity will transmit the taste 
information via the central nervous system to different physiological targets like intestine via 
tongue-brain-intestine loop. The oral cavity, therefore, plays a significant role in the eating 
behaviour. 
The taste buds localized in the lingual papillae relay the information. There are three main 
types of papillae: fungiform, foliated and circumvallate papillae (Figure 1). The binding of the 
tastant to its taste receptor located in the papillae induces, via [Ca2+], taste signals transmitted 
via the cranial nerve muscle IX and VII to the NTS, connected to different areas of the brain 
involved in food intake and the digestive tract. 
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Figure 1. Nerve pathways involved in taste perception. At the lingual level, the papillae are 
innervated by afferent nerve fibers belonging to two pairs of cranial nerves. Thus, the fungiform 
papillae and the anterior part of the foliated papillae establish synaptic contacts with the chorda-
tympani nerve (CT, i.e., pairs of cranial nerves VII). The posteror part of the foliated papillae and the 
circumvallate papillae are innervated by fibers from the glossopharyngeal lingual branch (i.e., pair of 
cranial nerves IX). The few papillae present in the upper esophagus are connected to branches of the 
vagus nerve (nerve X). At the central level, the nucleus of the solitary tract (NST) is the first gustatory 
relay. The integration of tatse signals from the taste buds is mediated by brain areas (hypothalamus, 
nucleus accumbens, thalamus) whose role in the resultaion of the eating behavior is well established. 
The NST sends information back to the digestive tract through efferent vagal nerve fibers. VII 
tympanic chord, IX glossopharyngeal nerve, NST nucleus of solitary tract. Adapted from Martin et al. 
(2010). 
Orosensory perception of dietary lipids has long been perceived as dependent only on their 
textural and olfactory properties. However, during the last recent years, the existence of a 
sixth taste modality, dedicated to the perception of dietary lipids, has been proposed. Indeed, 
the recent discovery of lipid receptors in rodents and humans suggests that lipids can be 
detected by the taste pathway (Mattes, 2011; Passilly-Degrace et al., 2009). Hence, CD36 
(Cluster of differentiation 36) has been suggested to play the role of a lingual lipid receptor 
(Laugerette et al., 2005). In addition, it has been proposed, in the first place, that the GPR120 
lingual receptor (G protein-coupled receptor 120) also has a role in lipid detection. However, 
it seems that this is not the case (Ancel et al., 2015). Indeed, GPR120 has been clearly 
demonstrated to play a “regulatory” role in the control of lipid feeding behaviour (Ozdener et 
al., 2014). Long-chain fatty acids (LCFA) have been shown to induce a cephalic response and 
influence the gastric motility of the gastrointestinal system as well as the hormonal cascade of 
satiety (Little and Feinle-Bisset, 2011). Obese individuals appear to have an attenuated oral 
and gastrointestinal chemoreception of fatty acids (FA) (Little and Feinle-Bisset, 2011). Oral 
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detection of fatty acids has two major roles: the cephalic phase activation and the regulation 
of fat and energy intake (Little and Feinle-Bisset, 2010). In this context, many studies aimed 
at analyzing lipid perception have been conducted to understand how individuals make high-
fat dietary choices in terms of the quality and quantity they consume (Ebba et al., 2012). A 
large number of studies concluded that oral fat sensitivity is a key factor in food-selection 
(Keller, 2012; Keller et al., 2012; Melis et al., 2015a; Stewart et al., 2010, 2011a; Tepper and 
Nurse, 1997) (Figure 2).  
 
Figure 2. Sensory, genetic, personal and neuronal factors influencing the perception of fat taste. BMI 
body mass index, CD36 cluster of differenciation 36, GPR120 G-protein coupler receptor 120, FFA free 
fatty acid, PROP 6-n-Propylthiouracil, SNP single nucleotide polymorphism, TAG triacylglycerol. 
Adapted from Heinze et al. (2015). 
 
A defect in an individual's ability to detect dietary lipids would be linked to overconsumption 
of fatty foods (Keast et al., 2014). 
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1. Gustative perception 
1.1. General introduction 
The primary organ responsible for the sense of taste is the tongue. It contains biological 
machinery for identifying non-volatile compounds in food and non-food products that are 
placed in the oral cavity (Keast and Costanzo, 2015).  
Humans recognize and distinguish 5 basic taste qualities; sweet, umami, salty, sour and bitter. 
Basically, sweet detects energy-rich food; umami, the taste of L-glutamate reflecting a food’s 
protein content; salty is responsible for the electrolyte balance; sour prevents ingestion of food 
that is damaged or not mature enough; finally, bitter warns about potential presence of 
harmfull compounds (Figure 3) (Chaudhari and Roper, 2010). 
 
Figure 3. Taste qualities, taste receptors and natural stimuli. Human taste is characterized by 5 basic 
tastes qualities: sweet, umami, salty, sour and bitter. Recently, a sixth taste dedicated to the fat 
perception has been proposed. Adapted from Chaudhari and Roper (2010). 
Taste perception relays the information triggered by ingested food from the oral cavity to the 
rest of the body. It occurs in the taste buds included in the papillae and mostly located, in the 
dorsal epithelium of the tongue. There are 3 main types of papillae: fungiform, foliated and 
circumvallate papillae (Figure 4). Each taste bud contains 30 to 100 taste cells. There are 
mainly 3 types of cells in the taste buds: type I cells which are qualified by their properties as 
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glial-like cells; type II cells, corresponding to taste receptor cells, which express 
phospholipase Cβ2 (PLCβ2) and TRPM5 (Transient receptor potential cation channel 
subfamily M member 5) channels and type III cells which are pre-synaptic cells (Chaudhari 
and Roper, 2010). The taste bud cells (TBC) undergo continual turnover with a life span of 
about 10 days (Perea-Martinez et al., 2013). It has been recently shown that a lingual 
population of stem cells are involved in the production of mature TBC in the lingual papillae 
(Takeda et al., 2013). TBC derived from a pool of multipotent progenitor cells that are 
localized in the basal regions surrounding taste buds (Takeda et al., 2013; Yee et al., 2013). 
The binding of a sapid molecule to its receptor leads to changes in membrane potential and to 
an increase in the concentration of free calcium, [Ca2+]i. The depolarization of the taste cell 
triggers the release of neurotransmitters such as serotonin (5-HT) (El-Yassimi et al., 2008). 
The taste signals from the oral cavity are then transmitted to cranial nerve VII (the cranial 
nerve tympanum) and IX (the glossopharyngeal lingual branch) and then to the nucleus of the 
solitary tract (NST) (Figure 4) (Gaillard et al., 2008). The NST is connected to different areas 
of the brain involved in food intake, reward, memory and the digestive tract (Besnard et al., 
2010).  
 
Figure 4. Peripheral gustatory system. A. Localization of circumvallate, fungiform and foliate papillae 
on the human tongue. B. Sagittal section of a circumvallate papilla (CVP) characterized by a dome-
shaped structure highlighting the vicinity with the von Ebner glands. C. Schematic representation of a 
taste bud. CA-VI carbonic anhydrase, rNTS rostral nucleus of the solitary tract, VEGP protein of the 
Ebner glands, V trigeminal terminations, VII afferent fibers of the nerve of the tympanic chord, IX 
afferent fibers of the glossopharyngeal nerve. Adapted from Besnard et al. (2016). 
Chapter 1 
25/214 
First part: State of the Art Chapter 1: Physiology of the taste system 
1.2. Taste physiology: from detection to perception 
The oral detection of tastants by gustatory papillae, as mentioned above, triggers signals that 
are transmitted by the afferent gustatory fibers from the chorda-tympani (CT) and 
glossopharyngeal (GL) nerves (cranial nerve VII and IX, respectively) to the nucleus of 
tractus solitaries (NTS) (Figure 5-1). The NST receives information from the peripheral 
gustatory detection system, the digestive tract and the brain and is connected to different brain 
areas. The NST also sends gustatory signals towards the digestive tract via afferent vagal 
fibers (Figure 5-2). This cephalic phase reflex prepares, by anticipation, the digestive tract to 
food digestion (Power and Schulkin, 2008). The NTS projects taste signals to the primary 
gustatory cortex (PGC) constituted of the anterior insula and the frontal operculum (Fop). 
PCG is involved in identification and evaluation of intensity of tastants. Then, inputs from 
PGC reach the orbitofrontal cortex (OFC) which is involved in the evaluation of reward value 
associated with taste (Figure 5-3). The OFC is a sensory platform that receives inputs linked 
to food palatability such as smell or texture and send important informations with the reward 
pathway, constituted by the mesolimbic system, about hedonic experience (liking) and 
incentive salience (wanting) (Berridge, 1996). The mesolimbic system, an integrated pathway 
including the amygdala and hippocampus are involved in learned memory and the ventral 
tegmental as well as nucleus accumbens are mainly involved in the motivation of eating 
behaviour (Besnard, 2016). This system is responsible for taste perception and builds the 
hedonic value (Figure 5-4). 
Post-ingestive regulatory signals provide real-time information about the feeding status to the 
hypothalamus that constitutes the “metabolic brain”. It is involved in the control of food 
intake and energy expenditure (Figure 5-5). It has been shown that taste-responsive neurons 
directly project to the lateral hypothalamus (Li et al., 2013) suggesting that orosensory signals 
are able to influence homeostatic functions of the hypothalamus and internal signals, in the 
same way, can modulate the “emotional brain” function (Figure 5-6). Finally, anatomical 
interconnections link the mesolimbic system and the hypothalamus (Figure 5-7). It emerges 
that the regulation of appetite is based on a subtle balance between the “emotional brain”, i.e. 
the hedonic hunger, and the “metabolic brain”.  
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Figure 5. Taste perception: emotional and metabolic brain involvement. 1. Oral detection of tastants 
by gustatory papillae. NTS sends gustatory signals toward the digestive tract allowing a digestive 
anticipation. 3. Cephalic integration of the taste signals. 4. The mesolimbic system is responsible for 
taste perception and builds the hedonic value. 5. Post-ingestive regulatory signals provide real-time 
information about the feeding status. 6. Orosensory signals influence homeostatic functions. 7. 
Anatomical interconnections link the mesolimbic system and the hypothalamus. NTS, nucleus of 
tractus solitarius; FOp, frontal operculum; OFC, orbito-frontal cortex. Adapted from Besnard (2016). 
2. Orosensory detection of dietary lipids 
"Fat" is the term used to refer to triglycerides and fats that are essential components of a 
traditional food intake in humans. Dietary fatty acid deficiency leads to impaired vision, 
stunting, skin lesions and reduced learning abilities (Connor et al., 1992). In contrast, 
overconsumption of fat induces negative health effects such as obesity (Stewart et al., 2011a; 
Swinburn et al., 2011), diabetes (Ravussin and Smith, 2002) and cancer (Giovannucci et al., 
1993; Prentice and Sheppard, 1990). 
Fat has been mentioned as a taste modality in 330 years before J-C by Aristotle (Aristotle, 
350AD). Recent work has suggested that there is a sixth taste for lipid perception (Khan and 
Besnard, 2009; Laugerette et al., 2005). To define a flavor as a primary taste, it should meet 4 
criteria: a unique class of tastant molecules, a specific reception system, an implication of the 
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gustatory and physiological pathways. Indeed, the lipid perception system seems to respond to 
these conditions (Gilbertson and Khan, 2014). 
2.1. Fat taste agonists 
Dietary fats, i.e., triglyceride, do not appear to be effective stimuli. Indeed, compared to what 
is observed in intestinal fat sensing, the fat detection in the oral cavity appears to be 
dependent on the presence of fatty acids (FA). In humans, sensory detection of FA occurs 
within the millimolar range (0.02–6.4 mM) (Stewart et al., 2010). This detection threshold is 
consistent with the concentrations of FA naturally present in foods (0.76–3% w/v). It has been 
asserted that a lipolytic activity in saliva has been shown to be sufficient to produce 
micromolar amounts of fatty acids within the detectable range (Stewart et al., 2010). 
Furthermore, lingual lipase appeared to have an influence on fatty acid thresholds as the 
addition of orlistat (a lipase inhibitor) increased fatty acid thresholds (Pepino et al., 2012). 
2.2. Fat taste receptors in taste bud cells 
2.2.1. GPR40 and GPR120 
G protein-coupled receptors (GPCR) belong to seven-transmembrane domain receptors. 
Sweet, bitter and umami taste perception is initiated by binding of tastants to specific GPCR. 
Two GPRCR, GPR120 and GPR40 (G protein-coupled receptor 40), were detected on mouse 
papillae. GPR120 was co-expressed with TRPM5, a marker of type II taste receptor cells 
(TRC) (Cartoni et al., 2010) whereas GPR40 was mainly found in type I cells which are not 
true TRC (Cartoni et al., 2010). Nevertheless, Galindo et al. (2012) failed to detected GPR40, 
at protein and mRNA levels, in human papillae and Hirasawa et al. (2008) also failed to detect 
GPR40 in rat gustatory papillae.  
 
Figure 6. Predictive structure of human GPR120. Arrows indicate polymorphisms. Adapted from Mo 
et al.  (2013). 
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GPR120, also known as FFAR4 (free fatty acid receptor 4) has been identified as an orphan 
receptor in 2003 (Fredriksson et al., 2003) (Figure 6). GPR120 has been disorphaned in 2005. 
Indeed, GPR120 is activated by MCFA (Medium-chain fatty acid) and LCFA (Hirasawa et 
al., 2005). GPR120 is widely expressed in tissues such as brain, adipose tissue, heart and 
especially in lungs and gut (Hirasawa et al., 2005). GPR120 has been shown to mediate anti-
inflammatory effects (Oh et al., 2010). Over the last few years, GPR120 has raised interest as 
it has been identified as a potential target for metabolic disorders such as type 2 diabetes 
mellitus or obesity (Mo et al., 2013; Ulven and Christiansen, 2015). 
GPR120 was initially reported to be a plausible candidate for LCFA detection by taste buds 
because GPR120-/- mice were unable to properly detect an oily source during a behavioural 
test (Cartoni et al., 2010). Nevertheless, this finding has not been reproduced (Ancel et al., 
2015; Sclafani et al., 2013). Moreover, healthy volunteers subjected to two-alternative force 
choice (AFC) tests were unable to detect an oral sensation consecutive to a pharmacological 
activation of GPR120 (Godinot et al., 2013). These inconsistencies strongly suggest that 
GPR120 is not a major player in oral fat detection. In contrast, an implication of GPR120 in 
the LCFA mediated release of the incretin hormone glucagon-like peptide-1 (GLP-1) by 
mouse TBC is likely, as previously demonstrated in enteroendocrine L-cells (Hirasawa et al., 
2005). Indeed GPR120 and GLP-1 are found to be co-localized in a subset of mouse TBC 
(Martin et al., 2012). Moreover, LCFA elicit GLP-1 release by freshly isolated mouse 
circumvallate papillae (Martin et al., 2012). Ozdener et al. (2014) clearly demonstrated that 
GPR120 plays an alternative role in lingual detection of fatty acids. In fact, in the fasting 
situation, GPR120 is downregulated and in a fed-situation, it is upregulated in the raft fraction 
of mouse TBC. 
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2.2.2. CD36 
 
Figure 7. Structural features of CD36. It is noteworthy the hair-pin loop structure of the extracellular 
segment, suitable for the LCFA binding. Solid triangles show potential glycosylation sites. The red-
coloured box shows a potential membrane-embedded domain. The green-coloured box on the outer 
membrane segment shows a proline rich region with the location of cysteine residues indicated within 
red circles. Adapted from Khan and Besnard (2009). 
 
The Cluster of Differenciation 36 (CD36) formerly known as FAT for fatty acid translocase is 
a multifunctional glycoprotein. CD36 has been first identified 50 years ago (Silverstein and 
Febbraio, 2000) in mammary globules. The protein has been very well conserved over 300 
million years (Ozbek et al., 2010). The first ligand has been described in 1993. Indeed, CD36 
has been identified as a macrophage receptor for oxidized low density lipoprotein (Endemann 
et al., 1993).  
CD36 is expressed in various tissues such as the heart, the kidney and the gut and is involved 
in various functions such as immunity, inflammation, angiogenesis, thrombosis or 
atherogenesis. CD36 has also been found to be a lipido-sensor in numerous organs including 
the brain, the lingual and the gut epithelium suggesting a functional continuity between these 
tissues (Martin et al., 2011a). 
CD36 is an integral membrane ditopic glycoprotein with a large extracellular hydrophobic 
hair-spin structure between two short cytoplasmic tails (Figure 7) (Abumrad et al., 1993; 
Greenwalt et al., 1992). It belongs to scavenger receptor family and expresses the binding 
sites for a number of ligands such as fatty acids, thrombospondin-1, oxidized low-density 
lipoproteins (LDL), growth hormone (GH)-releasing peptides (Silverstein and Febbraio). 
CD36 exhibits high affinity (in the order of nanomolar) for fatty acids (Baillie et al., 1996) 
(Figure 8). CD36 appeared to be highly expressed on the apical region of mice circumvallate 
papillae. The foliate and fungiform papillae also express this glycoprotein but to a lesser 
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extent. In human beings, CD36 has been detected in human foliate and circumvallate papillae 
(Simons et al., 2011).  
 
Figure 8. Comparison of the main characteristics of CD36 and GPR120 in the mouse. FA, fatty acid; 
KO, knockout; LCFA, long-chain fatty acid; MCFA, medium-chain fatty acid; TBC, taste bud cells. 
Adapted from Besnard et al. (2016). 
In mice, the CD36 deletion completely suppressed spontaneous preference for lipid solutions 
(Laugerette et al., 2005). This effect on feeding behaviour is lipid-specific since sweet 
preference and bitter aversion were not affected in these transgenic mice. It is remarkable that 
CD36 failed to influence post-oral fat conditioning in mice. Indeed, Sclafani and Ackroff 
(2012) and Sclafani et al. (2007) reported that CD36 deletion decreased fat preference and 
consumption but also enhanced the ability of mice to compensate for the calories provided by 
their optional fat intake in fat conditioned experiments. They also proposed that CD36 might 
be involved in fat “detection” when GPR120 whereas take part in the regulation of post-
ingestive lipid behaviour. 
 
Figure 9. Localization of lingual von Ebner's gland. Sagittal section of a circumvallate papilla (CVP) 
with its typical dome-shaped structure and its anatomical relationship with the von Ebner glands. 
Adapted from Khan and Besnard (2009). 
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The local release of lingual lipase by the von Ebner’s gland in the clefts of circumvallate 
papillae (Kawai and Fushiki, 2003) exposes the CD36 directly to a microclimate potentially 
rich in long-chain fatty acids (LCFA) (Figure 9). This organization allows the degradation of 
triglyceride into fatty acids (FA) that promote the fat detection in the oral cavity. 
2.2.3. Others candidates  
Other orphans GPCR have been suggested to bind fatty acids. GPR41and GPR43 are 
receptors for the short chain (C2:0–C6:0) saturated fatty acids (Galindo et al., 2012; 
Miyamoto et al., 2016; Ulven, 2012) whereas GPR84 appears to be predominately activated 
by medium chain (C8:0–C14:0) fatty acids (Venkataraman and Kuo, 2005; Wang et al., 
2006). Besides, GPR41 and GPR84 have been shown to be abundantly expressed by 
posterior, probably circumvallate, papillae in rat (Gilbertson et al., 2010) whereas absent on 
fungiform papillae. As for GPR43, the receptor was present on both mouse fungiform and 
posterior papillae. There are currently no functional data on GPR41/43 in the taste system, 
preliminary data suggest that mouse TBC respond to medium chain fatty acids like myristic 
acid and lauric acid that are ligands of GPR84. However, the role of these TBC-expressed 
fatty acid-activated GPCR in fat taste perception remains to be elucidates in detail. 
2.3. Signalling transduction mediated by LCFA in taste bud cells 
During the eating period, LCFA bind to CD36, followed by the communication with GPR120. 
This binding triggers intracellular signal transduction involving successively the Src-PTK, 
phospholipase C (PLC) activation and inositol trisphosphate (IP3) production which induces 
Ca2+ release by the endoplasmic reticulum (ER) (Figure 10-1). Ca2+ activates stromal 
interaction molecule (STIM1) reinforcing the [Ca2+]i accumulation by opening Orai1 and 
Orai1/3 channels (Figure 10-2). The rise in [Ca2+]i induces a TBC depolarization via TRPM5 
channels (Figure 10-3). LCFA also block the delayed rectifying potassium channels (DRK) 
channels via CD36 translocation or directly in order to maintain the cell activation (Figure 10-
4). The Ca2+ rise produces cell depolarization leading to ATP efflux triggering serotonin (5-
HT) release by type III cells via the calcium homeostasis modulator 1 (CALHM1) channels 
(Figure 10-5). Indeed, Subramaniam et al. (2016) showed that LA-evoked Ca2+ signalling and 
ERK1/2 phosphorylation were decreased in CALHM1-deficient TBC. Moreover, Erk1-/- and 
Calhm1-/- mice exhibit reduced preferences for oily solutions. These results suggested that 
ERK1/2-MAPK cascade and voltage-gated CALHM1 Ca2+ channels are involved in oro-
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gustatory detection of dietary lipids (Subramaniam et al., 2016). ATP leads to the activation 
of primary gustatory neurons, type II and type III cells (Figure 10-6). Then, 5-HT mediates 
the modulation of the taste signal (Figure 10-7). It is noteworthy that FFA could also convey 
the taste signal to the NST via the non gustatory epithelium and the trigeminal endings 
(Figure 10-8).  
 
Figure 10. Signalisation induced by LCFA (working model). 1. LCFA binds to CD36 and activates the 
cascade of PLCβ-IP3 thus releasing Ca2+ from the ER pool. 2. The depletion of the ER Ca2+ pool induces 
the aggregation of STIM1 toward SOC channels like Orai1 and Orai1/3. 3. The Ca2+ increase also 
activates the TRPM5 channels responsible for the cell depolarization. 4. The activation of the DRK 
channels is triggered by the Na+ influx. 5. Ca2+ rise produces cell depolarization leading to ATP efflux. 
6. ATP leads to the activation of primary gustatory neurons, type II and type III cells and to 5-HT 
liberation from Type III cells. 7. 5-HT mediates the modulation of the taste signal. 8.  FFA could also 
convey the taste signal to the NST via the non gustatory epithelium and the trigeminal endings 
Obligatory genes for the ȃfattyȄ taste transduction are shown framed. FFA, free fatty acids; LCFA, 
long-chain fatty acids; PUFA, polyunsatured fatty acids; 5-HT, serotonin; r-NTS, rostral nucleus of 
solitary tract; V,trigeminal nerve; VII, chorda tympani nerve; IX, glosso-pharyngeal nerve. Adapted 
from Besnard et al. (2016). 
After cell depolarisation, neurotransmitters such as 5-HT are secreted toward the afferent 
gustatory nerve fibres (specifically VIIth and IXth cranial nerves) (Passilly-Degrace et al., 
2014), which relay the signal to the nucleus of solitary tract (NST), and then to the brain stem 
and digestive tract (Besnard et al., 2016a; El-Yassimi et al., 2008; Gilbertson and Khan, 2014; 
Passilly-Degrace et al., 2014) (Figure 10).  
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2.3.1. CD36/GPR120 cooperation hypotheses  
CD36 and GPR120 are co-expressed in mouse and human TBC (Martin et al., 2012; Ozdener 
et al., 2014) and both are able to bind and to be activated by LCFA (Baillie et al., 1996; 
Hirasawa et al., 2005). They are two putative gustarory lipid receptors however, a functional 
redundancy seems unlikely. 
2.3.1.1. Direct cooperation hypothesis  
This hypothesis suggests that the simultaneous presence of CD36 and GPR120 in TBC is 
absolutely required to properly detect the presence of LCFA in saliva. It was postulated that 
LCFA binding to CD36 should activate GPR120 to initiate the signal transduction cascade 
leading to transmitter release and, hence, fat detection (Gilbertson and Khan, 2014; Gilbertson 
et al., 2010). This prioritization is based on the fact that CD36 displays a greater binding 
affinity for LCFA than GPR120 and is known to act as a cofactor facilitating recognition of 
derived lipids by Toll-like receptors in the mouse (Hoebe et al., 2005). However, this scenario 
is challenged by behavioural studies performed using knockout mouse models Indeed, 
detection and preferential consumption of lipid sources are not affected by a targeted GPR120 
gene deletion (Ancel et al., 2015; Sclafani et al., 2007), likely because CD36 gene expression 
in circumvallate papillae (CVP) is maintained in this mouse model (Ancel et al., 2015). 
Therefore, a role for GPR120 as a primary lipid receptor responsible for the oral fat detection 
appears to be largely speculative (Besnard et al., 2016). 
2.3.1.2. Indirect cooperation hypothesis 
An indirect cooperation between CD36 and GPR120 is suggested by several observations. 
Indeed, hormones and LCFA are known to regulate the membrane localization of CD36. In 
the digestive tract, the presence of LCFA in the intestinal lumen also induced a rapid 
disappearance of CD36 from the apical side of enterocytes, leading to a partial degradation by 
the ubiquitin-proteasome pathway (Tran et al., 2011). This ligand-mediated negative feedback 
likely constitutes a physiological desensitization mechanism that progressively abolishes the 
LCFA-mediated CD36 signalling in enterocytes during the postprandial period (Tran et al., 
2011). A similar dynamic regulation of CD36 seems to exist in TBC. Indeed, lipid deposition 
onto the lingual epithelium is enough to induce a dramatic decrease in the CD36 protein levels 
in mouse CVP (Martin et al., 2011b). In line with this observation, CD36 in CVP displays a 
diurnal variation, with a progressive decrease during the active feeding period (i.e., dark 
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period). It is tempting to speculate that this downregulation of CD36 might lead to a 
progressive decrease in the motivation to eat fatty foods during a meal as lingual CD36 is 
significantly involved in the avidity for lipids (Laugerette et al., 2005; Martin et al., 2011b; 
Ozdener et al., 2014; Sclafani et al., 2007). Conversely to CD36, GPR120 levels in the mouse 
CVP remains globally stable throughout the day and appear to be insensitive to the lipid 
content of the diet (Martin et al., 2011b).  
It is also known that GPR120 is broadly expressed in the distal small intestine and colon, 
where it is coexpressed with GLP-1 in the enteroendocrine L cells (Hirasawa et al., 2005). 
During the prandial period, stimulation of GPR120 by LCFA promotes the secretion of 
intestinal GLP-1, increasing circulating insulin (Hirasawa et al., 2005). GLP-1 is known to 
modulate sweet and umami taste sensitivities in the mouse (Martin et al., 2009; Shin et al., 
2008). Behavioural experiments, conducted using GLP-1R-/- mice, have shown a reduced 
capacity to detect low concentrations of rapeseed oil, demonstrating for the first time that 
GLP-1 also modulates the fat taste sensitivity (Martin et al., 2012). The molecular mechanism 
by which this control takes place is not yet fully established. However, the dynamic 
downregulation of CD36 in CVP, normally triggered by LCFA (Martin et al., 2011b), was 
lacking in GPL1-R-/- mice (Martin et al., 2012). This finding provides the first evidence that 
GRP120 might be able to modulate the CD36-mediated detection of oral lipid, via GLP-1 
secretion.  
Thus, Besnard et al. (2016) proposed the following “indirect cooperation” scenario (Figure 
11). At the beginning of a feeding period, LCFA binding to CD36 into lipid rafts (Pohl et al., 
2005) results in the formation of a multimolecular complex of transmembrane proteins, 
including adaptors (Heit et al., 2013), members of Src protein-tyrosine kinase (Src-PTK) , and 
caveolin-1 (Cav1) (Fig 11-1). This multimolecular platform should be able both to trigger a 
downstream signal and to limit its duration by the partial degradation of the ligand-receptor 
complex. Indeed, because Src kinases activate PLC (Makranz et al., 2004), this event might 
result in a signalling cascade responsible for a rapid rise in Ca2+ levels, initiating 
neurotransmitter release and, in turn, transfering a lipid signal to the brain (Figure 11-2).  
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Figure 11. Respective role of CD36 and GPR120 in taste bud cells: indirect cooperation hypothesis. 1. 
LCFA binding to CD36 into lipid rafts results in the formation of a multimolecular complex of 
transmembrane proteins, including adaptors, members of Src protein-tyrosine kinase (Src-PTK) , and 
caveolin-1 (Cav1). 2. This multimolecular platform should be able both to trigger a downstream signal 
and to limit its duration by the partial degradation of the ligand-receptor complex. 3. Ubiquitination of 
CD36 induces a gradual decrease in the attraction for fat during the meal. 4.  When the oral LCFA 
levels become sufficient to allow the binding and activation of GPR120 in lipid raft triggers the GLP-1 
release by TBC. 5. GLP-1 acts on its cognate receptor located in gustatory nerve endings to modulate 
taste sensitivity. LCFA, long-chain fatty acid; Src PTK, Src protein tyrosine kinases; Cav1, caveolin 1; 
Ub, ubiquitination; G΅q, protein G; GLP-1, glucagon like peptide-1. Adapted from Besnard et al. 
(2016). 
Ubiquitination of CD36, by inducing its progressive removal from the plasma membrane (Su 
and Abumrad, 2009), might allow its subsequent partial degradation by the proteasome 
pathway (Tran et al., 2011), inducing a gradual decrease in the attraction for fat during the 
meal (Martin et al., 2011b) (Figure 11-3). The molecular mechanism by which this negative 
feedback takes place in TBC remains to be elucidated. One potential route of internalization 
of CD36 is the caveolae-dependent pathway used by toll-like receptors (TLR) (Shuto et al., 
2005). Studies showing that Caveolin-1 (Cav1) gene disruption is associated with altered 
subcellular localization and function of CD36 (Ring et al., 2006) are consistent with this 
hypothesis. When the oral LCFA levels become sufficient to allow the binding and activation 
of GPR120 in lipid raft (Ozdener et al., 2014) triggers the GLP-1 release by TBC (Martin et 
al., 2012; Ozdener et al., 2014) (Figure 11-4). GLP-1 acts on its cognate receptor located in 
gustatory nerve endings (Shin et al., 2008) to modulate taste sensitivity (i.e., fat, sweet, and 
umami tastes; Figure 11-5). The use of Glp-1r-/- mice has revealed an involvement of GLP-1 
in the dynamic regulation of CD36 by LCFA (Martin et al., 2012). The mechanism by which 
this regulation takes place is presently unknown (Figure 11).  
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It seems that chemical information combines with textural signals to form the complete 
sensory perception of fat (Liu et al., 2016). 
2.4. Gustatory and reward brain circuits  
Peterschmitt et al. (2018) recently studied the implication of gustatory and reward brain 
circuits following the lingual application of LCFA (LA). They found that LA induced c-Fos 
expression in the NST, the parabrachial nucleus (PBN) and the ventroposterior medialis 
parvocellularis (VPMPC) of the thalamus, that are regions known to be activated by gustatory 
signals. LA also induced c-Fos expression in central amygdala and ventral tegmental area 
(VTA) involved in food reward. Finally, they observed that LA induced high expression of 
genes involved in memory consolidation in the arcuate nucleus (Arc) and hippocampus 
(Hipp). They consequently proposed the following model: LA deposition induces the 
activation of the gustatory pathway. The gustatory signal is conveyed to the NST that 
transmits the information to the PBN. Next, the gustatory part of the thalamus (VPMPC) is 
activated and the signal reaches the gustatory insular cortical areas (AI,GI/DI) with 
modulatory influences of the central amygaloid nucleus (CeA) and the posterior part of the 
lateral hypothalamus, the parasubthalamic nucleus/calbindin nucleus (PSTN/CbN) (Figure 
12). Thus, they demonstrated that oral lipid taste perception triggers both gustatory and 
reward pathways. 
 
Figure 12. Schematic representation of the gustatory pathway activation involving metabolic, 
reward and learning, and memory processes. Acb, accumbens nucleus; AI, agranular insular cortex; 
Arc, arcuate nucleus; BLA, basolateral amygdaloid nucleus; CeA, central amygdaloid nucleus; GI/DI, 
granular/dysgranular insular cortex; Hbn, habenula; Hipp, hippocampus; mPFC, medial prefrontal 
cortex; NST, nucleus of the solitary tract; PBN, parabrachial nucleus; PSTN/CbN, parasubthalamic 
nucleus/calbindin nucleus; VPM, ventral posteromedial thalamic nucleus; VPMPC, ventroposterior 
medialis parvocellularis; VTA, ventral tegmental area. Adapted from Peterschmitt et al. (2018). 
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3. Orosensory detection of bitter compounds 
3.1. Bitter taste agonists 
The ability to taste bitterness is linked to a critical function for survival allowing animals to 
discriminate safe from potentially harmful foods. Thank to its innate negative hedonic value 
(Steiner et al., 2001), bitterness perception prevents feeding, and differences in bitter taste 
sensitivity influence human dietary behaviour. The bitter taste perception is controlled by the 
taste 2 receptor (TAS2R) gene family. There are 25 human TAS2R genes (Drayna, 2005) 
with many associated polymorphisms and a wide range of individual differences in bitter taste 
sensitivity (Chandrashekar et al., 2000). This explains in part why thousands of chemically 
dissimilar agonists can elicit a single taste quality. The most common role is played by 
TAS2R16 and TAS2R38.  
3.1.1. TAS2R16 
TAS2R16 is a bitter taste receptor gene located on chromosome 7, has traditionally been 
associated with the detection of toxic β–D-glucopyranosides, such as salicin from willow bark 
(Bufe et al., 2002; Greene et al., 2011; Soranzo et al., 2005). Several studies have also 
reported that bitter taste receptors are expressed in cell types that are not directly involved in 
oral sensory perception. Indeed, nucleotide polymorphisms in or near the coding exon of 
TAS2R16 have been identified as risk factors for alcohol and nicotine dependence (Hayes et 
al., 2011; Hinrichs et al., 2006; Mangold et al., 2008) in African Americans. These 
polymorphisms have also been correlated with differences in lifespan and senescence among 
individuals in an isolated European population from southern Italy (Campa et al., 2012). Thus, 
bitter taste receptors participate in a variety of biological processes, including metabolism and 
immune response. 
3.1.2. TAS2R38 
The TAS2R38 gene is one of the most widely studied. TAS2R38 encodes a seven 
transmembrane G protein-coupled receptor (Drayna, 2005). It binds to thiourea group 
contained in synthetic compounds such as phenylthiocarbamide (PTC) and 6- n- 
propylthiouracil (PROP) (Kim and Drayna, 2005). 
Fox (1932) serendipitously discovered that phenylthiocarbamide (PTC) concentration that 
tasted extremely bitter for some people were virtually tasteless for others. Indeed, sensitivity 
to PTC, a compound containing an -N-C=S group, is used as a phenotypic marker for oral 
sensations (Tepper, 2008). 
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3.2. Signal transduction mediated by bitter in taste bud cells 
The generation of bitter taste starts when a bitter compound enters the oral cavity. The ligand 
binds to a TAS2R receptor expressed in the apical membrane of receptor cells in taste buds. It 
triggers a cascade of signalling events, involving α-gustducin, PLCβ2 and inositol 
trisphosphate (IP3) activation (Zhang et al., 2003b), leading to Ca2+ influx and ultimately to 
the release of neurotransmitter. The neurotransmitters activate an afferent nerve fiber that 
transmits the signal via the cranial nerves VII and IX to the brain (Figure 13). The taste 
signals transit through the brain and provide input to circuits involed in various functions, 
such as physiological reflexes, discriminative perception, and affective processing. It 
illustrates the complexity of the mechanisms intervening between the application of the bitter 
stimulus and the generation of the behavioural response. 
 
Figure 13. Mechanism occuring between the application of the bitter tastant and the generation of 
the behavioral response. Ligand binds to a T2R G-protein coupled receptor expressed in the apical 
membrane in taste buds triggereing a cascade of signaling events, leading to the release of 
neurotransmitters. This mechanism activates afferent nerve fibers that transmit the signal via the 
cranial nerve to the brain. Papillae are distributed in distinct fields in the oral, pharyngeal and 
laryngeal epithelia with each field innervated by a different cranial nerve branch. VPMPC, ventral 
posterior medial nucleus, parvocellular subdivision. Adapted from Mennella et al. (2013). 
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Chapter 2 
Taste system and its regulatory pathways 
 
1. Factors involved in impaired oro-sensory perception and obesity 
1.1. Alteration of the salivary composition 
The flow of saliva is increased during a meal and it is utilized to form a moisturized bolus of 
foodstuff thus soaking the masticated food in salivary enzymes to increase its flavor 
perception, initiate the digestion, and promote swallowing (Zolotukhin, 2013). Saliva plays a 
significant role in the orosensory perception of dietary components. Indeed, during a meal, the 
major part of saliva is produced by the salivary glands and only a few is produced by minor 
salivary glands such as the von Ebner’s glands (VEG; Figure 14). VEG secrete directly into 
the clefts of papillae, known to house the great majority of taste buds (Figure 14). A 
preduodenal lipase (LIPPF) has been shown to be synthesized and secreted by VEG in rodents 
(Hamosh and Scow, 1973), its anatomical location highlights an involvement in promoting 
the enzymatic release of FFA from dietary triglycerides (TG) directly in the vicinity of taste 
buds, thus facilitating their detection by the TBC (Figure 14). 
 
Figure 14. Location of von Ebner’s glands in the circumvallate papillae. Sagittal section of a 
circumvallate papillae (CVP) highlighting the vicinity of taste buds with the von Ebner’s glands in the 
clefts of the CVP. Adapted from Besnard et al. (2016). 
LIPPF expression is lacking in human VEG (Spielman et al., 1993), nevertheless a similar 
mechanism involving a lipase activity leading to a partial TG breakdown of FFA is likely to 
occur in human saliva (Neyraud et al., 2012; Pepino et al., 2012; Stewart et al., 2010; Voigt et 
al., 2014). Indeed, a recent study revealed the presence of alternative lipase isoforms (LIPK, 
LIPM, LIPN) that are also known to induce TG cleavage (Voigt et al., 2014). The 
interindividual variation in oral fat detection could be caused by variability in the expression 
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of these lipases (Chevrot et al., 2013; Mattes, 2009; Tucker and Mattes, 2013). Indeed, a 
positive relationship between lipolysis efficacy and intensity of perceived fattiness was 
recently reported in healthy humans (Neyraud et al., 2012). VEG has also been shown to 
produce and secrete proteins such as VEG protein (VEGP) belonging to the lipocalin 
superfamily (Kock et al., 1994; Schmale et al., 1990) (Figure 14). This lipophilic ligand 
carrier protein is known to bind a remarkable array of small hydrophobic molecules, including 
LCFA, or bitter compounds. VEGP could also be involved in TBC protection against the 
detergent effects of FFA (Bläker et al., 1993). VEG also produce carbonic anhydrase VI (CA-
VI) involved in the regulation of the acid-base balance in different tissues (Leinonen et al., 
2001; Sly and Hu, 1995). CA-VI generates a neutral or slightly alkaline microclimate in the 
immediate proximity of TBC thought to play a role in taste bud responsiveness by controlling 
proton-gated K channels involved in TBC depolarization (Leinonen et al., 2001), and by 
limiting TBC apoptosis (Henkin et al., 1999a). 
Obesity has been implicated in impaired salivary secretion. Lasisi et al. (2018) showed that 
the re-establishement of normal diet in high fat-diet-induced obesity rats reversed the altered 
salivary composition. 
Although it is well established that saliva plays a significant role in taste receptor activation 
by orally applied chemical compounds, its involvement has not been extensively studied. 
Variations of general taste sensitivity as been associated with differences in the expression of 
salivary proteins, such as carbonic anhydrase 6 (Feeney and Hayes, 2014). Also, oral 
sensitivity to PROP is related to expression of specific salivary proteins (Glendinning, 1992; 
Mennella and Beauchamp, 2008). Perception of PROP bitterness is also governed by 
chemical composition of saliva (Melis et al., 2013a). Mennella et al. (2013) highlighted that 
proline-rich proteins found in saliva can bind with bitter-tasting tannins found in some foods, 
increasing their acceptability (Glendinning, 1992). Moreover, proline-rich proteins arise from 
gene clusters that are interleafed with bitter receptor genes, highlighting a common regulatory 
mechanism and function (Cabras et al., 2012). Besides, greater PROP responsiveness has 
been also shown to be related to high salivary levels of Ps-1 and II-2, two specific proteins 
that belong to the basic proline-rich protein family (bPRP) (Cabras et al., 2012; Melis et al., 
2013a).  
Melis et al. (2015) explained that the formation of this PROP•ArgH+hydrogen-bonded adduct 
could enhance bitterness intensity by increasing the solubility of PROP in saliva and its 
availability to receptor sites. Thus, L-Arginin could act as a ‘carrier’ of various bitter 
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molecules in saliva and enhance PROP taste responsiveness by facilitating the availability of 
PROP molecule at receptor site.  
1.2. Alteration in the oral microbiota 
The oral microbiota is comprised of about 700 bacterial species (Paster et al., 2001). The 
bacteria of the oral cavity can be altered in pathological conditions such as oral cancer and 
dental caries. DiBaise et al. (2008) first demonstrated a direct association between gut 
microbiota and obesity. Germ-free C57Bl6 mice infected by fecal samples from WT mice 
displayed 60% more fat than their germ-free counterparts. The bacteria responsible from this 
effect belonged to the Firmicutes phylum. The author proposed that subjects predisposed to 
obesity may have Firmicutes gut levels that promote more efficient extraction and/or storage 
of energy from the diet. 1 gram of bacteria (1011 bacteria) is swallowed daily with the saliva 
(Socransky and Haffajee, 2005). It is likely that salivary microbiota would affect 
gastointestine microbiota. Furthermore, it has been shown that periodontitis has been 
correlated with overweight conditions (Socransky and Haffajee, 2005; Wood et al., 2003). 
Goodson et al. (2009) showed that 98.4% of the overweight women could be identified by the 
presence of Selenomonas noxia bacterium (belonging to the Firmicutes phylum) at a level 
greater than 1.05% of the total salivary bacteria. The authors also proposed different 
mechanism by which oral bacteria could affect body weight (Figure 15).  
First, the oral bacteria may contribute to increased metabolic efficiency. Indeed, by this 
mechanism, even a small excess in calorie consumption might result in weight gain. For 
example, an increase by 5% (100 calories/day) would add approximately 10 pounds of fat per 
year. A second hypothesis is that oral bacteria could increase weight gain by increasing 
appetite. By stimulating host appetite, the bacteria get more to eat. However, no data is 
available to corroborate this assumption. A third hypothesis is that oral bacteria redirect 
energy metabolism by facilitating insulin resistance through increasing levels of tumor 
necrosis factor α (TNFα) or reducing levels of adiponectin leading to increased fat storage. 
The composition of salivary bacteria seems to change in overweight subjects. It seems likely 
that S. noxia could serve as biological indicators of change in oral microbial ecology and of a 
developing overweight condition. Of even greater interest is the possibility that oral bacteria 
may participate in the pathology that leads to obesity (Goodson et al., 2009).  
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Figure 15. Three possible hypotheses by which oral bacteria could affect body weight and 
contribute to obesity. Hypothesis 1, the oral bacteria may contribute to increased metabolic efficiency. 
Hypothesis 2, the oral bacteria increase appetite. Hypothesis 3, the oral bacteria redirect energy 
metabolism. Adapted from Goodson et al. (2009). 
1.3. Inflammatory status 
It has been shown that overweight or obese people were related to an increase in 
inflammatory dental and periodontal diseases with an altered health profile and plasma 
inflammatory mediators (Thanakun et al., 2017). Wang et al. (2009) suggested that TLR and 
interferon (IFN) pathways function collaboratively in recognizing pathogens and mediating 
inflammatory responses in taste tissue. This process, however, may interfere with normal taste 
transduction and taste bud cell turnover and contributes to the development of taste disorders.  
Acute lipopolysaccharide (LPS)-induced inflammation appeared to inhibit proliferation from 
taste progenitor cells, to decrease the number of newly born cells entering taste buds and to 
shorten the average lifespan of mature TBC (Cohn et al., 2010). It has been shown that a state 
of low-grade chronic inflammation plays a crucial role in obesity-related metabolic disorders 
(Hotamisligil, 2006; Shoelson et al., 2006). Indeed, the increased amount of visceral adipose 
tissue is linked to pro-inflammatory cytokine productions, such as tumor necrosis factor α 
(TNFα) and interleukin 6 (IL6). This production is up-regulated in obese subjects and is likely 
to act on receptors in tast buds, such as cell death cascades (Feng et al., 2014, 2015). TNFα is 
known to be a key mediator of obesity-related pathologies. Ideed, TNFα-/- mice exhibit higher 
insulin sensitivity, lower free-fatty acid levels, triglycerides and leptin levels (Uysal et al., 
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1997; Ventre et al., 1997). It has been shown that, in HFD-fed mice, expression of TNFα in 
taste tissue was significantly higher compared to lean controls (Kaufman et al., 2018) 
suggesting that prolonged obesity is linked to inflammatory response in taste epithelium. 
Moreover, direct injection of TNFα into the tongues of lean mice triggered to an increase in 
apoptosis in taste buds. Obese TNFα-/- mice did not show a reduction in taste bud abundance 
or in taste progenitor cells demonstrated in obese WT mice.  Finally, mice adiposity-specific 
deletion of Sel1L, an essential adaptor protein in the ER-associated degradation also know as 
a universal quality-control sytem, did not show an increase in TNFα expression and taste bud 
machinery and marker of self-renewal were unaffected (Kaufman et al., 2018).  
It has been reported a correlation between taste bud density and perceived taste intensity 
(Miller and Reedy, 1990). Also, human taste function has been shown to decline with weight 
gain in college-age males (Noel et al., 2017). Kaufman et al. (2018) showed that obese mice 
displayed significant reduction in tast bud abundance but with no difference in the size and in 
the balance between Type I, II and III cells compared to lean mice. These findings highlight 
that taste dysfunction that occurs in obese subjects may originate from a fundamental change 
in gustatory morphology arising from a reduction in taste bud abundance. 
Kaufman et al. (2018) suggested that their data imply that the metabolic effects of obesity 
trigger a decline in taste and not merely the oral exposure to fat and that gross adiposity 
stemming from chronic exposure to a HFD is associated with a low-grade inflammatory 
response, causing a disruption in the homeostatic mechanisms of taste bud maintenance and 
renewal. Inhibition of proinflammatory cascades, whether by genetic deletion of TNFα or by 
resistance to adipogenesis, is sufficient to avert the systematic loss of taste buds due to an 
obesogenic diet. 
1.4. The “obese tongue” phenotype? 
The overconsumption of lipid-rich food in obese subjects could be caused by an impairment 
in fat taste sensitivity linked to an altered gustatory papillae microbial and salivary 
environment. This may constitute the “obese tongue” phenotype as evoked by Besnard et al. 
(2018). Indeed, as obesity is associated with a dysbiosis in the gut microbiota (Nicholson et 
al., 2012), a similary phenomene could occur at the oral level. Moreover, the bacterial 
composition in saliva from overweight subjects appeared to be different from lean subjects 
(Goodson et al., 2009) as mention in the 1.2. section. The composition of the oral microbiota 
is highly sensitive to environmental condition changes such as variation in the salivary flux 
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and composition (Avila et al., 2009) and obesity is likely to be associated with modifications 
in salivary parameters (saliva or lipase activity) that are involved in oral fat detection (Vors et 
al., 2015). It appeared that the salivary composition was limited between normal weighted and 
obese subjects revealing no association between BMI and oral ecology. However, the salivary 
composition from non taster subjects, i.e. subjects that experience the sense of taste with far 
lower intensity than taster subjects, were characterized by a greater bacterial variety including 
members of families belonging to Gram-negative species linked to pro-inflammatory LPS 
molecules. Conversaly, salivary from taster subjects displayed increased abundance of the 
Lactobacillaceae family that exhibits anti-inflammatory functions. Thus, resident CVP 
microbiota in non taster subjects is prone to local inflammation that could impact the 
sensitivity of fat taste perception. The salivary composition also highlighted differences 
between taster and non-taster subjects (Figure 16). Besnard et al. (2018) proposed the 
following working hypothesis: taster subjects are characterized by an oral microbiota prone to 
decrease local inflammation contrary to non-taster subjects (Figure 16-1). Furtermore, taster 
subjects exhibit a salivary lysozyme activity associated with a lower bacteria diversity (Figure 
16-2) and with fat emulsion destabilization that facilitates the release of LA that will activate 
lipid sensors in TBC (Figure 16-3). Finally, the total antioxidant capacity of saliva in taster 
subjects is more important than in non-taster subjects facilitating the lipid sensing by 
protecting LA and the gustatory epithelium against, respectively, lipoperoxidation and tissue 
damage (Figure 16-4). Thus, non-taster subjects are characterized by an oral microbiota prone 
to increase local inflammation (Figure 16-5), a sustained salivary flux that might prevent 
access of LA to the TBC (Figure 16-6) and by a high carbonic anhydrase-VI activity, 
nevertheless, its modality of action remains elusive (Figure 16-7). 
Indeed, taster subjects were characterized by higher lysozyme levels which are linked to 
antimicrobial activity (Jollès and Jollès, 1984), correlated with a weaker bacterial diversity. 
Moreover, the lysozyme-mediated destabilization of the negatively charged fatty acid has 
been proposed to increase fatty sensation (Feron and Poette, 2013; Poette et al., 2014). Indeed, 
CD36 binds ionized LCFA with an affinity in the nanomolar range (Baillie et al., 1996). 
Besnard et al. (2018) proposed that the higher total antioxidant capacity (Greenberg et al., 
1999) of saliva in taster subjects might protect unsaturated FFA (e.g. LA) and taste receptors 
against the lipoper-oxidation and the tissue damage, respectively (Mounayar et al., 2013), 
facilitating activation of the fatty acid signalling pathway in taste bud cells. Conversely in the 
non taster group, salivary flow rate and CA-VI activity were positively correlated to higher 
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LA detection threshold values (i.e. lower fatty taste sensitivity). A high salivary flow, 
diminishing by dilution the LA access to taste receptor cells (i.e. CD36), might render these 
subjects poorly sensitive to lipids. The CA-IV activity was identified as a marker of the oral 
sensitivity to lipids (Mounayar et al., 2014) and plays a role in the salivary buffer capacity 
(Peres et al., 2010), the growth and the development of taste buds (Henkin et al., 1999b) and 
bitter taste sensitivity (Padiglia et al., 2010). Taken altogether, these findings suggest that 
specific microbial and salivary environments surrounding CVP are involved in the fatty taste 
sensitivity and suggest the existence of an “obese tongue“ phenotype (Besnard et al., 2018). 
 
 
Figure 16. Involvement of the micro-environment surrounding the gustatory circumvallate papillae 
(CVP) in tasters (T) and non-tasters (NT) and their putative consequence on the fatty taste 
sensitivity (working model). 1. Tasters are characterized by a host-associated microbiota prone to 
decrease local inflammation whereas non-tasters are characterized by a microbiota prone to increase 
local inflammation. 2. In the salivary, the lysozyme activity is associated with a lower bacteria diversity 
3. It induces destabilization of the fat emulsion facilitating the release of linoleic acid (LA). 4. The total 
antioxidant capacity of saliva facilitates the lipid sensing by protecting LCFA and gustatory epithelium 
against lipoperoxidation and tissue damage. In non-tasters, 5. the salivary flow might decrease the LA 
access to taste receptors and 6. The involvement of a high carbonic anhydrase-VI activity remains 
elusive. CA-VI, carbonic anhydrase-VI; TAC, total antioxidant capacity. Adapted from Besnard et al. 
(2018). 
2. Detection of dietary lipids and bitterness by the olfactory system 
The olfactory sensation is triggered by the detection of odor ligands by olfactory receptors. 
The human genome encodes more than 400 olfactory receptors, thus it is hypothesized that a 
combinatorial code occurs in which one olfactory receptor can be activated by a set of odorant 
ligands and one odorant ligand can activate a combination of olfactory receptors (Malnic et 
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al., 1999). The ligand-biding cavity associated with olfactory receptors response cover a large 
spectrum. Orthonasal activation refers to sniffing through the nose which leads to sensory 
cells activation in the olfactory epithelium. This is the pathway used to sense odours in the 
environment. While, retronasal stiulation occurs during food ingestion when volatile 
molecules released from the food in the mouth are pumped from the back of the oral cavity up 
through the nasopharynx to the olfactory epithelium (Figure 17).  
 
Figure 17. Orthonasal and retronasal smell mechanism in humans. (on the left) Orthonasal and 
retronasal smell humans. (on the right) Brain systems involved in smell perception during retronasal 
olfaction (breathing out), with food in the oral cavity Air flows indicated by dashed and dotted lines; 
dotted lines indicate air carrying odour molecules. ACC, accumbens; AM, amygda la; AVI, anterior 
ventral insular cortex; DI, dorsal insular cortex; LH, lateral hypothalamus; LOFC, lateral orbitofrontal 
cortex; MOFC, medial or bitofrontal cortex; NST, nucleus of the solitary tract; OB, olfactory bulb; OC, 
olfactory cortex; OE, olfactory epithelium; PPC, posterior parietal cortex; SOM, somatosensory cortex; 
V, VII, IX, X, cranial nerves; VC, primary visual cortex; VPM, ventral posteromedial thalamic nucleus. 
Adapted from Shepherd (2006, 2011). 
Odorants, like fats and many bitter compounds, are hydrophobic and rely on protein binding 
to effectively travel hydrophobic mediums, such as nasal mucus or saliva, to reach their 
receptors (Briand et al., 2002). It has been shown that retronasal odors can enhance taste 
intensity (Melis et al., 2015b).  
2.1. Fat taste receptors 
Olfaction plays a role in the preference for fatty foods and triglycerides (Ramirez, 1993). 
Humans are also able to detect fatty content, fatty acids, through their sense of smell alone 
(Bolton and Halpern, 2010) even in combination with other food scents (Boesveldt and 
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Lundström, 2014). The system of detection by olfactory sensory neurons remains unknown. 
One study has shown that up to 8% of mature olfactory neurons express CD36 (Oberland et 
al., 2015). CD36 has been shown to be expressed by olfactory receptor cells in mouse and 
plays a role in olfaction (Lee et al., 2015). 
2.2. Bitter taste receptors 
It has also been shown that PROP and oleic acid induced [Ca2+]i responses in cultured human 
olfactory cells respond (Tomassini Barbarossa et al., 2017). The bitter receptors expressed in 
the nose and upper airways contribute to innate defense by detecting invading pathogens and 
toxins (Lee et al., 2014) (Figure 18). 
 
Figure 18. Proposed mechanism for T2R and T1R signalling in sinonasal chemosensory cells. The 
binding of a bitter agonist to its receptor induces a T2R signaling Gα gust dependent and activates IP3 
production which induces Ca2+ release by the ER. The binding of a sweet agonist with its receptor 
triggers the T1R signaling that likely activates an alternative G protein that acts through cAMP/PKA 
and may inhibit IP3R-mediated calcium signaling.  Adapted from Lee et al. (2014). 
These findings suggest an olfactory role in ingestive behaviour. Besides, interesting findings 
have been shown investigating the odorant-binding protein 2a (OBPIIa) gene that is expressed 
in the olfactory cleft with high affinity for LCFA. Barbarossa et al. showed that a common 
single nucleotide polymorphism in the OBPIIa gene were involved in bitterness perception of 
fat (Tomassini Barbarossa et al., 2017). They found that the subjects homozygous for 
rs2590498 A-allele or heterozygous perceived bitterness in milkshakes containing oleic acid 
but not when noseclips were included.  
Subjects homozygous for the rs2590498 A-allele also perceived PROP as more bitter than 
subjects homozygous for the G-allele in every TAS2R38 groups, i.e., AVI/AVI, PAV/AVI, 
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PAV/PAV. These findings suggest a role of the olfactory system in the modulation of taste 
sensitivity that might have physiological implications. 
Flavour perception is one of the most complexes of human behaviour. It involves almost all 
the senses. The sense of smell, among others, is involved through odour images generated in 
the olfactory pathways. The perceptual systems are closely linked to learning, memory, 
emotion so that the distributed neural mechanisms contribute to food preference and food 
craving (Shepherd, 2006). 
3. Existence of a taste system in the digestive tract  
3.1. Digestive tract  
It has been established that an infusion of a lipid emulsion in the small intestine decreases 
food intake in animals and humans (Greenberg et al., 1999; Matzinger et al., 2000). The 
understanding of this underlying mechanism has led to the gut-brain axis paradigm. LCFA 
induce intestinal lipid sensors activation which induces the release of appetite regulating 
peptides that transit via the vagal afferent fiber and/or blood flow. It eventually modulates the 
activity of hypothalamic areas corresponding to the “metabolic brain” known to be involved 
in food intake regulation and energy expenditure (Blouet and Schwartz, 2010) (Figure 19).  
 
Figure 19. Role of the gut in lipid homeostasis. During digestion, LCFA are released from dietary 
triglyceride. In the oral cavity, fat taste receptors (CD36, GPR120), on the surface of TBC located on the 
apical surface of the tongue, trigger fat taste perception through the secretion of neurotransmitters, 
signal transmission to the brain and the induction of the early cephalic phase of digestion (blue 
arrows). In the intestinal tract, LCFA have satiety effects (green arrows) mediated by the release of 
anorexigenic peptides and lipid messenger (GLP-1, CCK, OEA). Lipid sensing in the gut mediated by 
the increase in long-chain faty acyl-coenzyme A inhibits glucose production by the liver through an 
intestine-brain-liver axis. Adapted from Abumrad and Davidson (2012). 
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CD36 has been shown to be mainly expressed in the proximal party of the small intestine in 
rodents (Poirier et al., 1996) and humans (Lobo et al., 2001) and in the apical side of entero-
endocrine cells involved in secretin and cholecystokinin (CCK) secretion (Sundaresan et al., 
2013) (Figure 19). Furthermore, acute intra-duodenal infusion of sulfo-N-succinimidyl oleate 
(SSO), a CD36 inhibitor (Kuda et al., 2013), leads to anorectic response that is abolished in 
CD36-/- mice. Then, CD36 is involed in enterocyte production of oleylethanolamide (OEA), 
an anorectic lipid messenger synthesized from dietary oleix acid (Schwartz, 2011), that is 
lacking in CD36-/- mice (Schwartz et al., 2008). Besides, OEA is also involved in the release 
of GLP-1 by the entero-endocrine L cells (Lauffer et al., 2009).  
The perception of LCFA by lingual CD36 induces the generation of taste signals that are 
conveyed to the “emotional brain” (Figure 20-1). A cephalic reflex loop triggers the digestive 
anticipation via CD36 (Figure 20-2). The binding of LCFA to intestinal CD36 leads to the 
release of satiety related hormones such as secretin and CCK by the entero-endocrine cells 
(Figure 20-3) to the production of the endocannabinoid lipid messenger OEA by enterocytes 
(Figure 20-4). OEA, then, promotes GLP-1 release, known to decrease the food intake (Figure 
20-5). In the same time, chylomicrons (CM) and the satiety peptide apoprotein AIV 
(ApoAIV) are synthesized and secreted by the enterocytes (Figure 20-6). Finally, postprandial 
hyperinsulinemia alters the intestinal CD36 mediated lipid sensing (Figure 20-7). 
Taken together, these findings support the implication of CD36 as an intestinal lipid sensor in 
food regulation (Figure 20). 
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Figure 20. Working hypothesis of the role de CD36/SR-B2 expressed along the tongue-gut axis on 
eating behaviour. ŗ. Fat taste perception by the ȃemotional brainȄ. Ř. Cephalic reflex loop responsible 
for the digestive anticipation via CD36. 3. Release of satiety hormones secretin and cholecystokinin 
(CCK) by entero-endocrine cells. 4. Production of the endocannabinoid anorectic lipid messenger 
oleoylethanolamide (OEA) by enterocytes. 5. Production of the anorexigenic peptide, glucagon-like 
peptid-2 (GLP-1) by OEA. 6. Synthesis and secretion of intestinal TG-rich lipoprotein such as 
chylomicrons (CM) and the satiety peptid apoprotein AIV (ApoAIV) by enterocytes. LCFA, long-chain 
fatty acids; LPL, lipoprotein lipase. Adapted from Niot and Besnard (2017). 
It is noteworthy that CD36 is also involved in the synthesis and secretion of large 
chylomicrons, lipoproteins responsible for lipids transport, by enterocytes during the post-
prandial period (Niot et al., 2009). Indeed, CD36-/- mice exhibit a reduction of chylomicrons 
size leading to postprandial hyperglycemia (Drover et al., 2005; Masuda et al., 
2009).Intestinal CD36 contribute to regulate the eating behaviour. As suggested in the taste 
bud cell, CD36 rapidly diseappeared from the brush border membrane of enterocytes in the 
presence of LCFA in the intestinal lumen suggesting a role of CD36 in the early stage of fat 
absorption (Tran et al., 2011). 
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Regarding the bitter taste and TAS2R, taste receptors have also been identified in a variety of 
nongustatory tissues, such as the gut, where they have been proposed to play a role in nutrient 
and toxin sensing (Mennella et al., 2013). 
Thus, taste not only helps decide whether a food is noxious or palatable but also prepares the 
gastrointestinal tract for post-ingestive metabolic events.  
3.2. The tongue-gut axis 
The relation of the tongue-gut axis in relation to appetite control is to be considered. 
There is a functional continuum along the oro-intestinal axis allowing the brain to analyze and 
regulate in real time the ingestion, digestion, absorption and metabolic fate of dietary lipids. 
This system requires the presence of sensors capable of detecting the presence of lipids at the 
lingual, intestinal and cerebral level. We have shown that CD36 plays an essential role in this 
system. At the lingual level, CD36 is clearly involved in taste perception of dietary lipids 
(Kuda et al., 2013; Laugerette et al., 2005). At the intestinal level, CD36 allows the detection 
of lipids during the postprandial period and adapts their absorption to make it optimal (Niot et 
al., 2009). It also transmits this information (presence or absence of lipids at the intestinal 
level) to the brain thus participating in the establishment of satiety. Finally, at the central 
level, CD36 is found in certain hypothalamic neurons known to be involved in the control of 
food intake.  
The orosensory detection of fat food induces cephalic reflex triggering early digestive 
secretion such as exocrine pancreatic secretion and biliary secretion (Figure 21-1). The 
“emotional brain” perceives the taste signals and instantly evaluates the hedonic value of food 
(Figure 21-2). A bidirectional commucation between the “emotional” and the “metabolic” 
brain leads to the regulation of the eating behaviour towards food choice (Figure 21-3 and 4). 
Then, food arrival in the small intestine leads to postingestive detection of energetic nutrients 
by the taste receptors located on enteroendocrine cells (Figure 21-5). This detection triggers 
the release of neurotransmitters and hormones that modulate the eating behaviour via enteric 
vagal afferents (Figure 21-6). The cascade of events triggered by the detection of energetic 
nutrients in the small intestine induces the production of metabolic signals that allow a 
homeostatic regulation of the “metabolic brain” (Figure 21-7). 
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There appears to be a coordinated response of fatty acids throughout the digestive tract 
(Figure 21). In this way, the insensitive individuals orally, are also in the gastrointestinal tract 
and thus overconsumption fatty foods and energy (Keast and Costanzo, 2015). 
 
Figure 21. Physiological consequences on the digestive function and eating behaviour of oral and 
post-oral detection of energy nutrients. 1. Taste-induced cephalic reflex leading to early digestive 
secretion preparing the body for food arrival. 2. Activation of the ȃemotionalȄ brain responsible for an 
instantaneous evaluation of hedonic value of foods. 3 and 4. Dialogue between the ȃemotionalȄ and 
ȃmetabolicȄ brain leading to the decision making at the basis of eating behavior, including food choice. 
5. Postingestive detection of energy nutrients by receptors, including taste receptors, expressed by 
enteroendocrine cells. 6. Modulation of eating behavior by the enteroendocrine-derived 
neurotransmitters and hormones via receptors located in the enteric vagal afferents. 7. Homeostatic 
regulation of the ȃmetabolic brainȄ by metabolic signals. BBB, blood-brain barrier; DMX, dorsal motor 
nucleus of vagus nerve; Nac, nucleus accumbens; NST, nucleus of solitary tract; OFC, orbito-frontal 
cortex; PFC, prefrontal cortex; VTA, ventral tegmental area; VII, chorda tympani nerve; IX, glosso-
pharyngeal nerve; X, vagus nerve. Adapted from Besnard et al. (2016). 
4. Endocrine hormones  
4.1. Oxytocin 
Oxytocin is a neuropeptide composed of 9 amino acids produced in the hypothalamus. It has 
been discovered in 1906 and named “oxytocin”, “swift birth” in Greek, because of it 
involvement in the contraction of the uterus of pregnant cats (Dale, 1906). Oxytocin is widly 
spread as it can be found across almost the entire animal kingdom (Donaldson and Young, 
2008). 
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The physiological function of oxytocin was originally known for promoting delivery and milk 
ejection in mammalian females. However, its involvement in new physiological functions 
such as change in paternal and maternal behaviour toward children (Naber et al., 2010), 
increasing capacity to understand other people feelings (Domes et al., 2007), improvement of 
social communication (Burkett et al., 2016) and also in psychiatric diseases (Feldman et al., 
2016). Another important issue involving oxytocin is its implication in food intake regulation.  
4.1.1. Physiological role of oxytocin in feeding behaviour regulation  
Oxytocin is synthesized in the paraventricular nucleus (PVN) and by the supraoptic nucleus 
(SON). The magnocellular oxytocin neurons in the PVN and SON project to the posterior 
pituitary gland and secrete oxytocin into the periphery circulation system (Bargmann and 
Scharrer, 1951) and into the central nervous system (CNS) (Maejima et al., 2014). Albeit the 
oxytocin is secreted into the peripheral circuitry and in the CNS, the effect of oxytocin on 
food intake is generally considered to be regulated mainly by the oxytocin secreted within the 
CNS (Altirriba et al., 2015). 
Arletti et al. (1989) first reported the anorexigenic effect of oxytocin in rat. Afterward, the 
effect was also shown in mice (Maejima et al., 2011), monkeys (Blevins et al., 2015) and 
humans (Lawson et al., 2015; Thienel et al., 2016). However, the body weight (BW) 
reduction observed with oxytocin treatment would not be only due to food intake reduction 
but also to increase in lipolysis in adipose tissue and decrease in fat mass (Altirriba et al., 
2014; Blevins et al., 2015; Gajdosechova et al., 2014; Maejima et al., 2017; Yi et al., 2015). 
Oxytocin neurons are activated following food consumption or ingestion (Hume et al., 2017; 
Johnstone et al., 2006). Thus, oxytocin plays an important role in the end of food intake. 
Indeed, hypothalamic Oxytocin mRNA expression is reduced with fasting and recovers with 
refeeding (Kublaoui et al., 2008). Several studies explored the involvement of oxytocin in 
food intake. In this way, suppression of oxytocin exocytosis or genetic reduction of oxytocin 
increased food intake (Kublaoui et al., 2008; Zhang et al., 2011); suppression of oxytocin 
receptor or ablation of neurons expression oxytocin receptors increased body weight gain (Wu 
et al., 2012) and, in the NTS, triggered hyperphagia (Baskin et al., 2010; Ong et al., 2017). 
Finally, oxytocin receptor activation in the arcuate nucleus (ARC) leads to satiety (Fenselau et 
al., 2017). 
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Furthermore, the oxytocin secretion shows a circadian rhythmic pattern. Indeed, circulation 
oxytocin levels is higher during the light phase corresponding to the suppression of feeding in 
rodents (Zhang and Cai, 2011). Moreover, oxytocin antagonist ICV injection increased food 
intake more effectively in the light phase than in the dark phase, the feeding phase (Zhang and 
Cai, 2011). Oxytocin seems to be involved in suppressing food intake during non-feeding 
phase. However, some reports on oxytocin receptor-deficient mice showed no difference in 
food intake (Takayanagi et al., 2008; Wu et al., 2012). But it can also reveal the existence of 
compensatory mechanisms.  
All together, these findings suggest that oxytocin receptor signalling seems to be involved in 
energy expenditure and feeding regulations. However, the precise mechanism involved is not 
completely elucidated. 
4.1.2. Oxytocin anorexigenic neural pathway 
The oxytocin is synthesized in the PVN and SON of the hypothalamus (Bargmann and 
Scharrer, 1951). The PVN receives projections from the ARC (Bouret et al., 2004). Two 
opposite types of neurons regulate feeding behaviour and are found in the ARC: neurons 
containing proopiomelanocortin/cocaine- and amphetamine-regulated transcript 
(POMC/CART); and neurons containing neuropeptide-Y/agouti-related peptide (NPY/AgRP) 
(Schwartz et al., 2000). POMPC is the precursor of α-melanocyte-stimulating hormone (α-
MSH), a strong anorexigenic peptide whereas NPY is a strong orexigenic peptide. Due to the 
fact that the tight junctions of the blood brain barrier are looser in this brain area, the ARC 
receives the peripheral conditions through factors in the blood stream such as leptin and 
glucose (Langlet et al., 2013). The ARC constitutes, thereby, the first-order neurons 
(Schwartz et al., 2000). The peripheral hormonal information received is then conveyed to the 
second-order neurons that include the PVN. The communication from the first-order to the 
second-order neurons triggers orexigenic or anorexigenic behaviour (Figure 22).  
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Figure 22. Representative scheme of the oxytocin neuronal circuits controlling food intake. Arrow-
headed lines and bar-headed lines indicate activation and inhibition, respectively. Oxytocin neurons 
and innervations are drawn in red, POMC/CART neurons in green, AgRP/NPY neurons in blue, leptin 
protein in purple circles, and oxytocin protein in red circles. Oxt, oxytocin ; POMC, pro-
opiomelanocortin ; CART, cocaine- and amphetamine-regulatedtranscript ; AgRP, agouti-related 
protein;NPY, neuropeptideY ; CCK, cholecystokinin ; LepR, leptinreceptor ; OxtR, oxytocin receptor ; 
ARC, arcuatenucleus ; PVN, paraventricular nucleus ; NTS, nucleus of the solitary tract. Adapted from 
Altirriba et al. (2015). 
4.1.3. Oxytocin anorexigenic neuronal pathway and peripheral inputs 
The NST is connected to different brain areas associated with food intake, rewarding, 
memory, and processes integrating visceral signals (Besnard et al., 2016). It responds to meal-
related signals from the vagal afferent (Schwartz, 2006). The vagal afferent senses gut-
secreted peptides such as CCK or GLP-1 and conveys the information to the NST that 
receives abundant projections from the PVN oxytocin neurons (Affleck et al., 2012). It has 
been shown that CCK intraperitoneal injection leads to c-fos expressions in the PVN where 
oxytocin neurons are selectively activated (Katoh et al., 2014). Gut hormone secreted 
postprandially participate to suppress food intake via the vagal afferent NTS-PVN oxytocin 
neurons. 
4.1.4. Oxytocin and reward-related brain regions 
Projections from the tegmental area (VTA) to the nucleus accumbens (NAc) play a crucial 
role in reward-related feeding behaviour (Adamantidis et al., 2011). Dopamine neurons are 
largely distributed in the VTA. It has been shown that neural pathway from VTA dopamine 
neurons to NAc is related to drug addiction (Volkow and Morales, 2015) and eating a 
palatable food intake activates dopamine neurons in the VTA and NAc (Valdivia et al., 2014). 
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Several studies showed that oxytocin treatment decreased the fructose-sweetened beverages 
consumption in monkeys (Blevins et al., 2015), intra-VTA oxytocin injection reduced sucrose 
intake in rats (Mullis et al., 2013) and oxytocin curtailed reward-driven food intake such as 
highly palatable chocolate cookie consumption in humans (Ott et al., 2013). Xiao et al. (2017) 
showed that PVN oxytocin neurons project to the VTA dopamine neurons and activate 
dopamine neurons, suggesting oxytocin is involved in the balance of dopamine neurons. 
Finally, oxytocin administration to NAc decreases food and palatable sucrose intake 
(Herisson et al., 2016) (Figure 23).  
 
Figure 23. Proposed model for oxytocin-related neural pathways that regulate food intake. Oxytocin 
neurons in the PVN and SON activate POMC neurons in the ARC. Oxytocin neurons in the PVN are 
subsequently activated by the POMC derived α-MSH. In the SON, oxytocin neurons express KATP 
channel and are glucose sensors that activate POMC neurons in the ARC. NPY/AgRP neurons project 
to the PVN oxytocin neurons and suppress their neural activity. PVN oxytocin neurons project to the 
POMC neurons in the NTS. Melanocortin receptors are expressed in the DMNV constituting the first 
nucleus of the vagal afferent. The DMNV regulates the gastrointestinal system and delays gastric 
emptying. In reward-related feeding, oxytocin neurons in the PVN activate VTA neurons. VTA 
dopamine neurons project to the NAc and promote reward-related feeding. PVN oxytocin suppresses 
these neurons and decreases reward-related feeding. The red arrows indicate the stimulatory 
projections and the blue arrows indicate the inhibitory projections. Adapted from Maejima et al. (2018). 
Taken together these findings exhibit the oxytocin as a promising neuropeptide for the 
prevention and the treatment of obesity. 
Spetter et al. (2018) concluded that during the preprandial state, oxytocin stimulates 
dopaminergic reward-processing circuits. Whereas during the prandial state, oxytocin curbs 
the food intake by enhancing the activity of brain regions link to exert cognitive control, while 
increasing the activity of regions involved in the process of food reward value. 
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4.1.5. Fields of applications of oxytocin 
Oxytocin is involved in psychological research areas such as autism (Aoki et al., 2014) or 
schizophrenia (Bradley and Woolley, 2017) in humans. Regarding obesity treatment, oxytocin 
showed encouraging effects. Indeed, oxytocin infusions using mini-pumps for two weeks in 
HFD-induced obese mice decreased significantly the body weight (BW) in only two days. 
Moreover, the decrease in food intake observed lasted seven days after the treatment. The 
effect on BW was dose dependent and maintained throughout the oxytocin treatment period 
(Maejima et al., 2017). This effect was also observed in human (Thienel et al., 2016). Besides, 
oxytocin seems to induce increased energy expenditure with decreased respiratory quotient in 
mice during the light phase of the treatment period (Maejima et al., 2011). The reduction of 
BW induced by oxytocin could also be due to diet-induced thermogenesis (Ong et al., 2017). 
Oxytocin treatment also improved factors linked to the metabolic disorder: decreased lipid-
droplets in the hepatocyte and decreased size of adipocytes in the mesenteric fat (Maejima et 
al., 2011), decreased abdominal and subcutaneous fat without reducing muscle mass 
(Maejima et al., 2017), increased lipolysis and fatty acid β-oxidation (Deblon et al., 2011; 
Eckertova et al., 2011). It also noteworthy to highlight the fact that chronic treatment with 
oxytocin seems also to be effective in decreasing BW of leptin-resistnt obese mice (Altirriba 
et al., 2014; Iwasaki et al., 2015) and rats (Balazova et al., 2016) suggesting that oxytocin is 
independent from leptin sensitivity. It is of paramount importance as human obesity is 
characterized by a leptin resistance, the ability of oxytocin to be effective despite leptin-
resistance provides it an important benefice as an anti-obesity agent. 
As stated above, oxytocin effects are more potent in severe obesity. Maejima et al. (2018) 
hypothesized that this effect may be due to the increment of oxytocin receptor expression in 
the brain and adipose tissue. The authors also reported that severely obesity is generally 
linked with insulin and leptin resistance associated with increases in plasma leptin and insulin 
levels that promotes insulin and leptin resistances and, by the way, diabetes and obesity. 
Conversely, in obese state, plasma oxytocin levels are decreased and oxytocin receptors are 
increased without oxytocin resistance establishment. These statements are to be considered 
since, as an anti-obesity agent, oxytocin may decrease fat mass and therefore induce reduction 
of plasma leptin levels and consequently improve leptin resistance (Figure 24). In addition, 
oxytocin, known to protect insulin-secreting β-cells from chronic high-glucose conditions in 
humans (Elabd et al., 2014) may improve insulin secretion (Maejima et al., 2015) and, 
therefore, improve glucose tolerance. 
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Figure 24. The potential of exogenous oxytocin as an anti-obesity treatment.  Obesity is characterized 
by increased plasma leptin levels, leptin resistance, decreased plasma oxytocin levels and increased 
oxytocin receptor expression in adipose tissue and the CNS. Exogenous oxytocin has been shown to 
decrease fat mass and food intake and also to improve leptin resistance in obese animals and humans 
and in leptin-resistant animal models. Furthermore, oxytocin has been shown to protect insulin-
secreting pancreatic β-cells in obese conditions, promote insulin secretion and improve fatty liver. 
Oxytocin emerges as a potential anti-obesity drug. Adapted from  Maejima et al. (2018). 
Considering the number of advantages presented by oxytocin in an obesity treatment context, 
it appeared to be an effective anti-obesity drug (Figure 25). Moreover, the anorexigenic effect 
of oxytocin are also found with nasal treatment that is noninvasive and a recent study showed 
that oral oxytocin supplementation could be also considered (Higashida et al., 2017). 
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Figure 25. Schematic representation oxytocin involvement on energy homeostasis. OT release within 
the CNS, spinal cord, and from the neurohypophysis into the circulation (shown in black arrows) may 
impact metabolic processes (shown in gray) that result in the reduction of body weight. Dotted arrow 
represents implicated pathways from sympathetic preganglionic neurons in the spinal cord to WAT. 
Reported opposing effects denoted by arrows pointed in opposite directions to one another. ARC, 
arcuate nucleus; CCK, cholecystokinin; BAT, brown adipose tissue; NTS, nucleus of the solitary tract; 
PVN, paraventricular nucleus; SON, supraoptic nucleus; and VTA, ventral tegmental area. Adapted 
from Blevins and Baskin (2015). 
4.2.7. Oxytocin in the peripheral taste system 
In addition to act within central circuits, oxytocin seems to also influence the peripheral taste 
system. Indeed, mouse taste buds have been shown to express oxytocin receptor (OTR) 
(Sinclair et al., 2010). Besides, oxytocin, in the nanomolar range, elicits Ca2+ responses  in 
taste bud cells (Sinclair et al., 2010). OTR appeared to be expressed only by Glial –like (Type 
I) taste cells. It means that, if confirmed, oxytocin would modulate taste signals via a cell-to-
cell communication between Glial-like cells and Receptor cells. Besides, it highlights an 
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analogy with the central nervous system, where OTR is also co-expressed with glutamate-
aspartate transporter (GLAST) located in glial cells (Yoshida et al., 2009). 
It is likely oxytocin modulates centrally but also peripherally the feeding behaviour. 
4.2. Other endocrine hormones 
4.2.1. NPY 
Hormones appeared to have an important role in the modulation of taste sensitivities. 
Neuropeptide Y (NPY) is an orexigenic peptide in the central nervous system (Beck et al., 
2002). NPY is found in the neurons projecting from the arcuate nucleus (ARC) to the 
paraventricular nucleus (PVN). Intracerebroventricular injection of NPY induced an increase 
in food intake (Beck et al., 2002) whereas destruction of NPY neurons by a neurotoxic agent 
triggers a decrease in food intake (Stricker-Krongrad and Beck, 2004). NPY has been shown 
to reduce the delay between food intakes (Sindelar et al., 2005) and to increase eat motivation 
(Jewett et al., 1995). Interestingly, NPY is involved in the consumption of palatable food as 
demonstrated by the fact that the endocannabinoid receptor antagonist Rimonabant prevented 
the release of NPY (Gamber et al., 2005). 
4.2.2. Cholecystokinin 
Cholecystokinin (CCK) functions as a satiey signal (Ritter, 2004). CCK is secreted from 
enteroendocrine cells in presence of lipids and proteins (Sayegh and Ritter, 2003). CCK binds 
to its receptor, CCK1 or CCKA receptor, that is found on vagal afferents innervating the 
intestinal mucosa (Moran et al., 1997). The vagal afferent fibers project to the nucleus of the 
solitary tract and are involved in feeding termination. CCK has been shown to inhibit food 
intake (Lieverse et al., 1994) and the use of a CCK receptor antagonist increased food intake 
(Reidelberger and O’Rourke, 1989). 
During the prandial phase, fatty acids reach the small intestine triggering a slowdown of the 
gastric emptying and suppressing appetite through the release of the hormones CCK, 
glucagon-like peptide-1 (GLP-1) and peptide Y (PYY), and inhibition of ghrelin release 
(Feinle et al., 2003). An high-fat diet decreases the response to dietary fat in the GI tract (Park 
et al., 2007; Stewart et al., 2011b).  
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4.2.3. Ghrelin  
Ghrelin has been discovered in 1999. It is produced by closed-type enteroendocrine cells in 
the oxyntic glands of the gastric fundus (Date et al., 2000; Kojima et al., 1999), by some small 
intestinal enteroendocrine cells, pancreatic-islet cells, and neurons in various brain areas, 
including the arcuate nucleus of the hypothalamus (Arc) (Date et al., 2000; Kojima and 
Kangawa, 2005; Müller et al., 2015; Verhulst and Depoortere, 2012). The ghrelin receptor 
was described in 1996 as the growth hormone-secretagogue receptor-1A (GHSR1A) (Howard 
et al., 1996). It is widely expressed peripherally and centrally (Kojima and Kangawa, 2005; 
Müller et al., 2015; Verhulst and Depoortere, 2012). Plasma ghrelin levels increase 
progressively before meal onset and fall precipitously afterwards (Gibbons et al., 2013; 
Kirchner et al., 2012; Spiegel et al., 2011). Ghrelin concentrations at meal onset correlated 
with meal size in healthy-weight and overweight men and women (Gibbons et al., 2013).  
Ghrelin acts in the brain to stimulate eating, in the stomach to stimulate gastric emptying, and 
on the pancreatic-cells to inhibit insulin secretion. Ghrelin secretion is stimulated mainly by 
neural controls. Feedback from small-intestinal nutrient sensing, mediated in part by CCK and 
PYY(3–36) cells, inhibits ghrelin secretion during and after meals.  
In obese subjects, a diminished postprandial suppression was observed compared with lean 
individuals (le Roux et al., 2005). PYY infusion has also been shown to reduce the orexigenic 
hormone ghrelin levels (Batterham et al., 2003).  Ghrelin, the only orexigenic hormone, 
secreted by the fundus cells of the stomach, has been a target for potential vaccination. Anti-
ghrelin vaccine has been shown to decrease food intake, decrease hypothalamic orexigenic 
signals, and increase energy expenditure in rodents and pigs (Altabas and Zjačić-Rotkvić, 
2015; Bohórquez and Liddle, 2015). However, human studies have been disappointing with 
no weight loss shown in clinical trials (Altabas and Zjačić-Rotkvić, 2015; Colon-Gonzalez et 
al., 2013) indeed, it seems that IgG anti-ghrelin autoantibodies are able to protect ghrelin from 
degradation, suggesting that an autoimmune response may be involved in ghrelin’s orexigenic 
effects (Takagi et al., 2013). 
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Figure 26. Expression of hormones and their receptors in the three subtypes of taste bud cells. The 
specific taste perceptions are represented as sweet, bitter, umami, sour, salt and fat. CCK, 
cholecystokinin; CCK-AR, cholecystokinin-A receptor; CD36, platelet glycoprotein 4; GAL, galanin; 
GAL2-R, galanin receptor type 2; GHRP, ghrelin receptor; GLP-1, glucagon-like peptide 1; GLP-1R, 
glucagon-like peptide 1 receptor; GLP-2, glucagon-like peptide 2; GPR120, free fatty acid receptor 4; 
Lep-R, leptin receptor; NPY, neuropeptide Y; NPY1-R, neuropeptide Y receptor type 1; NPY4-R, 
neuropeptide Y receptor type 4; PYY, peptide tyrosine tyrosine; VIP, vasoactive intestinal peptide; VIP-
R, vasoactive intestinal peptide receptor. Adapted from Calvo and Egan (2015). 
Numerous gastro-intestinal hormones, known to regulate both the digestive tract (i.e. motility, 
secretions) and the appetite, such as GLP-1, CKK, neuropeptide Y (NPY), vasoactive 
intestinal peptide (VIP) and ghrelin are produced by the gustatory papillae, as well as their 
respective receptors (Figure 26).  
4.2.4. GLP-1 
The multifunctional hormone GLP-1 (Baggio and Drucker, 2007) is expressed on subsets of 
Type II and Type III taste cells, known to support the gustatory function, whereas its receptor 
is expressed on afferent gustatory nerves (Shin et al., 2008). LCFA lead to the release of GLP-
1 in freshly isolated mouse CVP (Martin et al., 2012). As demonstrated in the entero-
endocrine cells (Hirasawa et al., 2005), this event seems to be dependent of the activation of 
lingual GPR120 by LCFA (Martin et al., 2012). The fact that sweet and umami tastes are 
modulated by GLP-1 (Martin et al., 2009; Shin et al., 2008) and sweet taste sensitivity is 
enhanced by LCFA via the GLP- 1 signalling pathway (Martin et al., 2012) raised the 
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question of a possible role of GLP-1 on “fat taste” sensitivity. To address this issue, 
behavioural experiments were conducted using GLP-1R-/- mice. Interestingly, these mice 
displayed a lower sensitivity to oily solution (Martin et al., 2012). This effect is likely related 
to the disappearance, in GLP-1R-/- mice, of the down-regulation of CD36 protein levels 
normally triggered by LCFA in TRC (Martin et al., 2012). This finding provides the first 
evidence that GLP-1 regulates the signalling cascade controlling “fat taste” sensitivity, via 
CD36 which is expressed in taste buds. This regulatory loop (i.e. LCFA/GPR120/GLP-
1/CD36/sensitivity to lipids), which occurs locally, might be reinforced by GLP-1 produced 
elsewhere.  
Given the expression of the taste receptors throughout the alimentary canal, a mechanism may 
play an important role in this association.  
Indeed, LCFA combine with the fat receptors present on the taste bud cells and on the 
enteroendocrine cells of the intestine and releases satiety hormones (CCK, GLP-1 and PYY). 
This mecanism allow the transmission of the satiety information to the NST. 
Liu et al. (2016) proposed the following working hypothesis: LCFA are released by lingual 
lipase from dietary lipids present in food. LCFA binds to the fat receptors, CD36 and 
GPR120, inducing a rise in intracellular Ca2+. Consequently, a release of neurotransmitters 
such as 5-HT and NA and gastro-intestinal hormones such as CCK, GLP-1 and neuropeptide 
Y (NPY) is triggered. In return, hormones are able to regulate the functions of the fat taste 
receptors (Figure 27-1). The taste bud cell afferent nerve fibres VII and IX transmit the 
information to the NST (Figure 27-2). The integration of the signals by the NST induces the 
reflex to early digestive secretion. Indeed, pancreatic exocrine, gastric lipase and other 
hormones are secreted to hydrolyse the ingested LCFA. This mechanism allows the inhibition 
of ghrelin, the food intake stimulating hormone (Figure 27-3). LCFA, in turn, bind to fat taste 
receptors in the enteroendocrine cells triggering the increase of [Ca2+]i and also induce the 
release of satiety hormones such as CCK, GLP-1 and PYY (Figure 27-4). The nerve fiber X 
(vagus nerve) conveys the satiety information to the NST (Figure 27-5). Obese subjects 
appeared to express less receptors in the TBC and in intestinal cells than lean subjects. This 
could compromised fat sensing system by attenuating the oral signals conveyed to the brain 
and thus delays the satiety response inducing excess food intake. 
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Figure 27. Proposed mechanisms of the systemic energy regulation via fat taste receptors. 1. In the 
oral cavity, LCFA receptors (CD36, GPR120) present on the apical surface of taste bud cells in the 
tongue contribute to fat taste perception which associates with secretion of neurotransmitters, signal 
transmission to brain centers, and induction of the early cephalic phase of digestion. 2. The afferent 
nerve fibres VII and IX transmit the taste information to the nucleus of solitary tract (NST) of the brain. 
3. The NST integrates the signals and induces the reflex to early digestive secretion. As a response, 
gastric lipase, pancreatic exocrine and other hormones are secreted and further hydrolyse the ingested 
fats. Thus, the food intake stimulating hormone-ghrelin is inhibited. 4. The LCFA combine with the fat 
receptors GPR120, GPR41 and GPR43 on the enteroendocrine cells of the intestine and releases satiety 
hormones (CCK, GLP-1 and PYY). The signal transduction involves the elevation of Ca2+. 5. The vagus 
nerve (nerve fiber X) conveys the satiety information to the NST. The dash lines represent the 
compromised responses in the obese individuals. Adapted from Liu et al. (2016). 
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Chapter 3  
Modulation of fat taste preference 
 
1. Modulation of fat preference by endocannabinoids 
1.1. The endocannabinoid system  
The endocannabinoid system (ECS) comprises endogenous agonists, the endocannabinoids 
and receptors responsible for its actions: cannabinoid-1 receptor (CB1R) and cannabinoid-2 
receptor CB2R, as well as enzymatic system that catalysis its biosynthesis and degradation 
(DiPatrizio et al., 2013). 
The establishment of this system follows the discovery of -9-tetrahydrocannabinol (9THC) 
by Raphael Mechoulam in 1964 (Gaoni and Mechoulam, 1964). 9THC is the most active 
compound produced by the plant Cannabis sativa. Thus, the cannabinoid receptors have been 
identified: CB1R, a G protein-coupled membrane receptor (GPCR). The binding of 9THC to 
CB1R inhibits adenylyl cyclase and modulates the activity of Ca2+ and K+ channels in neurons 
(Matsuda et al., 1990). CB1R is widely expressed in the central and peripheral nervous system 
mainly in limbic structures (hypothalamus) and nucleus accumbens (Moldrich and Wenger, 
2000). They have also been detected in taste buds (Yoshida et al., 2010). CB2R, the second 
cannabinoid receptor subtype, meanwhile, is primarily expressed in the cells of the immune 
system. 
N-arachidonoyl ethanolamine (anandamide, AEA) (Devane et al., 1992) and 2-arachidonoyl 
glycerol (2-AG) (Sugiura et al., 1995) have been identified as the two major endogenous 
endocannabinoids acting on CB1 and CB2 receptors. They are derivatives of arachidonic acid, 
a ω6-polyunsaturated fatty acid. Anandamide and 2-AG are rapidly hydrolyzed by the fatty 
acid amide hydrolase and the mooacylglycerol lipase, respectively, into inactive compounds 
at cannabinoid receptors (Cravatt et al., 1996; Dinh et al., 2002). 
The cannabinoid receptors, the endocannabinoids and the enzymes catalyzing their 
biosynthesis and degradation constitute the endocannabinoid system (Figure 28). 
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Figure 28. The endocannabinoid system in neurons: CB1 signalling affects the expression of 
orexigenic and anoretic mediators in the hypothalamus. DAGL: sn-1 selective diacylglycerol lipase; 
EMT: putative endocannabinoid membrane transporters; FAAH: fatty acid amide hydrolase; MAGL: 
monoacylglycerol lipase; NArPE: N-arachidonoyl-phosphatidyl-ethanolamine; NAPE-PLD: N-acyl-
phosphatidylethanolamine–selective phospholipase D; CRH: corticotropin-releasing hormone; CART: 
cocaine-amphetamine–regulated transcript. Blunt-ended line indicates inhibition. Adapted from Di 
Marzo and Matias (2005). 
1.2. Involvement of brain endocannabinoids in the regulation of food 
intake  
It has been known since the 1970s that cannabis increases appetite and food consumption, 
particularly of palatable foods, in humans (Abel, 1975). Several studies have looked at 
endocannabinoids. As a result, exogenous administration of cannabinoids (anandamide) 
induces hyperphagia and preference for palatable substances (Williams and Kirkham, 1999). 
Endocannabinoids are thus orexigenic mediators. In addition, the use of CB1 receptor 
antagonists, such as rimonabant (SR-14716A), the first selective CB1R antagonist (Rinaldi-
Carmona et al., 1994), reduces food intake (Arnone et al., 1997). CB1 receptors therefore 
seem to be involved in food intake. It appeared that the endocannabinoid system tonically 
reinforces the motivation to find and consume food with high caloric value. It is likely that 
this reinforcement is mediated by the mesolimbic pathways involved in reward mechanisms. 
Besides, it seems that the ECS is activated “on demand” in the hypothalamus after short-term 
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food deprivation and then transiently regulates the levels and actions of other orexigenic and 
anorexigenic mediators to induce appetite (Di Marzo and Matias, 2005). It may exist a dual 
action in mesolimbic and hypothalamic regions. Indeed, endocannabinoid levels vary in the 
hypothalamus and the limbic forebrain during the phases of feeding behaviour in rats. The 
levels are high during food deprivation and low during food consumption (Kirkham et al., 
2002). Moreover, the changes in endocannabinoid levels in the hypothalamus seemed to be 
inversely correlated with the leptin blood levels. Leptin appeared to decrease 
endocannabinoid levels in the hypothalamus (Di Marzo et al., 2001).  
The ECS appeared to modulate food intake by regulating the expression of hypothalamic 
mediators. Indeed, CB1R have been shown to colocalize with corticotrophin-releasing 
hormone (CRH) in the paraventricular nucleus (PVN), with melanin-concentrating hormone 
in the lateral hypothalamus and also with pre-pro-orexin in the ventromedial hypothalamus 
(Cota et al., 2003). Furthermore, the CB1R-activation sensitizes orexin-1 receptors which is 
likely to enhance appetite-inducing action of orexins (Hilairet et al., 2003). Conversely, CB1R 
inhibits anorectic actions occurring downstream of melanocortin-4 receptors (Verty et al., 
2004). Finally, in the mesolimbic system, endocannabinoids are believed to enhance appetite 
by increasing dopamine release in the nucleus accumbens shell or by synergizing with 
opioides. Di Marzo and Matias (2005) suggested that endocannabinoids maintain directed 
behaviours elicited by a stimulus instead of reinforcing the ability of a stimulus to elicit 
approach behaviour.  
1.3. Peripheral control of food intake and endocannabinoids  
Another important target of endocannabinoids is the peripheral target, such as the digestive 
tract. Indeed, the ECS controls the food intake via the vagus nerve that connects the 
gastrointestinal tract and the medulla and brainstem involved in satiety. For example, it has 
been shown, in rats, that food deprivation increases anandamide levels in the duodenum. In 
the same way, food deprivation increases CB1R expression in CCK-1 receptor-expressing 
neurons of the nodose ganglion projecting to the duodenum. Feeding and CCK contribution 
re-establish low levels of CB1R in these neurons (Burdyga et al., 2004; Gómez et al., 2002). 
Di Marzo and Matias suggested that inhibition of ECS activity could mediate induction of 
satiety by CCK. They also suggested that fasting overcomes satiety by elevating small 
intestine endocannabinoid levels and by releasing vagal CB1R from CCK inhibition (Di 
Marzo and Matias, 2005). In other words, the desinhibition of the ECS in the vagus nerve 
leads to the lifting of satiety. 
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Given the many targets associated to food regulation and the possible benefits linked to the 
ECS activation or inhibition, rimonabant have been used in numerous studies. Rimonabant 
decreased food intake in ob/ob and db/db mice (Di Marzo et al., 2001) and also in Zucker rats 
(Vickers et al., 2003). Rimonabant treatment induced a significant decrease in fat mass, an 
improvement of metabolic parameters such as a decrease in insulin plasma levels, leptin 
levels, cholesterol and an increase in HDL/LDL ratio (Ravinet Trillou et al., 2003). 
Surprisingly, CB1R-/- mice consume as much high-fat food as wild-type mice but do not 
become obese and do not show insensitivity to insulin or leptin (Ravinet Trillou et al., 2004). 
It suggests that CB1R antagonists induce body weight and fat mass loss via their anorexigenic 
action and act on lipogenesis and fat accumulation by counteracting the peripheral 
endocannabinoid effects.  
CB1R have been shown to be expressed in white adipocytes. The activation of CB1R triggers 
activation of the lipoprotein lipase (Cota et al., 2003) and the CB1R blockade leads to up-
regulation of adiponectin, involved in reducing the expression of enzymes contributing to 
lipogenesis (Poirier et al., 2005).  
CB1R induced de novo fatty acid biosynthesis in the liver and hepatocytes by increasing, 
especially, the fatty acid synthase (Osei-Hyiaman et al., 2005). Moreover, it has been sown 
that CB1R agonist enhances the expression of the fatty acid synthase in the hypothalamus too 
(Osei-Hyiaman et al., 2005). Taken together, this findings support that endocannabinoids 
regulate energy homeostasis centrally, via the hypothalamus, and peripherally (Figure 29). 
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Figure 29. Endocannabinoid system involvement. CCK, cholecystokinin;  CRH, corticotrophin 
releasing hormone; MC4R, melanocortin receptor type 4; NTS, nucleus tractus solitarus; TRPV1, 
transient receptor potential canilloid 1 channel for capsaicin; Nac, nucleus accumbens. Adapted from 
Di Marzo and Matias (2005). 
Endocannabinoid antagonists were proposed for the treatment of obesity (Berry and 
Mechoulam, 2002). Three one-year studies were carried out in human using oral dose of 
rimonabant: Rimonabant in Obesity (RIO)-North America, RIO-Lipids and RIO-Europe 
trials. After one year treatment, the weight loss observed was between 5 and 10%, many 
parameters were improved such as blood triglyceride levels, high density lipoprotein (HDL) 
cholesterol levels, fasting insulin levels and adiponectin levels. Nevertheless, the treatment 
induced side effects, i.e., nausea, diarrhea, dizziness, depression, anxiety and tolerance. 
Thus, the ECS is activated transiently after fasting and/or exposure to palatable foods and 
triggers appetite by reducing satiety and eventually stimulating lipogenesis and decreasing 
energy expenditure (Figure 29). It raised the hypothesis of a hyperactive ECS as a factor 
contributing to obesity and related disorders. 
These results also led to the hypothesis that the endogenous ECS plays a role in the regulation 
of appetite and food intake. As reported above, the ECS would also be involved in the reward 
process that drives the motivation and hedonic value of foods (Kirkham, 2003). Indeed, CB1 
receptors are expressed in the nucleus accumbens and the hypothalamus, regions belonging to 
the reward circuit. The endocannabinoid system is therefore a key regulator of palatable food 
intake (DiPatrizio and Piomelli, 2012). Indeed, endocannabinoids induce changes in eating 
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behaviour via the sensation of palatability of food components (Yoshida et al., 2010). Thus, 
the endocannabinoid system could be a critical component of the positive feedback 
mechanism required to maintain fat intake (DiPatrizio et al., 2013). 
CB1R has recently been shown to be expressed in taste bud cells (Yoshida et al., 2010). 
Subsequently, it was observed that the administration of cannabinoids had no effect on the 
food intake of CB1R-/- mice with respect to palatable foods (Yoshida et al., 2010). However, 
preference of oily solutions in CB1R-/- mice has never been investigated and could bring new 
insights in the treatment of obesity. 
2. Modulation of fat preference by bitter agonists 
2.1. Detection threshold and fat sensitivity 
The threshold of detection is the lowest level at which a stimulus is perceived (Keast and 
Roper, 2007; Webb et al., 2015). It is the concentration from which a subject can detect the 
presence of a compound other than water in the solution but cannot identify the quality. A 
high detection limit induces low sensitivity or a compromised taste function (Liu et al., 2016). 
The increase in the concentration of the stimulus makes it possible to reach the recognition 
threshold. This is the minimum level that characterizes the taste of the compound, i.e., sucrose 
is sweet. Beyond and for high concentrations, the supra-threshold is reached, the flavor is 
generally unpleasant and it appears that other sensory systems are involved, i.e., smell and 
chemesthesia (Keast and Costanzo, 2015). Oral sensitivity to fatty acids refers to an 
individual's ability to detect fatty acids in a complex matrix when tasting a solution. The 
ability to detect fatty acids differs between individuals and this divergence is the result of oral 
peripheral mechanisms responsible for chemoreception (Chalé-Rush et al., 2007). The 
measurement of the taste of fat in humans is complex (Figure 30). Some researchers believe 
that fatty acids do not elicit a full sensory taste quality of fat such as sweet or bitter, but rather 
define a threshold of detection (Newman and Keast, 2013; Stewart et al., 2010) but this 
remains controversial (Running et al., 2015). 
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Figure 30. Relationship between chemical concentration, detection threshold and recognition 
threshold. The left-hand side represents chemical concentration from 0 M solution to a saturated 
solution. The right-hand side represents the perceptual relationship to increasing concentration and 
where fatty acid detection is placed in comparison to the five basic tastes. Adapted from Keast & 
Costanzo (2015). 
CD36 and GPR120 genetic polymorphism is associated with low LCFA detection in some 
obese subjects. In the same way, the body-mass index (BMI) has been correlated with 
decreased detection sensitivity (high thresholds) of LCFA in obese subjects (Stewart et al., 
2011c). However, this assumption is still under debate as the absence of a correlation between 
body weight and fatty taste threshold in humans (Tucker et al., 2017), in contrast to what was 
observed in rodents. Thus BMI appeared to be a poor predictor of the fatty taste sensitivity.  
Nevertheless, detection thresholds for oleic acid were greater in overweight or obese than in 
lean subjects (Stewart et al., 2011b). Stewart and Keast (2012) also studied the effects of a 
high-fat and low-fat diet on LCFA-taste sensitivity in lean and overweight/obese subjects. 
Thay showed that fat contents of the diet modulated taste sensitivity to oleic acid among lean 
subjects. Indeed, oleic acid sensitivity was increased following a 4-week period of fat 
restriction and attenuated following the high-fat diet (Stewart and Keast, 2012). The failure of 
the high-fat diet to alter fatty acid taste thresholds among obese subjects suggests that these 
individuals were “adapted” to high-fat exposure. 
Gilbertson and Khan (2014) suggested that excessive dietary fat attenuates nutrient oro-
gustatory sensing, which could be associated with changes in diet and weight status. It is 
relevant as, in another study, subjects were categorized, on the basis of LCFA oral-detection 
thresholds, into two categories: hyposensitive or hypersensitive, and hyposensitive subjects 
consumed significantly more energy, fat, saturated fat, fatty foods, had greater BMI and were 
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less perceptive of small changes in the fat content of meal compared to hypersensitive 
subjects (Stewart et al., 2011a). 
2.2. Polymorphism 
2.2.1. CD36 single nucleotide polymorphism  
Interestingly, CD36 AA-genotype of rs1761667 has been associated with a highly functional 
CD36 and thus a high detection thresholds for fatty acids in different populations (Melis et al., 
2017; Mrizak et al., 2015; Pepino et al., 2012; Sayed et al., 2015). Furthermore, CD36 
polymorphism has been proposed to be closely related to disorders linked with excess of body 
lipids (Love-Gregory and Abumrad, 2011). In addition, this genotype is also linked to de novo 
lipogenesis markers in obese subjects (Melis et al., 2017).  
In humans, the common single-nucleotide polymorphism rs1761667 has been shown to 
reduce the gene expression of CD36 (Love-Gregory et al., 2011). It is also linked to a deep 
attenuation of the sensitivity to oral fat (Pepino et al., 2012). Thus, several pieces of evidence 
have been reported concerning the effect of the polymorphism rs1761667 on CD36 protein 
expression levels, which could explain variations in orosensory perception of fats leading to 
body weight gain. Subjects with the CD36 polymorphism rs1761667 are likely to be prone to 
become obese. 
In our team, a study has been recently conducted on obese Tunisian women and showed that 
the participants with A-allele of rs1761667 polymorphism exhibited decreased oral sensitivity 
(high thresholds) to oleic acid (Mrizak et al., 2015). In another study conducted on young 
Algerian children age seven to eight, we have observed higher A-allele frequency of 
rs1761667 polymorphism in obese children compared to leans (Sayed et al., 2015). As 
expected, the obese young children exhibited higher detection threshold for oleic acid than 
lean participants (Sayed et al., 2015). 
2.2.2 TAS2R38 single nucleotide polymorphism  
The TAS2R38 gene presents three functional single nucleotide polymorphisms (SNPs) in 
gene nucleotide positions 145 (rs713598 C/G), 785 (rs1726866 C/T) and 886 (rs10246939 
G/A) encoding for amino acid substitutions at position 49 (alanine/proline, A49P), 262 
(valine/alanine, V262A) and 296 (isoleucie/valine, I296V) (Drayna, 2005; Kim et al., 2003). 
The SNP result in two major haplotypes PAV and AVI, Proline-Alanine-Valine and Alanine-
Valine-Isoleucine rescpectively, and three rare (AAI, PVI and AAV) involved in bitter taste 
Chapter 3 
73/214 
First part: State of the Art Chapter 3: Modulating of fat taste preference 
perception of phenylthiocarbamide (PTC) and 6-n-propylthiouracil (PROP). It has been 
reported that PTC tastes extremely bitter to people and not bitter to authors (Fox, 1932). A 
subset of the population, classified as “non-tasters,” cannot detect the presence of the 
compounds propylthiouracil (PROP) and phenylthiocarbamide (PTC) at moderate 
concentrations that all others, referred to as “tasters,” find exceptionally bitter.  
Recently, the PROP taster status has been link to the genetic ability to taste the bitterness of 
PROP and is used as an index of chemosensory perception (Drayna, 2005; Kim et al., 2003; 
Tepper, 2008). Bartoshuk and al. first described the existence of groups, equivalent to 25% of 
individuals, defined as “supertasters” who perceive intense bitterness from PROP and PTC 
(Bartoshuk et al., 1994).  
PAV represents the taster allele while AVI stands for the non-taster allele. Thus, subjects 
carrying the dominant diplotype (PAV/PAV or PAV/AVI) detect higher bitternerss intensity 
towards PROP whereas individuals carrying the homozygous recessive diplotype (AVI/AVI) 
detect less or not bitterness (Garneau et al., 2014). Interestingly, the TAS2R38 phenotype 
seems to influence dietary habits. Indeed, it has been reported that individuals carrying 
AVI/AVI diplotype have higher vegetable consumption belonging to brassica vegetable 
compared to individuals carrying PAV/PAV and PAV/AVI diplotypes (Duffy et al., 2004; 
Sacerdote et al., 2007). Moreover, taster individuals reported less liking for vegetables and, 
thus, consumed fewer vegetables (Bell and Tepper, 2006; Drewnowski and Gomez-Carneros, 
2000). 
Various factors such as experiences, income and cultural food habits may also influence food 
preferences and consumption (Mennella et al., 2005). By the way, salt taste has been shown to 
inhibit bitterness in food and enhances flavour (Keast et al., 2003). Besides, Burd et al. (2013) 
showed that two children groups exhibiting a non-taster status were likely to develop obesity, 
the non-tasters from unhealthy food environment had higher BMI and developed more 
incidence of obesity than the non-tasters from healthy food environment.  
Lipchock et al. (2013) provided the first experimental evidence that mRNA expression 
amounts of the PAV allele of the TAS2R38 taste receptor gene correlate with sensory 
perception of bitterness and with dietary habits in humans.  
Taken together, PTC and PROP may affect food preferences and susceptibility to certain 
diseases. Polymorphisms in TAS2R38 can alter the perception characteristics of food and thus 
impact ingestive behaviour and nutrient intake.  
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2.3. Link between CD36/TAS2R38 
The taste modalities might interact with each other and also with other senses and these 
interactions might be critical in obesity (Khan et al., 2018a). A relationship between fat and 
bitter taste has been recently proposed. Indeed, some reports have suggested there exists a 
higher preference for dietary fat in PROP non-taster than that in PROP-taster participants 
(Karmous et al., 2018a; Tepper and Nurse, 1997; Tepper et al., 2008).  
Moreover, Melis et al. (2015) showed there is an association between orosensory perception 
of oleic acid, rs1761667 single nucleotide polymorphism (SNP) in the CD36 gene and PROP 
tasting status. These investiagtions further observed that bitter non-taster subjects also 
presented a reduced oral fat perception, inducing high fat food consumption and, 
consequently, high risk for obesity (Keller, 2012). Our team showed that CD36 rs1761667 
genotype and TAS2R38 rs1726866 and rs10246939 genotypes were associated with higher 
PROP detection thresholds and higher BMI in obese subjects than normal weight participants. 
These observations revealed the existence of an association between PROP detection 
threshold and CD36 and TAS2R38 genotypes (Khan et al., 2018a). 
Recently, bitterness perceived in milkshakes containing very dilute concentrations of oleic 
acid and that bitter perception was dramatically reduced when subjects tasted the milkshakes 
wearing noseclips (Tomassini Barbarossa et al., 2017). Moreover, non-taster individuals have 
been reported to show reduced ability to distinguish fat content in food (Hayes and Duffy, 
2007). Indeed, bitter non-tasters appeared to be unable to discriminate fat content in high and 
low-fat italian salad dressing and also fatty acids in a high-fat food (Nasser et al., 2001; 
Tepper and Nurse, 1998). Consequently, these subjects are reported to have higher 
consumption of dietary fat and high energy food as compared to tasters (Keller and Tepper, 
2004; Tepper et al., 2011). Whereas, PROP supertasters might avoid high-fat food due to their 
intense sensations (Duffy and Bartoshuk, 2000). 
Melis et al. (2015) showed for the first time a correlation between CD36 SNP and the 
decreased fat taste perception observed in PROP non-taster subjects. It appeared that subjects 
exhibited the AVI/AVI TAS2R38 phenotype homozygous for the G-allele of the rs171667 for 
CD36 had 11-fold lower detection threshod for oleic acid than subjects with the AVI/AVI 
TAS2R38 genotype but with a homozygous AA genotype of the rs1761667 polymorphism. It 
also appeared that PROP non-tasters had higher threshod for oleic acid than super-tasters. 
They observed that AA-genotype of rs1761667 exhibited increased BMI and decreased 
sensitivity to fat and bitter taste perception.  
Chapter 3 
75/214 
First part: State of the Art Chapter 3: Modulating of fat taste preference 
Several studies showed that PROP non-tasters have a lower density of fungiform papillae than 
PROP tasters (Melis et al., 2013b; Shahbake et al., 2005; Yeomans et al., 2009). Ebba et al. 
(2012) hypothesized that the increased ability to taste linoleic acid exhibited by PROP tasters, 
compared with non-tasters, could be ascribed to the difference in density of fungiform 
papillae between these two groups. Indeed, Melis et al. (2015) observed a lower density of 
fungiform papillae in PROP non-tasters, who also exhibit a lower capability to detect oleic 
acid compared with PROP tasters. They suggest that a high expression level of CD36 in 
gustatory cells seems to be a determining factor for detecting dietary fat only in subjects who 
have a low density of taste papillae.  
Recently, investigations about orosensory of LCFA and PROP showed that PROP detection 
threshold was associated with LA detection threshold in obesity in a Tunisian population 
(Karmous et al., 2018) (Figure 31).  
 
Figure 31. Relationship between PROP and LA detection thresholds. The bitter taster status, here, 
represented by the PROP detection threshold, appeared proportional to the fat taster status, 
represented by the fat taster status. In other words, individuals non-taster for fat, thus exhibiting a high 
LA threshold are proned to also exhibit a high PROP threshold and consequently to be bitter non-
taster. Adapted from Karmous et al. (2018). 
At the cellular and molecular levels, both fat taste, i.e, CD36 and GPR120 (Figure 32-1), and 
bitter taste, i.e, TAS2R16 and TAS2R38, receptors are expressed in type-II cells (Figure 32-
2). Thus, both pathways might activate gustducin for downstream signalling receptors (Roper 
and Chaudhari, 2017) followed by activation of PLCβ2 which is involved in hydrolyse of 
phosphatidylinositol4,5-bisphosphate (PIP2) into inositol trisphosphate (IP3) (Figure32-3). 
Then, IP3 binds to its receptor, IP3R, on the ER and triggers Ca2+ release (Figure 32-4). This 
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rise in [Ca2+]i leads to the opening of TRPM5 channels (Figure 32-5) that triggers an increase 
in free intracellular concentration of Na+ resulting in cell depolarization and the release of 
neurotransmitters (Figure 32-5). Thus, Khan et al. (2018) stated that the common mechanism 
might be “Ca2+-signalling” between the bitter and the fat taste perception. 
The elucidation of a cross-talk between fat and bitter taste modalities could find applications 
in food industry, obesity treatment and pharmaceutical industry for reducing the bitterness of 
the medicaments in children especially (Mennella et al., 2013). 
 
Figure 32. A cross-talk between fat and bitter taste modalities. 1. The dietary fatty acids bind to CD36 
and/or directly to GPR120. 2. Bitter tastants bind to their receptors belonging to the T2R family. 3. The 
binding activates the cascade of PLCβ-IP3. 4. The IP3 generated binds to IP3R and triggers the release of 
Ca2+ from the endoplasmic reticulum pool. 5. Increases in [Ca2+]i activate TRPM5 channels responsible 
for cell depolarization. Very high increases in [Ca2+]i inhibit TRPM5. 6. Increases in [Ca2+]i  trigger the 
release of neurotransmitters such as serotonin and ATP. Adapted from Khan et al. (2018). 
 
Keller (2012) suggested that fat and bitter taste receptors might play different roles. Indeed, 
TAS2R38 would be involved in textural perception of dietary fat according to the PROP 
taster status and CD36 would influence chemosensory perception of fat.  
Another explanation has been advanced involving the density of taste papillae and the number 
of taste bud cells (Feeney et al., 2011; Miller, 1986; Zhang et al., 2009). It appears that 
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individuals with high density of taste papillae exhibit high sensitivity to oro-sensory detection 
of bitter and fatty acids. However, this assumption is debated as Hayes et al. (2008) found no 
relation between decreased bitter taste perception and fungiform density.  
Otherwise, Khan et al. (2018) hypothesized that simultaneous administration of fat and bitter 
tasting agents results in very high increases in [Ca2+]i due to the opening of store-operated 
calcium channels, following the activation of fat taste receptors. Such increases in [Ca2+]i 
much higher than required, may trigger inhibition of TRPM5 channels and, consequently, 
inhibition of bitter-taste perception. 
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Working hypotheses  
CB1R involvement in dietary fatty acids perception 
 
The proportions of linoleic acid (18:2) have increased significantly in Western diets since the 
twentieth century from 1 to 8% of the total energy intake. This increase is correlated with the 
increase in the prevalence of obesity during this same period (Alvheim et al., 2012). Recently, 
the hypothesis of a spontaneous preference for lipids associated with the taste of fat has 
emerged and could explain the behavioural aspect related to obesity. Yoshida et al. (2010) 
tested the feeding preferences in wild-type and CB1R-/- mice treated with an endocannabinoid 
agonist, 2-AG. As a result, only the intake of sugar solutions was increased in wild mice 
treated with 2-AG, the consumption of bitter, salty, acid and umami solutions were not 
affected by the same treatment. No change in consumption was observed in CB1R-/- mice 
(Yoshida et al., 2010). This study demonstrates a change in palatability perception by 
endocannabinoids via CB1R receptors. 
Because excess lipid food intake is associated with obesity and the endocannabinoid system 
via CB1R receptors enhances food intake (perception of sweetness in particular), we propose 
to study the role of the CB1 receptor in the preference dietary lipids. Indeed, the involvement 
of the endocannabinoid system in the gustatory perception of dietary fats via CB1R in the 
lingual epithelium has not been studied yet. We propose to study the role of CB1R in fat 
preference in mice using behavioral tests, biochemical and Ca2+ studies. We hypothesized that 
the ECS would affect, via lingual CB1R, fat taste detection as early as in TBC. 
The project aims at elucidating the following tasks:  
1) To study the consequences of the deletion of Cb1r in mice invalidated for the gene 
(CB1R-/-) on the perception of dietary fatty acids. 
2)  To study the consequence of the deletion of Cb1r gene on the expression of CD36 and 
GPR120 proteins  
3) To study the cellular signalling mechanisms, via CD36 and GPR120 receptors in 
CB1R-/- mice taste cells. 
4) To study the consequences of the deletion of the gene on the GLP-1 release by taste 
bud cells. 
This could enable new anti-obesity treatment involving the synthesis of chemical agents such 
as “inverse agonists”, agonist for CD36 and GPR120 and antagonist for CB1R. 
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Bidirectional communication between bitter and fat gustatory modalities in 
human gustatory cells 
 
Bitter taste is detected by the lingual T2R38 receptor. It has been proposed that non-tasters for 
fatty acids are also non-tasters for bitter taste. Besides, CD36 gene polymorphism leads to a 
decrease in protein expression and, consequently, a decrease in the oro-sensory detection of 
fat taste. Some subjects who express CD36 polymorphism also exhibit an increase in the bitter 
detection threshold. So, there might exist an interaction between the two taste modalities, i.e., 
fat and bitter tastes. Hence the ability to detect fatty acids and the potential cross-talk between 
fat and bitter tastes remain an important issue to explore as it could constitute new anti-
obesity strategies. We hypothesized that bitter and fat taste share a common downstream 
signalling mechanism. We have investigated the relationship between fat and bitter taste by 
studying downstream signalling mechanisms in human immortalized fungiform cells, HTC-8. 
The project aims at elucidating the following tasks:  
1) To study the expression of dietary lipids taste receptors (CD36 and GPR120) and 
bitter taste receptor (TAS2R38) to investigate whether the 2 receptors are co-
expressed by human fungiform taste bud cells. 
2) To study cell signalling, particularly Ca2+ signal, via CD36/GPR120 and T2R38 to 
investigate the bidirectional communication between these 2 receptor families. 
3) To study the role played by autocrine/paracrine agents like oxytocin that is released 
from TBC in the modulation of the fat taste modality. 
These tasks has been performed on human fungiforms cells (HTC-8) immortalized by BRAIN 
institute (Zwingenberg, Germany).  
The highlighting of the cross-talk between these two taste modalities could allow the 
possibility to establish new personalized food strategies taking into account of bitter and fat 
taste receptor polymorphisms (sensitivity threshold) for overweigh or cancer patients.  
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1. Material & Methods 
1.1.  Ethical approval 
French guidelines for the use and care of laboratory animals were followed, and the 
experimental protocols were approved by the regional animal ethic committee of the 
University of Burgundy. In vivo studies were performed on male C57BL/6J wild type (WT) 
mice (Janvier Labs, Le Genest Saint Isle, France) and CB1R–/– mice (generous gift from Dr. 
James Pickel, National Institute of Mental Health, Bethesda, MD, USA) with a C57BL/6J 
background. Animals were individually housed in a controlled environment (constant 
temperature and humidity, dark period from 19:00 to 7:00). The mice had free access to 
standard regular chow and tap water during the experiments, unless otherwise specified.  
1.2. Behavioural experiments 
1.2.1. Two-bottle preference tests 
After being deprived of water for 6 h, mice were offered simultaneously two bottles, 
containing either control or experimental solution for 12 h. To minimize bias due to textural 
properties, the two solutions contained 0.3% xanthan gum (w/v, Sigma, Saint Quentin-
Fallavier, France), whereas the experimental solutions were added with either 0.2% rapeseed 
oil (w/v, Fleur de Colza, Lesieur, France) or 0.2% linoleic acid (w/v, LA, Sigma, Saint 
Quentin-Fallavier, France). At the end of each test, the intake of control and experimental 
solutions was recorded by weighing the feeders/bottles. The experiments were repeated two 
times, independently. 
In parallel, two groups (n = 5 each) of 10 WT mice, treated daily with rimonabant 
(SR141716, 10 mg/kg of body weight, Sanofi, Paris, France) or vehicle (0.1% DMSO/0.025% 
Tween 80 in 0.9% NaCl), by an intraperitoneal injection for 26 days, were subjected to the 
same two-bottle preference test. Food intake and weight were monitored during the 
experiment. 
1.2.2. Licking tests 
The CB1R−/− (n = 9) and WT (n = 9) mice were deprived of food and water for 6 h before the 
test. The mice were conditioned to choose between a palatable (4% sucrose) and a control 
solution. Once the mice were conditioned, they were randomly subjected to two-bottle test, 
containing either control (0.3% xanthan gum) or a test solution (0.3% xanthan gum + 0.2% 
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linoleic acid, LA). The number of licks, motivated by each bottle, was recorded using 
computer-controlled lickometers (Med Associates, Fairfax, VT, USA). Data were analyzed 
for 5 min from the first lick. 
1.3. Papillae and taste buds isolation  
The mice were anesthetized with 2% isoflurane gas, and then sacrificed by cervical 
dislocation. Taste bud cells (TBC) were isolated according to previously published procedure 
(El-Yassimi et al., 2008). In brief, lingual epithelium was separated from connective tissues 
by enzymatic dissociation (elastase and dispase mixture, 2 mg/mL each in Tyrode buffer: 120 
mM NaCl, 5 mM KCl, 10 mM HEPES, 1 mM CaCl2, 10 mM glucose, 1 mM MgCl2, 10 mM 
Na pyruvate, pH 7.4) (Figure 33).  
 
Figure 33. Tast bud isolation. From Miyamoto et al. (1996). 
Samples were frozen immediately in liquid nitrogen and stored at −80 °C (not exceeding one 
month) until RNA extraction, or lysed in a buffer for Western blot analyses. For real-time 
qPCR and Western blot, each point corresponds to a pool of TBC from four mice. 
1.4. Real-time qPCR 
Total RNA from CB1R−/− and WT TBC (n = 6) was extracted by using TRIzol method 
according to the manufacturer’s recommendations (Invitrogen, Cergy-Pontoise, France). After 
purification, mRNA was resuspended in RNase free water. The samples were then analyzed 
and quantified using Traycell (Hellma Analytics, Müllheim, Germany). Samples having 
purity (A260/A280) between 1.80 and 2.00 were retained for the rest of the experiment. mRNA 
(500 ng) was reverse-transcribed into cDNA using M-MLV reverse transcriptase (Invitrogen, 
Cergy-Pontoise, France) in a 20 µL of reaction volume containing 5 µL mRNA, 1 µL random 
primer (100 ng/µL) (Invitrogen, Cergy-Pontoise, France), 0.4 µL dNTP (25 mM), 8.6 µL 
RNase-free water. After incubation for 5 min at 65 °C, 2 µL 5× First-Strand Buffer, 1 µL 
DTT, 1 µL M-MLV (200 UI) and 1 µL RNaseOUT were added, and the samples were 
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incubated for 1 h at 42 °C and then for 15 min at 70 °C. Real time qPCR reactions were 
performed on 10 ng cDNA in a 20 µL of reaction volume in triplicates with a StepOnePlus 
(Life Technologies, Saint-Aubin, France) device with the use of SYBR green PCR Master 
Mix (Life Technologies, Saint-Aubin, France). For each gene (Table 1), a standard curve was 
established from five cDNA dilutions (50 ng to 0.05 ng per well) and used to determine the 
PCR efficiency. Real time qPCR reactions were performed with a denaturing step of 95 °C for 
10 min, followed by 40 cycles of 95 °C for 15 s and 60 °C for 1 min. The primer specificity 
was checked using the melt curves. The comparative 2−ΔΔCT method was used for relative 
quantification.  
Table 1 : List of primers 
GLP-1R Forward GGACACATGAAGTCATCTTTGCCT Reverse CAAGCCCTGGAAGGAAGTGAAGGA 
P-GCG Forward TGCTGAAGGGACCTTTACCAGTGA Reverse GCCTTTCACCAGCCAAGCAATGAA 
β-actin Forward TTCTTTGCAGCTCCTTCGTT Reverse ATGGAGGGGAATACAGCCC 
1.5. Western Blotting 
Freshly isolated mouse TBC were lysed using a micro-potter in 20 µL of TSE buffer (50 mM 
Tris HCl, 150 mM NaCl, 1 mM EDTA, 1% Nonidet P40, 5 µL/mL protease inhibitors 
(Sigma, Saint Quentin-Fallavier, France)) (Zhang et al., 2003a). Samples were stored on ice 
for 30 min, and then centrifuged (10,000g, 10 min, 4 °C). Lysates were used immediately or 
stored at −80 °C until the assay. Protein concentrations in homogenates were assayed using 
the BCA assay (Sigma, Saint Quentin-Fallavier, France). Denatured proteins (25 µg) were 
separated by SDS-PAGE (8%) and transferred to a polyvinylidene difluoride membrane. 
After being blocked for 3 h using a TBS buffer containing 5% BSA and 0.05% Tween-20, the 
membrane was incubated overnight with the primary antibody (Table 2). The α-gustducin was 
used as an internal reference protein. After a set of washes, the appropriate peroxidase-
conjugated secondary antibody was added. Antibody labeling was detected by 
chemiluminescence (Clarity, Bio-Rad, Marnes-la-Coquette, France).  
Table 2 : List of primary antibodies used in Western blotting 
Primary antibody Reference Supplier Dilution 
CD36 AF2519 R&D Systems 1:1000 
GNAT3/α-gustducin sc-395 Santa Cruz 1:200 
GPR120 ab97272 Abcam 1:500 
β-actin sc-47778 Santa Cruz 1:5000 
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1.6. Tissue culture of TBC and GLP-1 release 
Papillae from WT and CB1R−/− mice were isolated and incubated at 36 °C. The incubation 
media contained either 33 μM fatty acid-free BSA alone (control group) or 200 μM linoleic 
acid (LA) mixed and vortexed with 33 μM fatty acid-free BSA. After 2 h of incubation, the 
media were collected, and the active GLP-1 release was measured by ELISA (Millipore 
S.A.S., Molsheim, France). As the secretion of GLP-1 by TBC is very low, to be sure to 
detect active GLP-1 in the incubation medium, 10 pM of pure GLP-1 was systematically 
added in each experimental well, but not in standard curve, according to the manufacturers’ 
recommendations. The dipeptidyl peptidase 4 (DPP4) inhibitor (0.1%, Millipore S.A.S., 
Molsheim, France) was added to the medium to prevent GLP-1 degradation. 
1.7. Measurement of Ca2+ signalling 
TBC were freshly isolated from mouse tongues as described by Dramane et al. (2012). The 
cells were cultured onto 24-well plates, containing RPMI-1640 medium, supplemented with 
10% fetal calf serum, 2 mM glutamine, 50 µg/mL penicillin–streptomycin, and 20 mM 
HEPES, and incubated overnight at 37 °C. The next day, the supernatant was discarded. The 
cells were then incubated with Fura-2/AM (Invitrogen, Cergy-Pontoise, France) at 1 μM for 
30 min at 37 °C in loading buffer which contained the following: 110 mM NaCl, 5.4 mM 
KCl, 25 mM NaHCO3, 0.8 mM MgCl2, 0.4 mM KH2PO4, 20 mM Hepes, 1.2 mM CaCl2, 10 
mM Glucose; pH 7.4 (Figure 34). After adding the test molecules into the wells, the changes 
in intracellular free Ca2+ (F340/F380) were monitored under the Nikon microscope (TiU) by 
using S-fluor 40× oil immersion objective. NIS-Elements software was used to record the 
images. The microscope was equipped with Luca-S EM-CCD (Andor technology, Gometz-le-
châtel, France) camera for real-time recording of 16-bit digital images. The dual excitation 
fluorescence imaging system was used to analyze individual cells. The changes in 
intracellular free Ca2+ were expressed as ΔRatio, calculated as the difference between F340 and 
F380. All test molecules were added in small volumes with no interruption in recordings. For 
Ca2+ signalling experiments, the fatty acid was dissolved in ethanol (0.1%, v/v) and added 
into the experimental cuvette. 
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2. Results 
2.1.  The absence of CB1R gene induces a low preference for fatty 
solutions independently of postprandial factors 
CB1R-/- mice displayed a significant decrease in the preference for the fatty solutions 
(rapeseed oil and LA) compared to wild type mice (Figure 35a, b). Hormonal post-ingestive 
regulatory feedback greatly influences metabolism and appetite and, consequently, behaviour 
during long-term two-bottle preference tests (Parker et al., 2014; Sclafani and Ackroff, 2012). 
Therefore, we performed short-term licking tests to measure fat preference limiting post-
ingestive cues. LA was chosen among other LCFA because it showed the best results in two-
bottle preference tests (data not shown). As shown in Figure 1c, the number of licks for LA 
was significantly higher in WT mice than in CB1R-/- mice confirming the low preference in 
CB1R-/- mice for fatty solutions. 
 
Figure 35. Effect of CB1R gene invalidation on preference for lipids.Two bottles (control and 
experimental) were simultaneously offered to WT and CB1R-/- mice for 12 hours. Experimental solution 
contained: (a) 0.2% of rapeseed oil (w/v); (b) 0.2% of linoleic acid (w/v) diluted in xanthan gum. 
Control solution contained 0.3% of xanthan gum (w/v). Values are expressed as mean ± SEM (n=5). 
Dotted line represents the absence of preference. (c) Short-term (5 min) licking tests in wild type and 
CB1R-/- mice were performed as described in Materials and methods. Animals were subjected 
successively to a control solution (xanthan gum) and an experimental solution containing 0.2% of 
linoleic acid. Values are expressed as mean ± SEM (n=9). 
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2.2. Treatment with rimonabant induces a low preference for fatty 
solutions and does not alter feeding behaviour or body weight  
The mice treated with rimonabant for 26 days exhibited the same behaviour as CB1R-/- mice, 
i.e. a low preference for fatty solutions (Figure 36a, b). Interestingly, lean mice fed with 
standard diet and treated with rimonabant did not show reduced food intake or reduction in 
body weight (Figure 36c). As the rimonabant induces an early and transient effect, we 
monitored these parameters for 5 days before starting two-bottle preference tests. Thus, no 
bias interfered with the behavioural experiments.   
     
Figure 36. Effect of rimonabant on preference for lipids, body weight and feeding behaviour. (a, b) 
WT mice, treated with either rimonabant (10 mg.kg-1.day-1) or vehicle (CTRL), were simultaneously 
offered two bottles, a control one and an experimental one. The latter bottle contained either 0.2% of 
rapeseed oil (w/v) in (a) or 0.2% of linoleic acid (w/v) in (b) diluted in xanthan gum. Control solution 
contained 0.3% of xanthan gum. Values are expressed as mean ± SEM (n=5). Dotted line represents the 
absence of preference. (c) Food intake and body weight variations in mice treated or not with 
rimonabant and fed a standard chow. Values are expressed as mean ± SEM (n=5). Black arrows indicate 
the beginning of the treatment with rimonabant. 
2.3. CD36 and GPR120 protein expressions are not altered in TBC of 
CB1R-/- mice 
CB1R gene invalidation did not interfere with CD36 and GPR120 expression levels in taste 
buds (Figure 37) from CB1R-/- and WT mice. α-gustducin, a marker of type II TBC, remained 
Results 
 
91/214 
Second part: Personal contributions  Modulation of fat preference by endocannabinoids 
stable (Figure 37). It seems that low preference for fatty solutions observed in CB1R-/- mice 
was not due to altered expression of CD36 and GPR120.  
 
Figure 37. Impact of CB1R gene invalidation on CD36 and GPR120 protein expressions. CD36 and 
GPR120 protein levels were measured by Western blotting in TBC (n=2) from WT and CB1R-/- mice. (a) 
A representative blot corresponding to a pool of total proteins from four mice TBC is shown. (b) The 
corresponding histogram shows CD36 and GPR120 protein levels. 
2.4. Cb1r gene invalidation induces a decrease in Pro-glucagon and 
Glp-1r mRNA and a low GLP-1 basal level  
According to previous published data (Ozdener et al., 2014), LCFA induces active GLP-1 
release by mouse TBC. Pro-glucagon and Glp-1r mRNA levels were significantly lower in 
CB1R-/- TBC than in WT TBC (Figure 38a). To measure the release of active GLP-1 in TBC, 
freshly isolated mouse TBC were incubated for 2 hours in an oxygenized medium containing 
anti-DPP4, to prevent GLP-1 degradation, and exposed or not to 200 µM LA. Notably in 
CB1R-/- mice TBC, GLP-1 release in the culture medium was significantly lower than that in 
WT TBC in both conditions. As expected, LA induced a small but significant rise in active 
GLP-1 levels in culture medium of WT TBC (Figure 38b). Interestingly, the rise elicited by 
LA in WT TBC was abrogated in CB1R-/- mice TBC (Figure 38b). These data suggest the 
absence of CB1R may alter GLP-1 production and explain the low preference in CB1R-/- mice 
for fatty solutions. 
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Figure 38. Effect of CB1R gene invalidation on GLP-1. (a) Pro-Glucagon and GLP-1r mRNA levels 
were assayed by real-time qPCR in mouse TBC from WT and CB1R-/- mice. Values are expressed as 
mean ± SEM (n=6). (b) GLP-1 release by freshly isolated mouse TBC incubated for 2 hours in the 
presence of 33 µM Fatty Acid-free BSA alone (CTRL) or with 200 µM linoleic acid (LA). Each value 
corresponds to the GLP-1 released by cultured TBC from three mice. Values are expressed as mean ± 
SD (n=2). 
2.5. Both LA and cannabinoids induce CB1R-dependent calcium 
responses in TBC 
In TBC, LCFA evokes increases in Ca2+ signalling (Dramane et al., 2012a). Here, we 
investigated the role played by CB1R on Ca2+ signalling using freshly isolated TBC from 
CB1R-/- and WT mice. As expected, LA triggered a higher rise in [Ca2+]i in WT TBC (Gaillard 
et al., 2008) (Figure 39a, f) than that in CB1R-/- TBC (Figure 38b, f). Similarly, arachidonyl-
2'-chloroethylamide (ACEA, a specific CB1R agonist), induced a rise in [Ca2+]i in WT TBC 
(Figure 39f). However, ACEA triggered a significant lower increase in [Ca2+]i in CB1R-/- TBC 
than that in WT TBC (Figure 39f). Finally, the combination of LA and ACEA also induced a 
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strong rise in [Ca2+]i in WT TBC (Figure 39c, f) corresponding to the combined effect of the 
two molecules that was not apparent in CB1R-/- TBC (Figure 39d, f). Interestingly, when 
tested on CB1R-/- TBC, ACEA still triggered a rise in [Ca2+]i, suggesting a role for other 
receptors in this model (Figure 38f). In line with this, blockade of TRPV1 with the specific 
antagonist, A784168, in CB1R-/- TBC curtailed the action of ACEA on calcium response 
(Figure 39e). 
 
Figure 39. Effects of linoleic acid (LA) and cannabinoids on Ca2+ signalling in mouse TBC. Ca2+ 
imaging studies were performed in calcium-containing (100% Ca2+) buffer. The changes in free 
intracellular Ca2+ concentrations (ΔF340/F380) were monitored under the Nikon microscope (TiU) by 
using S-fluor 40x oil immersion objectives. Colored time-lapse changes show the kinetics of the rise in 
[Ca2+]i levels in taste bud cells freshly isolated from WT mice (a) and CB1R-/- mice (b) following addition 
of LA (25 µM) and the corresponding graphs below. Changes in [Ca2+]i evoked by combined addition 
of ACEA (1.5 µM) and LA (25 µM) in WT (c) and CB1R-/- TBC (d), respectively. Changes in [Ca2+]i 
evoked by ACEA (1.5 µM) after a 15 minutes preincubation with A784168, a TRPV1 antagonist, in 
CB1R-/- TBC (e). The arrow heads indicate when the test molecules were added. Variations in ΔF340/F380 
Ratio induced by LA (25 µM), ACEA (1.5 µM) and ACEA (1.5 µM) in combination with LA (25 µM) in 
WT and CB1R-/- mice TBC (f). Values are expressed as mean ± SEM (n=5). 
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2.6. CB1R blockade significantly decreases calcium responses triggered 
by LA, AEA and ACEA in WT TBC  
To further explore the role of CB1R on calcium signalling, we preincubated WT TBC with the 
specific CB1R antagonist rimonabant. As observed in Figure 40, rimonabant significantly 
abrogated [Ca2+]i responses, induced by LA, AEA and ACEA (Figure 40c) corroborating the 
previous results observed in CB1R-/- TBC.  
 
Figure 40. Effects of rimonabant on linoleic acid in mTBC (LA) and cannabinoids-induced Ca2+ 
signalling in mTBC. Ca2+ imaging studies were performed in calcium-containing (100% Ca2+) buffer. 
The changes in free intracellular Ca2+ concentrations (ΔF340/F380) were monitored under the Nikon 
microscope (TiU) by using S-fluor 40x oil immersion objectives. Graphs show the increase in [Ca2+]i in 
taste bud cells freshly isolated from WT mice following addition of LA (25 µM), anandamide (AEA, 5 
µM) and ACEA (1.5 µM) (a). WT TBC before the addition of LA (25 µM), AEA (5 µM) and ACEA (1.5 
µM) were preincubated (15 minutes) with rimonabant (50 µM) (b). The arrow heads indicate when the 
test molecules were added. Changes in ΔF340/F380 Ratio induced by LA (25 µM), AEA (5 µM), and 
ACEA (1.5 µM) in WT mice TBC after a preincubation with or without rimonabant (RIMO, 50 µM) (c). 
Values are expressed as mean ± SEM (n=5). 
2.7.  AEA-induced Ca2+-signalling is PLC dependent  
Finally, in order to validate our model, we investigated the downstream CB1R pathway 
elicited by AEA treatment. Here, we used DB-cAMP, a cAMP analog and a 
phosphodiesterase inhibitor, and U73122, a phospholipase C inhibitor. We observed that DB-
Results 
 
95/214 
Second part: Personal contributions  Modulation of fat preference by endocannabinoids 
cAMP did not significantly alter the Ca2+ response induced by AEA. Conversely, a 
pretreatment with U73122 significantly decreased the Ca2+ response, indicating that the Ca2+ 
response triggers a PLC-dependent Ca2+ signalling (Figure 41). 
 
Figure 41. Effects of DB-cAMP and U73122 on anandamide (AEA, 5 µM)-induced Ca2+ signalling in 
TBC. Ca2+ imaging studies were performed in calcium-containing buffer. The changes in free 
intracellular Ca2+ concentrations (ΔF340/F380) were monitored under the Nikon microscope (TiU) by 
using S-fluor 40× oil immersion objectives. Graphs show the increase in [Ca2+]i in taste bud cells freshly 
isolated from WT mice following addition of anandamide (AEA, 5 µM) with or without preincubation 
(20 min) with DB-cAMP (1 mM) or preincubation (20 min) with U73122 (10 µM) (left panel). The 
arrowhead indicates when the test molecules were added. Changes as histograms (right panel) in 
ΔF340/F380 Ratio induced by anandamide (AEA, 5 µM) in WT mice TBC after a preincubation with or 
without DB-cAMP (1 mM) or U73122 (10 µM). Values are expressed as mean ± SEM (n = 6). 
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3. Discussion  
Williams and Kirkham (1999) demonstrated that CB1R is responsible for increased food 
intake, induced by an endocannabinoid agonist. Later on, Yoshida et al. (2010) revealed that 
endocannabinoids enhanced the gustatory responses to sweet tastants via CB1R. Indeed, the 
activation of endocannabinoid system (ECS) appears to be associated with hyperphagia and a 
preference for palatable food. Interestingly, CB1R are also expressed in a subset of taste bud 
cells (Yoshida et al., 2010). We report here that CB1R−/− mice displayed no preference for fat 
solutions compared to WT mice. The same behaviour was also observed when WT mice were 
treated with rimonabant, a CB1R blocker, confirming the role for this receptor in the detection 
of dietary lipids. We have employed LA as a candidate for LCFA because this fatty acid is 
abundantly present in Western food; however, it is possible that the saturated fatty acids like 
palmitic acid (PA) might also initiate the same gustatory response. Indeed, we have shown 
previously that LA and PA triggered the same increases in [Ca2+]i in mouse taste bud cells 
(Gaillard et al., 2008).  
In the present study, for behavioural experiments, we used whole body knockout mice for 
CB1R, and it is possible that the hypothalamic cannabinoid system, via the dopaminergic area, 
might be involved in fat taste preference (Melis et al., 2013c). Nonetheless, we sought to 
elucidate cellular mechanisms in the modulation of fat preference. We first tested the 
hypothesis whether there is an alteration in CD36 and GPR120 protein in TBC of CB1R−/− 
mice. In our study, CD36 and GPR120 protein expressions were not altered by the absence of 
CB1R, suggesting that the absence of preference for fatty solutions may be due to altered 
downstream signalling. Moreover, we checked the delivery of linoleic acid under both 
conditions, and we observed identical uptake of exogenous fatty acid. 
Previous studies indicated that both CD36 and GPR120 activation by a LCFA triggered 
mobilization of [Ca2+]i from the intracellular endoplasmic reticulum Ca2+ pool during fat taste 
perception (Galindo et al., 2012; Ozdener et al., 2014). In our study, we show, for the first 
time, that LA-mediated increase in [Ca2+]i was altered when CB1R was inactivated by 
rimonabant or by the absence of CB1R. In addition, the CB1R agonist ACEA also increased 
calcium flux per se in TBC, albeit with lower potency than LA. However, the effect of ACEA 
was maintained in TBC from CB1R−/− mice, raising the possibility that the increase in [Ca2+]i 
could be mediated by the receptors other than CB1R, for example, TRPV1. Indeed, it has been 
shown that activation of TRPV1 by endocannabinoids induces calcium signalling (Kentish 
and Page, 2015; Ryskamp et al., 2014). Besides, blockade of TRPV1 with A784168 totally 
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abolished [Ca2+]i response induced by ACEA, indicating that the residual calcium signal 
observed in CB1R−/− TBC with ACEA may be due to TRPV1 activity. Furthermore, it appears 
that the CB1R-coupled downstream signalling is PLC-dependent, in accordance with the 
observations of De Petrocellis et al. (2007). However, it remains to be elucidated in future 
whether anandamide, employed in the present study, activates the Gβδ subunit of CB1R, and 
activates PLC via PI-3-kinase pathway. As a whole, our data indicate that CB1R may play a 
crucial role in fat taste perception by modulating calcium signalling. 
As previously described, GLP-1−/− mice have reduced taste responses to dietary fat, 
suggesting that orosensory detection of LCFA could be associated to the secretion of lingual 
GLP-1 (Martin et al., 2012). Data reported herein showed that the secretion of active GLP-1 
induced by LA is strongly decreased in CB1R−/− mice suggesting the existence of a link 
between CB1R signalling and GLP-1 production. Hence, CB1R activation may stimulate 
proglucagon and GLP-1r production and, therefore, modulate perception threshold of LCFA. 
Further investigations are needed to explore the possibility whether GLP-1 secretion is 
stimulated via [Ca2+]i signalling in TBC or by other mechanisms (Takai et al., 2015). 
In conclusion, the present report shows that CB1R influences fat taste perception via 
regulating calcium signalling in TBC (Figure 38). It is proposed that CB1R activation induces 
a [Ca2+]i response that strengthens fat perception, that is mediated by CD36. Activation of 
ECS could, thereby, increase sensory stimuli relaying palatability of foods and, ultimately, 
stimulate food intake. The physiopathological relevance of such a regulatory pathway is 
supported by the fact that ECS tone is increased in obesity.  
These results suggest that by correcting the effects of the ECS as early as in the oral cavity we 
could modulate the orosensory detection of dietary lipids. We proposed the following 
schematic model summarizing the results obtained and the potential lingual CB1R 
involvement (Figure 42). Hence, a local action specifically targeting the lingual CB1R 
(enhancing or antagonizing), thus avoiding side effects that occurred with rimonabant 
treatment, would be likely to improve overweight or cancer patient care.  
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Figure 42. Schematic model of the proposed CB1R involvement in TBC. Modified from Gilbertson 
and Khan (2014) including the obtained results regarding the CB1 receptor and its interaction with 
CD36 and GPR120. 
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Abstract: Obesity is one of the major public health issues, and its prevalence is steadily increasing
all the world over. The endocannabinoid system (ECS) has been shown to be involved in the intake
of palatable food via activation of cannabinoid 1 receptor (CB1R). However, the involvement of
lingual CB1R in the orosensory perception of dietary fatty acids has never been investigated. In the
present study, behavioral tests on CB1R
−/− and wild type (WT) mice showed that the invalidation of
Cb1r gene was associated with low preference for solutions containing rapeseed oil or a long-chain
fatty acid (LCFA), such as linoleic acid (LA). Administration of rimonabant, a CB1R inverse agonist,
in mice also brought about a low preference for dietary fat. No difference in CD36 and GPR120
protein expressions were observed in taste bud cells (TBC) fromWT and CB1R
−/− mice. However,
LCFA induced a higher increase in [Ca2+]i in TBC from WT mice than that in TBC from CB1R
−/−
mice. TBC from CB1R
−/− mice also exhibited decreased Proglucagon and Glp-1rmRNA and a low
GLP-1 basal level. We report that CB1R is involved in fat taste perception via calcium signaling and
GLP-1 secretion.
Keywords: nutrition; lipids; fat taste; CD36; feeding behavior; cannabinoids; CB1R; GLP-1
1. Introduction
Due to the abundance of food resources in the modern era, the Western diet is comprised of more
than 40% of fat, thereby contributing to the increase in the prevalence of obesity that is associated with
a number of pathologies (type 2 diabetes mellitus, hypertension, cancer, and others).
The taste modalities represent an essential factor involved in food intake. It is nowwell established
that obese subjects exhibit higher spontaneous preference for fat than lean subjects [1,2]. Recent studies
have proposed the existence of a sixth taste modality dedicated to the orosensory perception of dietary
fat. The CD36 (cluster of differentiation 36) has been suggested to act as lingual lipid receptor [3].
The binding of a fatty acid to lingual CD36 in taste bud cells (TBC) leads to modifications in the
membrane potential and to an increase in free intracellular calcium concentrations, [Ca2+]i, followed
by the release of neurotransmitters [4,5]. These gustatory signals are transmitted from the oral cavity,
through the cranial nerve IX (lingual branch of the glossopharyngeal), to the nucleus of the solitary
tract (NST) [6]. The NST is connected to different brain areas associated with food intake, rewarding,
memory, and processes integrating visceral signals [7,8]. Hence, the integration of the gustatory signals
in brain triggers a behavioral and metabolic response [8].
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GPR120 (G protein-coupled receptor 120) has also been proposed to play a role in fat-related
regulation of satiation [8,9]. Nevertheless, GPR120 does not seem to have a major role in oral fat
detection. Indeed, contradictory results have been reported for behavioral tests in GPR120−/−
mice [10–12]. However, the implication of GPR120 in the release of the incretin hormone glucagon-like
peptide-1 (GLP-1) has been highlighted in mouse taste bud cells [9,13]. Thus, CD36 is likely to play
a role in the detection of dietary fatty acids in TBC, whereas GPR120 would be implicated in the
modulation of postprandial fat taste sensitivity.
The presence of GLP-1 and its receptor in the gustatory mucosa has been demonstrated [9,14,15],
suggesting that taste bud cells may modulate taste perception in an autocrine or a paracrine
manner. Indeed, linoleic acid (LA) has been reported to induce GLP-1 release in human TBC in
a GPR120-dependent manner [9]. Martin et al. [13] have suggested that GLP-1 is locally active and
might affect the basic functions in mouse taste buds. Besides, Shin et al. [15] showed that local GLP-1
signaling could enhance sweet-taste sensitivity, supporting the existence of a paracrine mechanism for
the regulation of taste function.
The implication of the endocannabinoid system in the regulation of food intake is well
documented [16–20]. Several studies have demonstrated that exogenous cannabinoids, like delta
9-tetrahydrocannabinol (∆9-THC) or anandamide (AEA), induce hyperphagia and preference for
palatable food [18,19] via cannabinoid-1 receptors (CB1R) [21]. Therefore, the CB1R blocker/inverse
agonist, rimonabant, has been used in the treatment of obesity [22–24].
Being largely expressed in the central and peripheral nervous system, CB1R has also been detected
in TBC, and it has been shown that the activation of these receptors by cannabinoids enhances sweet
taste [7]. However, the involvement of lingual CB1R in fat taste perception has never been investigated.
Considering that the increase in dietary fat intake plays an important role in the prevalence of obesity,
the present investigation was designed to assess whether the activation of CB1R in TBC is associated
with the altered orosensory perception of dietary lipids in CB1R
−/− and wild type (WT) mice.
2. Materials and Methods
2.1. Ethical Approval
French guidelines for the use and care of laboratory animals were followed, and the experimental
protocols were approved by the regional animal ethic committee of the University of Burgundy. In vivo
studies were performed on male C57BL/6J wild type (WT) mice (Janvier Labs, Le Genest Saint Isle,
France) and CB1R
–/– mice (generous gift from Dr. James Pickel, National Institute of Mental Health,
Bethesda, MD, USA) with a C57BL/6J background. Animals were individually housed in a controlled
environment (constant temperature and humidity, dark period from 19:00 to 7:00). The mice had free
access to standard regular chow and tap water during the experiments, unless otherwise specified.
2.2. Behavioral Experiments
2.2.1. Two-Bottle Preference Tests
After being deprived of water for 6 h, mice were offered simultaneously two bottles, containing
either control or experimental solution for 12 h. To minimize bias due to textural properties, the two
solutions contained 0.3% xanthan gum (w/v, Sigma, Saint Quentin-Fallavier, France), whereas the
experimental solutions were added with either 0.2% rapeseed oil (w/v, Fleur de Colza, Lesieur,
France) or 0.2% linoleic acid (w/v, LA, Sigma). At the end of each test, the intake of control and
experimental solutions was recorded by weighing the feeders/bottles. The experiments were repeated
two times, independently.
In parallel, two groups (n = 5 each) of 10 WT mice, treated daily with rimonabant (SR141716,
10 mg/kg of body weight, Sanofi, Paris, France) or vehicle (0.1% DMSO/0.025% Tween 80 in 0.9%
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NaCl), by an intraperitoneal injection for 26 days, were subjected to the same two-bottle preference
test. Food intake and weight were monitored during the experiment.
2.2.2. Licking Tests
The CB1R
−/− (n = 9) and WT (n = 9) mice were deprived of food and water for 6 h before the test.
The mice were conditioned to choose between a palatable (4% sucrose) and a control solution. Once the
mice were conditioned, they were randomly subjected to two-bottle test, containing either control
(0.3% xanthan gum) or a test solution (0.3% xanthan gum + 0.2% linoleic acid, LA). The number of
licks, motivated by each bottle, were recorded using computer-controlled lickometers (Med Associates,
Fairfax, VT, USA). Data were analyzed for 5 min from the first lick.
2.3. Papillae and Taste Buds Isolation
The mice were anesthetized with 2% isoflurane gas, and then sacrificed by cervical dislocation.
Taste bud cells (TBC) were isolated according to previously published procedure [4]. In brief, lingual
epithelium was separated from connective tissues by enzymatic dissociation (elastase and dispase
mixture, 2 mg/mL each in Tyrode buffer: 120 mM NaCl, 5 mM KCl, 10 mM HEPES, 1 mM CaCl2,
10 mM glucose, 1 mM MgCl2, 10 mM Na pyruvate, pH 7.4). Samples were frozen immediately in
liquid nitrogen and stored at −80 ◦C (not exceeding one month) until RNA extraction, or lysed in
a buffer for Western blot analyses. For real-time qPCR and Western blot, each point corresponds to
a pool of TBC from four mice.
2.4. Real-Time qPCR
Total RNA from CB1R
−/− and WT TBC (n = 6) was extracted by using TRIzol method
according to the manufacturer’s recommendations (Invitrogen, Cergy-Pontoise, France). After
purification, mRNA was resuspended in RNase free water. The samples were then analyzed
and quantified using Traycell (Hellma Analytics, Müllheim, Germany). Samples having a purity
(A260/A280) between 1.80 and 2.00 were retained for the rest of the experiment. mRNA (500
ng) was reverse-transcribed into cDNA using M-MLV reverse transcriptase (Invitrogen) in a 20
µL of reaction volume containing 5 µL mRNA, 1 µL random primer (100 ng/µL) (Invitrogen),
0.4 µL dNTP (25 mM), 8.6 µL RNase-free water. After incubation for 5 min at 65 ◦C, 2 µL 5×
First-Strand Buffer, 1 µL DTT, 1 µL M-MLV (200 UI) and 1 µL RNaseOUT were added, and the
samples were incubated for 1 h at 42 ◦C and then for 15 min at 70 ◦C. Real time qPCR reactions
were performed on 10 ng cDNA in a 20 µL of reaction volume in triplicates with a StepOnePlus
(Life Technologies, Saint-Aubin, France) device with the use of SYBR green PCR Master Mix (Life
Technologies, Saint-Aubin, France). For each gene, a standard curve was established from five
cDNA dilutions (50 ng to 0.05 ng per well) and used to determine the PCR efficiency. Forward and
reverse primer sequences used for amplification were 5′-GGACACATGAAGTCATCTTTGCCT-3′
and 5′-CAAGCCCTGGAAGGAAGTGAAGGA-3′ for Glp-1r (NM_021332), 5′-TGCTGAAGG
GACCTTTACCAGTGA-3′ and 5′-GCCTTTCACCAGCCAAGCAATGAA-3′ for Gcg (NM_008100), and
5′- TTCTTTGCAGCTCCTTCGTT-3′ and 5′-ATGGAGGGGAATACAGCCC-3′ for β-actin (NM_007393).
The amplicon size for Glp-1r is 107 bp and is located in the exon 11 and 12; for Gcg is 85 bp and is
located in the exon 4; for β-actin is 149 bp and is located in the exon 1 and 2. Real time qPCR reactions
were performed with a denaturing step of 95 ◦C for 10 min, followed by 40 cycles of 95 ◦C for 15 s
and 60 ◦C for 1 min. The primer specificity was checked using the melt curves. The PCR efficiency
was calculated as follow 10−1/slope − 1. The parameters for GLP-1r were as follows: slope −3.241,
y intercept 33.848, R2 0.98, and PCR efficiency 1.03; Gcg: slope −3.527, y intercept 29.296, R2 0.92, and
PCR efficiency 0.92; and β-actin: slope −2.837, y intercept 29.296, R2 0.996, and PCR efficiency 1.25.
The comparative 2−∆∆CT method was used for relative quantification.
Nutrients 2018, 10, 1347 4 of 12
2.5. Western Blotting
Freshly isolated mouse TBC were lysed using a micro-potter in 20 µL of TSE buffer (50 mM
Tris HCl, 150 mM NaCl, 1 mM EDTA, 1% Nonidet P40, 5 µL/mL protease inhibitors (Sigma)) [25].
Samples were stored on ice for 30 min, and then centrifuged (10,000 g, 10 min, 4◦C). Lysates were
used immediately or stored at −80 ◦C until the assay. Protein concentrations in homogenates were
assayed using the BCA assay (Sigma, Saint Quentin-Fallavier, France). Denatured proteins (25 µg) were
separated by SDS-PAGE (8%) and transferred to a polyvinylidene difluoride membrane. After being
blocked for 3 h using a TBS buffer containing 5% BSA and 0.05% Tween-20, the membrane was
incubated overnight with either of the antibodies: anti-CD36 antibody (R&D Systems, AF2519;
1:1000), anti-GPR120 antibody (Abcam, Paris, France, ab97272; 1:500), anti-α-gustducin antibody
(Santa Cruz, Heidelberg, Germany, sc-395; 1:200) and anti-β-actin antibody (Santa Cruz, Heidelberg,
Germany, sc-47778; 1:5000). The α-gustducin was used as an internal reference protein. After a set of
washes, the appropriate peroxidase-conjugated secondary antibody was added. Antibody labeling
was detected by chemiluminescence (Clarity, Bio-Rad, Marnes-la-Coquette, France).
2.6. Tissue Culture of TBC and GLP-1 Release
Papillae fromWT and CB1R
−/− mice were isolated and incubated at 36 ◦C. The incubation media
contained either 33 µM fatty acid-free BSA alone (control group) or 200 µM linoleic acid (LA) mixed
and vortexed with 33 µM fatty acid-free BSA. After 2 h of incubation, the media were collected, and the
active GLP-1 release was measured by ELISA (Millipore S.A.S., Molsheim, France). As the secretion of
GLP-1 by TBC is very low, to be sure to detect active GLP-1 in the incubation medium, 10 pM of pure
GLP-1 was systematically added in each experimental well, but not in standard curve, according to the
manufacturers’ recommendations. The dipeptidyl peptidase 4 (DPP4) inhibitor (0.1%, Millipore) was
added to the medium to prevent GLP-1 degradation.
2.7. Measurement of Ca2+ Signaling
TBC were freshly isolated from mouse tongues as described by Dramane et al. [26]. The cells were
cultured onto 24-well plates, containing RPMI-1640 medium, supplemented with 10% fetal calf serum,
2 mM glutamine, 50 µg/mL penicillin–streptomycin, and 20 mM HEPES, and incubated overnight at
37 ◦C. The next day, the supernatant was discarded. The cells were then incubated with Fura-2/AM
(Invitrogen) at 1 µM for 30 min at 37 ◦C in loading buffer which contained the following: 110 mMNaCl,
5.4 mM KCl, 25 mM NaHCO3, 0.8 mMMgCl2, 0.4 mM KH2PO4, 20 mM Hepes, 1.2 mM CaCl2, 10 mM
Glucose; pH 7.4. After adding the test molecules into the wells, the changes in intracellular free Ca2+
(F340/F380) were monitored under the Nikon microscope (TiU) by using S-fluor 40× oil immersion
objective. NIS-Elements software was used to record the images. The microscope was equipped with
Lucas EM-CCD (Andor Technology, Gometz-le-châtel, France) camera for real-time recording of 16-bit
digital images. The dual excitation fluorescence imaging system was used to analyze individual cells.
The changes in intracellular free Ca2+ were expressed as ∆Ratio, calculated as the difference between
F340 and F380. All test molecules were added in small volumes with no interruption in recordings.
For Ca2+ signaling experiments, the fatty acid was dissolved in ethanol (0.1%, v/v) and added into the
experimental cuvette.
Anandamide (AEA, CB1R endogenous ligand), arachidonyl-2
′-chloroethylamide (ACEA, CB1R
synthetic ligand), LA, DB-cAMP, and U73122 were supplied by Sigma (Saint Quentin-Fallavier, France).
A784168, TRPV1 (transient receptor potential vanilloid 1) antagonist, and rimonabant (CB1R inverse
agonist) were provided by Tocris (Bio-Techne, Lille, France) and Sanofi (Paris, France), respectively.
2.8. Statistics
Results are expressed as means ± SEM. The significance of differences between groups was
evaluated with GraphPad Prism (GraphPad Software, La Jolla, CA, USA) using two-tailed Student’s
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t-test or two-way ANOVA with Bonferroni correction. A p value of less or equal 0.05 was considered
to be statistically significant.
3. Results
3.1. The Absence of CB1R Gene Induces a Low Preference for Fatty Solutions Independently of
Postprandial Factors
CB1R
−/− mice displayed a significant decrease in the preference for the fatty solutions (rapeseed
oil and LA) compared to wild type mice (Figure 1a,b). Hormonal post-ingestive regulatory feedback
greatly influences metabolism and appetite and, consequently, behavior during long-term two-bottle
preference tests [27] under CB1R activation [28]. Therefore, we performed short-term licking tests to
measure fat preference limiting post-ingestive cues. LA was chosen among other LCFAs because it
showed the best results in two-bottle preference tests. As shown in Figure 1c, the number of licks
for LA was significantly higher in WT mice than in CB1R
−/− mice, confirming the low preference in
CB1R
−/− mice for fatty solutions.
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Figure 1. Effect of CB1R gene invalidation on preference for lipids. Two bottles (control
and experimental) were simultaneously offered to wild type (WT) and CB1R
−/− mice for 12 h.
The experimental solution contained (a) 0.2% of rapeseed oil (w/v); (b) 0.2% of linoleic acid (w/v)
diluted in xanthan gum. The control solution contained 0.3% of xanthan gum (w/v). Values are
expressed as mean ± SEM (n = 10). Dotted line represents the absence of preference in CB1R
−/−
mice (less than 50% of preference). (c) Short-term (5 min) licking tests in WT and CB1R
−/− mice
were performed as described in Materials and Methods. Animals were subjected to a control solution
(xanthan gum) and an experimental solution containing 0.2% of linoleic acid. Values are expressed as
mean ± SEM (n = 9).
3.2. Treatment with Rimonabant Induces a Low Preference for Fat Solutions and Does Not Alter
Feeding Behavior
The mice treated with rimonabant for 26 days exhibited the same behavior as CB1R
−/− mice,
i.e., a low preference for fatty solutions (Figure 2a,b). Interestingly, the mice treated with rimonabant
did not show reduced food intake or body weight (Figure 2c). As the rimonabant induces an early and
transient effect, we monitored these parameters for 5 days before starting two-bottle preference tests.
Thus, no bias interfered with the behavioral experiments.
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Figure 2. Effect of rimonabant on preference for lipids, body weight, and feeding behavior. (a,b) WT
mice, treated with either rimonabant (10 mg·kg−1·day−1) or vehicle (CTRL), were simultaneously
offered two bottles, a control one and an experimental one. The latter bottle contained either 0.2%
of rapeseed oil (w/v) (a) or 0.2% of linoleic acid (w/v) (b) diluted in xanthan gum. Control solution
contained 0.3% of xanthan gum. Values are expressed as mean± SEM (n = 5). Dotted line represents the
absence of preference in rimonabant-treatedmice (less than 50% of preference). (c) Food intake and body
weight variations in mice treated or not with rimonabant and fed a standard chow. Values are expressed
as mean ± SEM (n = 5). Black arrows indicate the beginning of the treatment with rimonabant.
3.3. CD36 and GPR120 Protein Expressions Are Not Altered in TBC of CB1R
−/− Mice
CB1R gene invalidation did not interfere with CD36 and GPR120 protein expression in taste buds
from CB1R
−/− (Figure 3). α-Gustducin, a marker of type II TBC, remained stable (Figure 3). It seems
that the low preference for fatty solutions observed in CB1R
−/− mice was not due to altered expression
of CD36 and GPR120.
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Figure 3. Impact of CB1R gene invalidation on CD36 and GPR120 protein expressions. CD36 and
GPR120 protein levels were measured by Western blotting in taste bud cells (TBC) (n = 2) from WT
and CB1R
−/− mice. (a) A representative blot corresponding to a pool of total proteins from four mice
TBC is shown. (b) The corresponding histogram shows CD36 and GPR120 protein levels. Values are
expressed as mean ± SD (n = 2).
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3.4. CB1R Gene Invalidation Induces a Decrease in Proglucagon and GLP-1r mRNA and Basal GLP-1 Level
Proglucagon and GLP-1rmRNA levels were significantly lower in CB1R
−/− TBC than WT TBC
(Figure 4a). According to previously published data [9], LA induces the release of GLP-1 from mouse
TBC. To measure the release of active GLP-1, the mouse TBC were incubated for 2 h in an oxygenized
medium containing anti-DPP4, to prevent GLP-1 degradation, and exposed, or not, to 200 µM LA.
In CB1R
−/− mice TBC, GLP-1 release in the culture medium was significantly lower than that in WT
TBC, in both basal and LA-stimulated conditions. As expected, LA induced a small, but significant,
release of active GLP-1 in culture medium of WT TBC (Figure 4b).
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Figure 4. Effect of CB1R gene invalidation on GLP-1. (a) Proglucagon (Gcg) and GLP-1rmRNA levels
were assayed by real-time qPCR in mouse TBC fromWT and CB1R
−/− mice. Values are expressed as
mean± SEM (n = 6). (b) ELISA results showing GLP-1 release by freshly isolated mouse TBC incubated
for 2 h in the presence of 33 µM fatty acid-free BSA alone (CTRL) or with 200 µM linoleic acid (LA).
Each value corresponds to the GLP-1 released by cultured TBC. We independently reproduced the
results twice, by using, each time, TBC from three mice. We observed identical results, and we pooled
them. Each point represents values as mean ± SD (n = 6).
3.5. Both LA and Cannabinoids Induce CB1R-Dependent Ca
2+ Responses in TBC
In mouse TBC, LCFA evokes increases in Ca2+ signaling [26]. As expected, LA triggered
a higher rise in [Ca2+]i in WT TBC [6] (Figure 5a,f) than that in CB1R
−/− TBC (Figure 5b,f). Similarly,
arachidonyl-2′-chloroethylamide (ACEA, a specific CB1R agonist), induced a rise in [Ca
2+]i in WT
TBC (Figure 5f). However, ACEA triggered a significantly lower increase in [Ca2+]i in CB1R
−/− TBC
than that in WT TBC (Figure 5f). Finally, the combination of LA and ACEA also induced a strong rise
in [Ca2+]i in WT TBC (Figure 5c,f) corresponding to the combined effect of the two molecules that
was not apparent in CB1R
−/− TBC (Figure 5d,f). Interestingly, when tested on CB1R
−/− TBC, ACEA
still triggered a rise in [Ca2+]i (Figure 5f). Furthermore, blockade of TRPV1 with a specific antagonist,
A784168, in CB1R
−/− TBC curtailed the action of ACEA on calcium response (Figure 5e).
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Figure 5. Effects of linoleic acid (LA) and cannabinoids on Ca2+ signaling in mouse TBC. Ca2+ imaging
studies were performed in calcium-containing (100% Ca2+) buffer. The changes in free intracellular
Ca2+ concentrations (∆F340/F380) were monitored under the Nikon microscope (TiU) by using S-fluor
40× oil immersion objectives. Colored time-lapse changes show the kinetics of the rise in [Ca2+]i levels
in taste bud cells freshly isolated fromWT mice (a) and CB1R
−/− mice (b) following addition of LA
(25 µM) and the corresponding graphs below. Changes in [Ca2+]i evoked by combined addition of
ACEA (1.5 µM) and LA (25 µM) in WT (c) and CB1R
−/− TBC (d), respectively. Changes in [Ca2+]i
evoked by ACEA (1.5 µM) after a 15 min preincubation with A784168, a TRPV1 antagonist, in CB1R
−/−
TBC (e). The arrowheads indicate when the test molecules were added. Variations in ∆F340/F380 Ratio
induced by LA (25 µM), ACEA (1.5 µM), and ACEA (1.5 µM), in combination with LA (25 µM), in WT
and CB1R
−/− mice TBC (f). Values are expressed as mean ± SEM (n = 5).
3.6. CB1R Blockade Significantly Decreases Ca
2+ Responses Triggered by LA, AEA, and ACEA in WT TBC
To further explore the role of CB1R on calcium signaling, we preincubated WT TBC with a specific
CB1R inverse agonist rimonabant. As observed in Figure 6, rimonabant significantly abrogated [Ca
2+]i
responses, induced by LA, AEA, and ACEA (Figure 6c), corroborating the previous results observed in
CB1R
−/− TBC.
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Figure 6. Effects of rimonabant on linoleic acid (LA) ca nabinoid-in uced Ca2+ signaling in TBC.
Ca2+ imaging studies were performed in calcium-containing buffer. The changes in free intracellular
Ca2+ concentrations (∆F340/F380) were monitored under the Nikon microscope (TiU) by using S-fluor
40× oil immersion objectives. Graphs show the increase in [Ca2+]i in taste bud cells freshly isolated
from WT mice following addition of LA (25 µM), anandamide (AEA, 5 µM), and ACEA (1.5 µM)
(a). WT TBC before the addition of LA (25 µM), AEA (5 µM) and ACEA (1.5 µM) were preincubated
(15 min) with rimonabant (50 µM) (b). The arrowheads indicate when the test molecules were added.
Changes in ∆F340/F380 Ratio induced by LA (25 µM), AEA (5 µM), and ACEA (1.5 µM) in WT mice
TBC after a preincubation with or without rimonabant (RIMO, 50 µM) (c). Values are expressed as
mean ± SEM (n = 5).
3.7. AEA-Induced Ca2+-Signaling Is PLC Dependent
Finally, in order to validate our model, we investigated the downstream CB1R pathway elicited
by AEA treatment. Here, we used DB-cAMP, a cAMP analog and a phosphodiesterase inhibitor, and
U73122, a phospholipase C inhibitor. We observed that DB-cAMP did not significantly alter the Ca2+
response induced by AEA. Conversely, a pretreatment with U73122 significantly decreased the Ca2+
response, indicating that the Ca2+ response triggers a PLC-dependent Ca2+ signaling (Figure 7).
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Figure 7. Effects of DB-cAMP and U73122 on anandamide (AEA, 5 µM)-induced Ca2+ signaling in TBC.
Ca2+ imaging studies were performed in calcium-containing buffer. The changes in free intracellular
Ca2+ concentrations (∆F340/F380) were monitored under the Nikon microscope (TiU) by using S-fluor
40× oil immersion objectives. Graphs show the increase in [Ca2+]i in taste bud cells freshly isolated
from WT mice following addition of anandamide (AEA, 5 µM) with or without preincubation (20 min)
with DB-cAMP (1 mM) or preincubation (20 min) with U73122 (10 µM) (left panel). The arrowhead
indicates when the test molecules were added. Changes as histograms (right panel) in ∆F340/F380 Ratio
induced by anandamide (AEA, 5 µM) in WT mice TBC after a preincubation with or without DB-cAMP
(1 mM) or U73122 (10 µM). Values are expressed as mean ± SEM (n = 6).
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4. Discussion
Williams and Kirkham [19] demonstrated that CB1R is responsible for increased food intake,
induced by an endocannabinoid agonist. Later on, Yoshida et al. [7] revealed that endocannabinoids
enhanced the gustatory responses to sweet tastants via CB1R. Indeed, the activation of endocannabinoid
system (ECS) appears to be associated with hyperphagia and a preference for palatable food.
Interestingly, CB1R are also expressed in a subset of taste bud cells [7]. We report here that CB1R
−/−
mice displayed no preference for fat solutions compared to WT mice. The same behavior was also
observed when WT mice were treated with rimonabant, a CB1R blocker, confirming the role for this
receptor in the detection of dietary lipids. We have employed LA as a candidate for LCFA because
this fatty acid is abundantly present in Western food; however, it is possible that the saturated fatty
acids like palmitic acid (PA) might also initiate the same gustatory response. Indeed, we have shown
previously that LA and PA triggered the same increases in [Ca2+]i in mouse taste bud cells [6].
In the present study, for behavioral experiments, we used whole body knockout mice for CB1R,
and it is possible that the hypothalamic cannabinoid system, via the dopaminergic area, might be
involved in fat taste preference [28]. Nonetheless, we sought to elucidate cellular mechanisms in the
modulation of fat preference. We first tested the hypothesis whether there is an alteration in CD36
and GPR120 protein in TBC of CB1R
−/− mice. In our study, CD36 and GPR120 protein expressions
were not altered by the absence of CB1R, suggesting that the absence of preference for fatty solutions
may be due to altered downstream signaling. Moreover, we checked the delivery of linoleic acid under
both conditions, and we observed identical uptake of exogenous fatty acid.
Previous studies indicated that both CD36 and GPR120 activation by a LCFA triggered
mobilization of [Ca2+]i from the intracellular endoplasmic reticulum Ca
2+ pool during fat taste
perception [9,29]. In our study, we show, for the first time, that LA-mediated increase in [Ca2+]i was
altered when CB1R was inactivated by rimonabant or by the absence of CB1R. In addition, the CB1R
agonist ACEA also increased calcium flux per se in TBC, albeit with lower potency than LA. However,
the effect of ACEA was maintained in TBC from CB1R
−/− mice, raising the possibility that the increase
in [Ca2+]i could be mediated by the receptors other than CB1R, for example, TRPV1. Indeed, it has
been shown that activation of TRPV1 by endocannabinoids induces calcium signaling [30,31]. Besides,
blockade of TRPV1 with A784168 totally abolished [Ca2+]i response induced by ACEA, indicating
that the residual calcium signal observed in CB1R
−/− TBC with ACEA may be due to TRPV1 activity.
Furthermore, it appears that the CB1R-coupled downstream signaling is PLC-dependent, in accordance
with the observations of De Petrocellis et al. [32]. However, it remains to be elucidated in future whether
anadamide, employed in the present study, activates the Gβγ subunit of CB1R, and activates PLC
via PI-3-kinase pathway. As a whole, our data indicate that CB1R may play a crucial role in fat taste
perception by modulating calcium signaling.
As previously described, GLP-1−/− mice have reduced taste responses to dietary fat, suggesting
that orosensory detection of LCFA could be associated to the secretion of lingual GLP-1 [13].
Data reported herein showed that the secretion of active GLP-1 induced by LA is strongly decreased
in CB1R
−/− mice suggesting the existence of a link between CB1R signaling and GLP-1 production.
Hence, CB1R activation may stimulate proglucagon and GLP-1r production and, therefore, modulate
perception threshold of LCFA. Further investigations are needed to explore the possibility whether
GLP-1 secretion is stimulated via [Ca2+]i signaling in TBC or by other mechanisms [33].
In conclusion, the present report shows that CB1R influences fat taste perception via regulating
calcium signaling in TBC. It is proposed that CB1R activation induces a [Ca
2+]i response that
strengthens fat perception, that is mediated by CD36. Activation of ECS could, thereby, increase sensory
stimuli relaying palatability of foods and, ultimately, stimulate food intake. The physiopathological
relevance of such a regulatory pathway is supported by the fact that ECS tone is increased in obesity.
Hence, the ECS seems to emerge as a key modulator of oral sweet and fat detection and may represent
a potential target for developing new anti-obesity strategies or, conversely, for enhancing food intake
in the case of loss of appetite as it occurs in cachexia.
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1. Material & Methods 
1.1. Cell culture 
HTC-8 cells were kindly provided by BRAIN (Zwingenberg, Germany). HFFC and Ulduz-1 
cell lines are human TBC that escaped death, not immortalized cells, and were provided by 
Mehmet Hakan Ozdener (USA). 
HTC-8, HFFC and Ulduz-1 cells were cultured in HTC-medium ,i.e., Basal Iscove Medium 
supplemented with GlutaMAX (Gibco) containing 20% MCDB 153 Basal Medium (Sigma), 
10% FCS (Dutsher), 1% antibiotic/antimicotic 100X (Sigma), 2.5 µg/ml Gentamycin (Gibco) 
and 10 µg/ml Insulin (Sigma). 
TAS2R38 overexpressing cells (HTC-8:TAS2R38) were cultured in HTC-medium added with 
0.5 µg/ml Puromycin (Sigma). 
1.2. Immunocytochemistry 
Cells were fixed in glacial ethanol 95% for 20 min. cells were blocked for 1 h with PBS 
containing 5% BSA and 0.2% Triton X-100. Next, the cells were incubated overnight at 4°C 
with a primary antibody. After washing, cells were incubated for 2 h at room temperature with 
a fluorescent anti-rabbit secondary antibody (Invitrogen, Alexa 488; 1:500). Regarding the co-
expression assay, the cells were washed and blocked again before adding an anti-TAS2R16 
primary antibody (Osenses, OST00468W; 1:300) or an anti-TAS2R38 primary antibody 
(Osenses, OST00440W; 1:300). Cells were next incubated with a fluorescent anti-rabbit 
secondary antibody (Invitrogen, Alexa 568; 1:500) and then all the cells were counterstained 
with DAPI (Sigma, 0.1µg/ml) to stain the nuclei. Fluorescence was analyzed under a Cell 
Observer (Zeiss). 
Table 3 : Liste of primary antibodies used in immunocytochemistry 
Primary antibody Reference Supplier Dilution 
CD36 HPA002018 Atlas Antibodies 1:50 
GNAT3/α-gustducin PA5-23986 ThermoFisher 1:50 
GPR120 sc-99105 Santa Cruz 1:50 
PLCβϮ sc-206 Santa Cruz 1:50 
TAS2R16 OST00468W Osenses 1:300 
TAS2R38 OST00440W Osenses 1:300 
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1.3. Real-time qPCR 
Total RNA from 2x106 were extracted by using TRIzol method according to the 
manufacturer’s recommendations (Invitrogen, Cergy-Pontoise, France). After purification, 
mRNA was resuspended in RNase free water. The samples were then analyzed and quantified 
using Traycell (Hellma Analytics, Müllheim, Germany). Samples having purity (A260/A280) 
between 1.80 and 2.00 were retained for the rest of the experiment. mRNA (1 µg) was 
reverse-transcribed into cDNA using  High Capacity RNA-to-cDNA kit (Applied Biosystems) 
and the samples were incubated for 1 h at 37 °C and then for 5 min at 95 °C.  
Real time qPCR reactions were performed on 10 ng cDNA in a 20 µL of reaction volume in 
triplicates with a StepOnePlus (Life Technologies, Saint-Aubin, France) device with the use 
of SYBR green PCR Master Mix (Life Technologies, Saint-Aubin, France). For each gene 
(Table 4), a standard curve was established from five cDNA dilutions (100 ng to 0.1 ng per 
well) and used to determine the PCR efficiency. Real time qPCR reactions were performed 
with a denaturing step of 95 °C for 10 min, followed by 40 cycles of 95 °C for 15 s and 60 °C 
for 1 min. The primer specificity was checked using the melt curves. The comparative 2−ΔΔCT 
method was used for relative quantification.  
Table 4 : List of primers 
Taste receptors 
CD36 Forward TCTGTGCCTGTTTTAACCCAA Reverse GCCAGTTGGAGACCTGCTTA 
GPR120 Forward CTTCTTCTCCGACGTCAAGG Reverse GAGGGATAGCGCTGATGAA 
TAS2R16 Forward GGCATCTCTCGCTTCTGTCT Reverse CCAGGGAAACAACCTCAAAA 
TAS2R38 Forward ACAGTGATTGTGTGCTGCTG Reverse GCTCTCCTCAACTTGGCATT 
Type I cell markers 
GLAST Forward CGAAGCCATCATGAGACTGGTA Reverse TCCCAGCAATCAGGAAGAGAA 
Type II cell markers 
GNAT3 Forward ATGAGGACCAACGACAAC Reverse GCGTAAGCTGCTGAGTCATTG 
PLCβ2 Forward TCCAGCCCACCAAGTTCGTCT Reverse CGAGGCCTTGGAGAGCAGGT 
Type III cell markers 
SNAP-25 Forward GGACGAACGGGAGCAGATG Reverse CGCTCACCTGCTCTAGGTTTC 
Hormones and receptors 
CCK Forward TCGCAGAGAACGGATGGCGA 
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Reverse GGGGTCCAGGTTCTGCAGGT 
CCK-AR Forward GCGATTTGCAAACCCTTACAG Reverse CACCTTCAAAGCATGGGATTTT 
GHRL Forward CACAGCAACAAAGCTGCACC Reverse AAGTCCAGCCAGAGCATGCC 
GHSR Forward AGCGCTACTTCGCCATC Reverse CCGATGAGACTGTAGAG 
Leptin Forward AACCCTGTGCGGATTCTTGT Reverse TCTTGGACTTTTTGGATGGGC 
Ob-R Forward CATTTTATCCCCATTGAGAAGTA Reverse CTGAAAATTAAGTCCTTGTGCCCAG 
P-GCG Forward TGCTGAAGGGACCTTTACCAGTGA Reverse GCCTTTCACCAGCCAAGCAATGAA 
GLP-1R Forward TTGGGGTGAACTTCCTCATC Reverse CTTGGCAAGTCTGCATTTGA 
OXT Forward GCTGAAACTTGATGGCTCCG Reverse TTCTGGGGTGGCTATGGG 
OTR Forward GTGCAGATGTGGAGCGTCT Reverse GTTGAGGCTGGCCAAGAG 
Housekeeping genes 
β-actin Forward GTACCACTGGCATCGTGATGGACT Reverse CCGCTCATTGCCAATGGTGAT 
GAPDH Forward GACAGTCAGCCGCATCTTCT Reverse TTAAAAGCAGCCCTGGTGAC 
OXT and OTR amplified cDNA were then deposited into an agarose gel electrophoresis: TAE 
1X containing 1.5% agarose (Invitrogen). 
1.4. Western Blotting 
2x106 cells were lysed using 100 µL of RIPA buffer (25 mM Tris HCl, 75 mM NaCl, 0.5 mM 
EDTA, 0.25% Sodium Deoxycholate, 0.05% SDS, 0.5% Nonidet P40, 10 µl/ml protease 
inhibitors (Sigma) (Zhang et al., 2003a). Samples were stored on ice for 20 min and then 
centrifuged (12,000 g, 15 min, 4°C). Lysates were used immediately or stored at −80°C until 
the assay. Protein concentrations in homogenates were assayed using the BCA assay (Sigma). 
Denaturated proteins (20 µg) were separated by SDS-PAGE and transferred to a 
polyvinylidene difluoride membrane. After having blocked for 3 hours using a TBS buffer 
containing 5% BSA and 0.05% Tween-20, the membrane was incubated overnight with a 
primary antibody (Table 5). 
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Table 5 : List of primary antibodies used in Western blotting 
Primary antibody Reference Supplier Dilution 
Taste receptors 
CD36 HPA002018 Atlas Antibodies 1:200 
GPR120 sc-390752 Santa Cruz 1:200 
TAS2R16 OST00468W Osenses 1:300 
TAS2R38 OST00440W Osenses 1:300 
Type I cell markers 
GLAST sc-515839 Santa Cruz 1:500 
Type II cell markers 
Gαt1 sc-136143 Santa Cruz 1:500 
GNAT3/α-gustducin PA5-23986 ThermoFisher 1:1000 
PLCβ2 sc-206 Santa Cruz 1:250 
PLCδ4 sc-373875 Santa Cruz 1:500 
Type III cell markers 
SNAP25 sc-20038 Santa Cruz 1:500 
Hormone receptors 
CCK-AR sc-514303 Santa Cruz 1:500 
GHS-R1 sc-374515 Santa Cruz 1:500 
GLP-1R sc-390774 Santa Cruz 1:500 
Ob-R sc-8391 Santa Cruz 1:500 
OTR sc-515709 Santa Cruz 1:300 
Calcium channels 
Orai1 AS-54653 AnaSpec 1:400 
Orai3 54688 AnaSpec 1:500 
β-actin sc-47778 Santa Cruz 1:5000 
After a set of washes, the appropriate peroxidase-conjugated secondary antibody was added. 
Antibody labeling was detected by chemiluminescence (Clarity, Bio-Rad, Marnes-la-
Coquette, France). 
1.5. Measurement of Ca2+ signalling 
Cells were cultured into 24-well plates, containing HTC-medium and incubated overnight at 
37°C. The next day, the supernatant was discarded. The cells were then incubated with Fura-
2/AM (1 μM) (Invitrogen) for 30 min at 37°C in loading buffer (100% Ca2+) which contained 
the following: 110 mM NaCl; 5.4 mM KCl; 25 mM NaHCO3; 0.8 mM MgCl2; 0.4 mM 
KH2PO4; 20 mM Hepes; 1.2 mM CaCl2; 10 mM Glucose, pH 7.4. The rest of the protocol has 
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been described p. 85 section 1.7. All test molecules were added in small volumes with no 
interruption in recordings. 
All chemicals used for the measurement of Ca2+ signalling were supplied by Sigma, except 
for D-Salicin, Sinigrin and ML-9 (Santa Cruz), Sulfosuccinimidyl Oleate and AH 7614 
(Cayman Chemical). 
Functional EC50 studies were performed as described above, agonists were added at 5 
different concentrations starting at 25 to 400 µM for LA, at 100 µM to 10mM for Sinigrin and 
PTC and at 1 mM to 20 mM for Salicin. Data were normalized and analyzed using GraphPad 
Prism (GraphPad Software). 
1.6. siRNA knockdown of Orai1 and Orai3 
HTC-8 cells were transfected with the siRNA ON-target plus Smart pool (100 µM) designed 
against Orai1 and Orai3 or non-targeting siRNA as a control (Dharmacon). 24 hours before 
treatment, the cells were cultured in Accell siRNA Delivery Media (Dharmacon) and further 
transfected with siRNA (Figure 43). After 72-hour incubation before Ca2+ measurements or 
Western blot analysis.  
 
Figure 43. siRNA machinery. Synthetic siRNA is transfected into cells. siRNA is incorporated into 
RISC, followed by unwinding of the double-stranded molecule by the helicase activity of RISC. The 
sense strand of siRNA is removed and the antisense strand recruits targeted mRNA, which is cleaved 
by RISC and subsequently degraded by cellular nucleases. Modified from Cejka et al. (2006). 
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1.7. Oxytocin mRNA essay and Oxytocin release 
HTC-8 cells were seeded into 6-weel plates, containing HTC-medium and incubated 3 days at 
37°C. The cells were then incubated with either HTC medium containing LA 100 µM, LA 
100 µM and SSO 1 µM, LA 100 µM and AH7614 30 µM, LA 100 µM and SSO 1 µM and 
AH7614 30 µM or with HTC medium alone. After 2 hours of incubation, the medium was 
collected and the oxytocin release was measured by ELISA (Fine Test, China). In parallel, the 
cells were extracted by using TRIzol (Invitrogen, Cergy-Pontoise, France) and qPCR were 
carried out (see section 1.3). 
1.8. Statistics 
Results are expressed as Means ± SEM. The significance of differences between groups was 
evaluated with ANOVA and Mann Whitney tests. A p value of less than 0.05 was considered 
to be statistically significant. 
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2.2. Expression of bitter and fat receptor in HTC-8 cells 
In a second time, we explored the localization of fat and bitter receptors in these cell lines. We 
observed that in the four TBC cell lines, CD36, GPR120, TAS2R16 and TAS2R38 are widely 
expressed at the plasma membrane level (Figures 45 A-D).  
           
  
Figure 45. Immunostaining of fat taste receptors (CD36 and GPR120) and bitter taste receptors 
(TAS2R16 and TAS2R38). Images were acquired with Zeiss Cell Observer station (Zeiss, Oberkochen, 
Germany) (A-D). Immunoreactivity for CD36, GPR120, TAS2R16 and TAS2R38 was observed in 
cultured HTC-8 (A), in cultured HTC-8:TAS2R38 (B), in cultured Ulduz-1 (C) and in cultured HFFC 
cells (D). 
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Figure 51. Immunostaining of the bitter taste receptor TAS2R38 and the fatty taste receptor CD36. 
Images were acquired with Zeiss Cell Observer station (Zeiss, Oberkochen, Germany) (A-B). 
Immunoreactivity for TAS2R38 (red) and CD36 (green) was observed in cultured HTC-8 (A), in 
cultured HTC-8:TAS2R38 (B), in cultured Ulduz-1 (C) and in cultured HFFC cells (D). 
HTC-8 cells co-expressed fat and the bitter taste receptor TAS2R16 as well as the other 
human cell lines. Indeed, CD36-positive cells are also positive for TAS2R16 (Figure 52). 
 
Figure 52. Immunostaining of the bitter taste receptor TAS2R16 and the fatty taste receptor CD36. 
Images were acquired with Zeiss Cell Observer station (Zeiss, Oberkochen, Germany) (A-B). 
Immunoreactivity for TAS2R16 (red) and CD36 (green) was observed in cultured HTC-8 (A), in 
cultured HTC-8:TAS2R38 (B), in cultured Ulduz-1 (C) and in cultured HFFC cells (D). 
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We observed that no significant differences appeared regarding fat and bitter receptors 
between the different cell lines. We therefore decided to conduct the study only on HTC-8 
cells. 
2.9 Linoleic acid triggered Ca2+ signalling in HTC-8 cells via CD36 
and GPR120 
The gene and protein expression profile of HTC-8 cells revealed that the cells express fat taste 
receptors CD36 and GPR120 (Figures 44-45). HTC-8 cells were stained with the Ca2+ dye 
Fura-2/AM and stimulated with increasing concentration of LA. LA evoked increases in Ca2+ 
signalling (Figure 53A). Concentration eliciting half-maximal responses (EC50) were 
determined at 67.44 µM (Figure 53B).  
 
Figure 53. LA induces increases in [Ca2+]i in HTC-8 cells. Ca2+ imaging studies were performed in 
calcium-containing (100% Ca2+) buffer. The changes in free intracellular Ca2+ concentrations (ΔF340/F380) 
were monitored under the Nikon microscope (TiU) by using S-fluor 40x oil immersion objectives. A-
Colored time-lapse changes show the kinetics of the rise in [Ca2+]i levels in HTC-8 cells following 
addition of LA (100 µM) and the corresponding graphs below. B-Graphs represent concentration-
response curve obtained with HTC-8 cells and the corresponding EC50 value. Values are expressed as 
mean ± SEM (n=5). 
2.10 Sinigrin, an agonist of TAS2R16, triggered Ca2+ signalling in HTC-
8 cells 
The gene and protein expression profile of HTC-8 cells revealed that the cells express the 
bitter taste receptors TAS2R16 and TAS2R38 (Figures 44-45). HTC-8 cells were stained with 
the Ca2+ dye Fura-2/AM and stimulated with increasing concentration of sinigrin. Sinigrin 
evoked increases in Ca2+ signalling (Figure 54A). Concentration eliciting half-maximal 
responses (EC50) were determined at 526.8 µM (Figure 54B).  
A B 
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Figure 54. Sinigrin induces increases in [Ca2+]i in HTC-8 cells. Ca2+ imaging studies were performed in 
calcium-containing (100% Ca2+) buffer. The changes in free intracellular Ca2+ concentrations (ΔF340/F380) 
were monitored under the Nikon microscope (TiU) by using S-fluor 40x oil immersion objectives. A-
Colored time-lapse changes show the kinetics of the rise in [Ca2+]i levels in HTC-8 cells following 
addition of Sinigrin (1 mM) and the corresponding graphs below. B-Graphs represent concentration-
response curve obtained with HTC-8 cells and the corresponding EC50 value. Values are expressed as 
mean ± SEM (n=5). 
2.11 PTC, an agonist of TAS2R16, triggered Ca2+ signalling in HTC-8 
cells 
The gene and protein expression profile of HTC-8 cells revealed that the cells express the 
bitter taste receptor TAS2R38 (Figures 44-45). HTC-8 cells were stained with the Ca2+ dye 
Fura-2/AM and stimulated with increasing concentration of PTC. PTC evoked increases in 
Ca2+ signalling (Figure 55A). Concentration eliciting half-maximal responses (EC50) were 
determined at 5.589 mM (Figure 55B).  
 
Figure 55. PTC induces increases in [Ca2+]i in HTC-8 cells. Ca2+ imaging studies were performed in 
calcium-containing (100% Ca2+) buffer. The changes in free intracellular Ca2+ concentrations (ΔF340/F380) 
were monitored under the Nikon microscope (TiU) by using S-fluor 40x oil immersion objectives. A-
Colored time-lapse changes show the kinetics of the rise in [Ca2+]i levels in HTC-8 cells following 
addition of PTC (10 mM) and the corresponding graphs below. B-Graphs represent concentration-
response curve obtained with HTC-8 cells and the corresponding EC50 value. Values are expressed as 
mean ± SEM (n=5). 
A B 
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2.12 Salicin, an agonist of TAS2R16 and TAS2R38, triggered Ca2+ 
signalling in HTC-8 cells 
The gene and protein expression profile of HTC-8 cells revealed that the cells express the 
bitter taste receptor TAS2R16 (Figures 44-45). HTC-8 cells were stained with the Ca2+ dye 
Fura-2/AM and stimulated with increasing concentration of salicin. Salicin evoked increases 
in Ca2+ signalling (Figure 56A). Concentration eliciting half-maximal responses (EC50) were 
determined at 13.21 mM (Figure 56B).  
 
Figure 56. Salicin induces increases in [Ca2+]i in HTC-8 cells. Ca2+ imaging studies were performed in 
calcium-containing (100% Ca2+) buffer. The changes in free intracellular Ca2+ concentrations (ΔF340/F380) 
were monitored under the Nikon microscope (TiU) by using S-fluor 40x oil immersion objectives. A-
Colored time-lapse changes show the kinetics of the rise in [Ca2+]i levels in HTC-8 cells following 
addition of Salicin (25 mM) and the corresponding graphs below. B-Graphs represent concentration-
response curve obtained with HTC-8 cells and the corresponding EC50 value. Values are expressed as 
mean ± SEM (n=5). 
2.13 CD36 and/or GPR120 inhibitors decrease fat and bitter Ca2+ 
signalling in HTC-8 cells 
As expected, AH7614, a GPR120 inhibitor, and SSO, a CD36 inhibitor, significantly 
abrogated [Ca2+]i responses induced by LA. Furthermore, synergistic blockade with AH7614 
and SSO in HTC-8 cells drastically curtailed the action of LA on calcium response (Figure 
57A). Interestingly, AH7614 and SSO added together, significantly abrogated [Ca2+]i 
responses induced by sinigrin (Figure 57B). In the same way, AH7614 and SSO added 
together, significantly abrogated [Ca2+]i responses induced by PTC (Figure 57C). Similarly, 
AH7614 and SSO added together, significantly abrogated [Ca2+]i responses induced by salicin 
(Figure 57D). 
A B 
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Figure 57. Ca2+ imaging studies were performed in calcium-containing (100% Ca2+) buffer. The 
changes in free intracellular Ca2+ concentrations (ΔF340/F380) were monitored under the Nikon 
microscope (TiU) by using S-fluor 40x oil immersion objectives. A- shows the variations in ΔF340/F380 
Ratio induced by LA (100 µM) after, or not, preincubation with SSO and/or AH7614. B- shows the 
variations in ΔF340/F380 Ratio induced by sinigrin (1 mM) after, or not, preincubation with SSO and 
AH7614. C- shows the variations in ΔF340/F380 Ratio induced by PTC (10 mM) after, or not, 
preincubation with SSO and AH7614. D- shows the variations in ΔF340/F380 Ratio induced by salicin (25 
mM) after, or not, preincubation with SSO and AH7614. Values are expressed as mean ± SEM (n=5). 
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2.14 PLC inhibitor decreases fat and bitter Ca2+ signalling in HTC-8 
cells 
To strengthen our findings, we finally tested the effect of a PLC inhibitor, U73122, on fat and 
bitter transduction signalling. It appeared that U73122 induced a significant decrease in 
[Ca2+]i signalling elicited by LA (Figure 58A). The PLC inhibitor also disrupted bitter taste 
[Ca2+]i signalling. Indeed, after a 20-minute preincubation with U73122, the rises triggered by 
PTC, salicin and sinigrin are significantly lower than in absence of U73122 (Figure 58B, C 
and D).  
 
Figure 58. U73122 induces reduced [Ca2+]i responses in HTC-8 cells. Ca2+ imaging studies were 
performed in calcium-containing (100% Ca2+) buffer. The changes in free intracellular Ca2+ 
concentrations (ΔF340/F380) were monitored under the Nikon microscope (TiU) by using S-fluor 40x oil 
immersion objectives. A- shows the kinetics of the rise in [Ca2+]i levels in HTC-8 cells following 
addition of LA (100 µM) after a 20 minutes preincubation with U73122 (0.5 µM) or not and the 
corresponding graphs beside. B- shows the kinetics of the rise in [Ca2+]i levels in HTC-8 cells following 
addition of PTC (10 mM) after a 20 minutes preincubation with U73122 (0.5 µM) or not and the 
corresponding graphs beside. C- shows the kinetics of the rise in [Ca2+]i levels in HTC-8 cells following 
addition of Salicin (25 mM) after a 20 minutes preincubation with U73122 (0.5 µM) or not and the 
corresponding graphs beside. D- shows the kinetics of the rise in [Ca2+]i levels in HTC-8 cells following 
addition of Sinigrin (1 mM) after a 20 minutes preincubation with U73122 (0.5 µM) or not and the 
corresponding graphs beside. 
2.15 Fat and bitter agonists mobilize Ca2+ extra and intracellular pool in 
HTC-8 cells 
We further studied the origin of the Ca2+. To do so, we used Ca2+-containing and Ca2+-free 
medium. LA-induced increases in [Ca2+]i were higher in Ca2+-containing as compared with 
Ca2+-free medium (Figure 59A). Similarly, we observed the same responses with the bitter 
A B 
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agonists, PTC, sinigrin and salicin, i.e., a strong decrease in [Ca2+]i responses (Figure 59B, C 
and D) suggesting a Ca2+-extracellular dependent pathway. 
 
Figure 59. Effects of LA, PTC, Sinigrin and Salicin on Ca2+ signalling in HTC-8 cells. The experiments 
were performed in Ca2+-containing and in Ca2+-free media. The changes in free intracellular Ca2+ 
concentrations (ΔF340/F380) were monitored under the Nikon microscope (TiU) by using S-fluor 40x oil 
immersion objectives. A-shows the changes in [Ca2+]i evoked by LA (100 µM) and the corresponding 
graph. B- shows the changes in [Ca2+]i evoked by PTC (10 mM) and the corresponding graph. C- shows 
the changes in [Ca2+]i evoked by Sinigrin (1 mM) and the corresponding graph. D- shows the changes 
in [Ca2+]i evoked by Salicin (25 mM) and the corresponding graph. Values are expressed as mean ± 
SEM (n=5). 
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2.16 Fat and bitter agonists trigger additive Ca2+ signalling in HTC-8 
cells 
The addition of LA and then sinigrin triggered an additive response (Figure 60A). Likewise, 
sinigrin added before LA induced an additive response (Figure 60B). Finally, when added in 
the same time, LA and sinigrin induced a huge rise equivalent to the amplitude obtained with 
the agonists added alone (Figure 60C). Similarly, PTC and salicin displayed the same 
responses. Indeed, PTC/salicin and LA added one after another induced additive responses 
(Figure 60D, E, G and H) and added in the same time, generated a response corresponding to 
the combined effect of the two agonists (Figure 60F and I). These results are in line with LA 
primarily interacting with CD36 while the bitter agonists activate its cognate TAS2R receptor. 
 
Figure 60. LA and bitter agonists induce additive [Ca2+]i responses in HTC-8 cells. Ca2+ imaging 
studies were performed in calcium-containing (100% Ca2+) buffer. The changes in free intracellular Ca2+ 
concentrations (ΔF340/F380) were monitored under the Nikon microscope (TiU) by using S-fluor 40x oil 
immersion objectives. A- shows the changes in [Ca2+]i evoked by LA (100 µM) following by Sinigrin (1 
mM). B- shows the changes in [Ca2+]i evoked by Sinigrin (1 mM) following by LA (100 µM). C- shows 
the changes in [Ca2+]i evoked by LA (100 µM) and Sinigrin (1 mM). D- shows the changes in [Ca2+]i 
evoked by LA (100 µM) following by PTC (10 mM). E- shows the changes in [Ca2+]i evoked by PTC (10 
mM) following by LA (100 µM). F- shows the changes in [Ca2+]i evoked by LA (100 µM) and PTC (10 
mM). G- shows the changes in [Ca2+]i evoked by LA (100 µM) following by Salicin (25 mM). H- shows 
the changes in [Ca2+]i evoked by Salicin (25 mM) following by LA (100 µM). I- shows the changes in 
[Ca2+]i evoked by LA (100 µM) and Salicin (25 mM).  
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2.17 Capacitative calcium influx blocker decreases fat and bitter Ca2+ 
signalling in HTC-8 cells 
Next, we investigated the downstream signalling using inhibitors known to inhibit fat taste 
signal transduction. We first used a capacitative calcium influx blocker, econazole. The 
capacitative calcium influx is a calcium current activated by the depletion of internal calcium. 
As expected, after a preincubation with econazole. LA evoked a significantly lower [Ca2+]i 
response than in absence of econazole (Figure 61A). Regarding bitter taste agonists, PTC 
induced a reduced [Ca2+]i response in presence of econazole (Figure 61B). Interestingly, 
salicin and sinigrin failed to raise [Ca2+]i in HTC-8 cells after a 30-minute preincubation with 
econazole (Figure 61C and D). 
 
Figure 61. Econazole induces reduced [Ca2+]i responses in HTC-8 cells. Ca2+ imaging studies were 
performed in calcium-containing (100% Ca2+) buffer. The changes in free intracellular Ca2+ 
concentrations (ΔF340/F380) were monitored under the Nikon microscope (TiU) by using S-fluor 40x oil 
immersion objectives. A- shows the kinetics of the rise in [Ca2+]i levels in HTC-8 cells following 
addition of LA (100 µM) after a 30 minutes preincubation with Econazole (30 µM) or not and the 
corresponding graphs beside. B- shows the kinetics of the rise in [Ca2+]i levels in HTC-8 cells following 
addition of PTC (10 mM) after a 30 minutes preincubation with Econazole (30 µM) or not and the 
corresponding graphs beside. C- shows the kinetics of the rise in [Ca2+]i levels in HTC-8 cells following 
addition of Salicin (25 mM) after a 30 minutes preincubation with Econazole (30 µM) or not and the 
corresponding graphs beside. D- shows the kinetics of the rise in [Ca2+]i levels in HTC-8 cells following 
addition of Sinigrin (1 mM) after a 30 minutes preincubation with Econazole (30 µM) or not and the 
corresponding graphs beside. 
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2.18 Receptor-mediated and voltage gated Ca2+ entry inhibitor decreases 
fat and bitter Ca2+ signalling in HTC-8 cells 
Then, we used a receptor-mediated Ca2+ entry and voltage gated Ca2+ entry inhibitor, 
SKF96365. We observed that the rise in [Ca2+]i induced by LA in HTC-8 cells was 
significantly diminished after a 30-minute preincubation with SKF96365 (Figure 62A). 
Similarly, [Ca2+]i response, in presence of SKF96365, after PTC stimulation was decreased 
(Figure 62B) and highly curtailed after salicin and sinigrin stimulation (Figure 62C and D).  
 
Figure 62. SKF96365 induces reduced [Ca2+]i responses in HTC-8 cells. Ca2+ imaging studies were 
performed in calcium-containing (100% Ca2+) buffer. The changes in free intracellular Ca2+ 
concentrations (ΔF340/F380) were monitored under the Nikon microscope (TiU) by using S-fluor 40x oil 
immersion objectives. A- shows the kinetics of the rise in [Ca2+]i levels in HTC-8 cells following 
addition of LA (100 µM) after a 30 minutes preincubation with SKF96365 (1 µM) or not and the 
corresponding graphs beside. B- shows the kinetics of the rise in [Ca2+]i levels in HTC-8 cells following 
addition of Sinigrin (1 mM) after a 30 minutes preincubation with SKF96365 (1 µM) or not and the 
corresponding graphs beside. C- shows the kinetics of the rise in [Ca2+]i levels in HTC-8 cells following 
addition of Salicin (25 mM) after a 30 minutes preincubation with SKF96365 (1 µM) or not and the 
corresponding graphs beside. D- shows the kinetics of the rise in [Ca2+]i levels in HTC-8 cells following 
addition of PTC (10 mM) after a 30 minutes preincubation with SKF96365 (1 µM) or not and the 
corresponding graphs beside. 
2.19 CALHM1 inhibitor decreases fat and bitter Ca2+ signalling in HTC-
8 cells 
The use of 2-APB, a inhibitor of CALHM1, induced significant decrease in the rise in [Ca2+]i 
induced by LA in HTC-8 cells after a 30-minute preincubation (Figure 63A). Similarly, 
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[Ca2+]i response, in presence of 2-APB, after Sinigrin, Salicin and PTC stimulation was 
decreased (Figure 63B, C and D). 
 
Figure 63. 2-APB induces reduced [Ca2+]i responses in HTC-8 cells. Ca2+ imaging studies were 
performed in calcium-containing (100% Ca2+) buffer. The changes in free intracellular Ca2+ 
concentrations (ΔF340/F380) were monitored under the Nikon microscope (TiU) by using S-fluor 40x oil 
immersion objectives. A- shows the kinetics of the rise in [Ca2+]i levels in HTC-8 cells following 
addition of LA (100 µM) after a 20 minutes preincubation with 2-APB (5 µM) or not and the 
corresponding graphs beside. B- shows the kinetics of the rise in [Ca2+]i levels in HTC-8 cells following 
addition of PTC (10 mM) after a 30 minutes preincubation with 2-APB (1 µM) or not and the 
corresponding graphs beside. C- shows the kinetics of the rise in [Ca2+]i levels in HTC-8 cells following 
addition of Salicin (25 mM) after a 30 minutes preincubation with 2-APB (1 µM) or not and the 
corresponding graphs beside. D- shows the kinetics of the rise in [Ca2+]i levels in HTC-8 cells following 
addition of Sinigrin (1 mM) after a 30 minutes preincubation with 2-APB (1 µM) or not and the 
corresponding graphs beside. 
2.20 Ca2+/calmodulin-dependent protein kinase and Stim1 inhibitor 
decreases fat and bitter Ca2+ signalling in HTC-8 cells 
Then, we investigated the role of Ca2+/calmodulin-dependent protein kinase and Stim1 using a 
selective inhibitor of CaMK and Stim1, ML-9. We observed, in the four conditions, that the 
rise in [Ca2+]i induced by LA, Sinigrin, Salicin and PTC in HTC-8 cells was significantly 
decreased after a 30-minute preincubation with ML-9 (Figure 64A, B, C and D respectively).  
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Figure 64. ML-9 induces reduced [Ca2+]i responses in HTC-8 cells. Ca2+ imaging studies were 
performed in calcium-containing (100% Ca2+) buffer. The changes in free intracellular Ca2+ 
concentrations (ΔF340/F380) were monitored under the Nikon microscope (TiU) by using S-fluor 40x oil 
immersion objectives. A- shows the kinetics of the rise in [Ca2+]i levels in HTC-8 cells following 
addition of LA (100 µM) after a 20 minutes preincubation with ML-9 (10 µM) or not and the 
corresponding graphs beside. B- shows the kinetics of the rise in [Ca2+]i levels in HTC-8 cells following 
addition of PTC (10 mM) after a 30 minutes preincubation with ML-9 (1 µM) or not and the 
corresponding graphs beside. C- shows the kinetics of the rise in [Ca2+]i levels in HTC-8 cells following 
addition of Salicin (25 mM) after a 30 minutes preincubation with ML-9 (1 µM) or not and the 
corresponding graphs beside. D- shows the kinetics of the rise in [Ca2+]i levels in HTC-8 cells following 
addition of Sinigrin (1 mM) after a 30 minutes preincubation with ML-9 (1 µM) or not and the 
corresponding graphs beside. 
2.21 Orai1 and 3 siRNA decrease fat and bitter Ca2+ signalling in HTC-8 
cells 
Finally, we treated HTC-8 cells for 72 h with siRNA directed against Orai1, Orai3 and 
Orai1/3 in the same time. We observed that Orai1 seems to be more involved in fat and bitter 
downstream signalling as the absence of Orai1 reduced significantly the rise in [Ca2+]i 
induced by LA, Sinigrin, Salicin and PTC in HTC-8 cells (Figure 65). Conversely, Orai3 
seems to be involved in a variable way as a treatment with siRNA against Orai3 does not 
seem to impact the Ca2+ response induced by LA and Sinigrin (Figure 64A and B). However, 
the rise in [Ca2+]i induced by Salicin and PTC in HTC-8 cells was decreased after treatment 
with Orai3 siRNA (Figure 65C and D). Nevertheless, the treatment with siRNA against Orai1 
and 3 induced, in the four conditions, induced a significant decreased in the rise in [Ca2+]i 
elicited by LA, Sinigrin, Salicin and PTC in HTC-8 cells (Figure 65). 
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Figure 65. Orai1 and Orai3 impact differently [Ca2+]i responses in HTC-8 cells. Ca2+ imaging studies 
were performed in calcium-containing (100% Ca2+) buffer. The changes in free intracellular Ca2+ 
concentrations (ΔF340/F380) were monitored under the Nikon microscope (TiU) by using S-fluor 40x oil 
immersion objectives. A- shows the kinetics of the rise in [Ca2+]i levels in HTC-8 cells following 
addition of LA (100 µM) after or not a  siRNA treatment directed against Orai1, Orai3 or both and the 
corresponding graphs beside. B- shows the kinetics of the rise in [Ca2+]i levels in HTC-8 cells following 
addition of PTC (10 mM) after or not a  siRNA treatment directed against Orai1, Orai3 or both and the 
corresponding graphs beside. C- shows the kinetics of the rise in [Ca2+]i levels in HTC-8 cells following 
addition of Salicin (25 mM) after or not a  siRNA treatment directed against Orai1, Orai3 or both and 
the corresponding graphs beside. D- shows the kinetics of the rise in [Ca2+]i levels in HTC-8 cells 
following addition of Sinigrin (1 mM) after or not a  siRNA treatment directed against Orai1, Orai3 or 
both and the corresponding graphs beside. E- Detection of Orai1, or Orai3 proteins by Western blotting 
after transfection with either scrambled RNA (control) or siRNA of Orai1, or Orai3 
2.22 Oxytocin and its cognate receptor is expressed by human taste bud 
cell lines 
The gene and protein expression profile of HTC-8 cells revealed that the cells express 
oxytocin and the oxytocin receptor (Figure 50 and 66). 
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Figure 66. Oxytocin (OXT) and its cognate receptor (OTR) expression. OXT and OTR mRNA levels 
assayed by real-time PCR in HTC-8, HTC-8:TAS2R38, Ulduz-1 and HFFC cells. B- OXT and OTR 
protein levels were measured by Western blotting in HTC-8, HTC-8:TAS2R38, Ulduz-1 and HFFC cells 
(n=5). Values are expressed as mean ± SEM (n=5).  
2.23 Oxytocin triggered Ca2+ signalling in HTC-8 cells 
HTC-8 cells were stained with the Ca2+ dye Fura-2/AM and stimulated with increasing 
concentration of oxytocin. Oxytocin evoked increases in Ca2+ signalling (Figure 67A). 
Concentration eliciting half-maximal responses (EC50) were determined at 15.28 mM (Figure 
67B).  
 
Figure 67. OXT induces increases in [Ca2+]i in HTC-8 cells. Ca2+ imaging studies were performed in 
calcium-containing (100% Ca2+) buffer. The changes in free intracellular Ca2+ concentrations (ΔF340/F380) 
were monitored under the Nikon microscope (TiU) by using S-fluor 40x oil immersion objectives. A-
Colored time-lapse changes show the kinetics of the rise in [Ca2+]i levels in HTC-8 cells following 
addition of OXT (40 nM) and the corresponding graphs below. B-Graphs represent concentration-
response curve obtained with HTC-8 cells and the corresponding EC50 value. Values are expressed as 
mean ± SEM (n=5). 
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2.24 GPR120 and CD36 are involved in the lipid-mediated release of 
oxytocin by HTC-8 cells 
We investigated the link between fat taste modulation and oxytocin release in HTC-8 
cells. To do so, we subjected HTC-8 cells to five different conditions: LA; LA and 
AH7614; LA and SSO; LA, AH7614 and SSO; and the control condition and we 
measured the oxytocin release in the supernantant. We observed that, LA induced a 
significant decrease in oxytocin release whereas treatment with AH7614 or SSO restored 
the oxytocin release that occurred in the control condition. Furthermore, the combination 
of AH7614 and SSO treatment led to an increase in oxytocin release compared to what is 
observed in the control condition (Figure 68). 
 
Figure 68. AH7614, a GPR120 inhibitor and SSO, a CD36 inhibitor increase active OXT release by 
HTC-8 cells. OXT release by HTC-8 cells incubated in the presence of HTC-Medium alone (CTRL, 
control), with 100 μM LA (LA), with 100 µM LA and 30 µM AH7614 (LA + AH7614), with 100 µM LA 
and 1 µM SSO (LA + SSO) or with 100 µM LA and 30 µM AH7614 in combinaison with 1 µM SSO (LA 
+ AH7614 + SSO). Each value corresponds to the OXT released by 0.x HTC-8 cells. Mean ± SEM (n = 
4).  
2.25 GPR120 and CD36 mediate the oxytocin mRNA expression in 
HTC-8 cells 
We next studied the role played by these different compounds on oxytocin at the mRNA 
level. Interestingly, LA induced a decreased in OXT mRNA expression in HTC-8 cells 
corroboring the results observed with the ELISA experiment. We also observed that treatment 
with AH7614 and SSO, in the same way, re-established the OXT mRNA expression. 
However, at the mRNA level, we did not notice the OXT increase that occurred with an 
AH7614 and SSO simultaneous treatment (Figure 69). 
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Figure 69. LA decreases OXT mRNA expression in HTC-8 cells. OXT mRNA expression in HTC-8 
cells incubated in the presence of HTC-Medium alone (CTRL, control), with 100 μM LA (LA), with 100 
µM LA and 30 µM AH7614 (LA + AH7614), with 100 µM LA and 1 µM SSO (LA + SSO) or with 100 µM 
LA and 30 µM AH7614 in combinaison with 1 µM SSO (LA + AH7614 + SSO). Each value corresponds 
to the OXT released by 0.x HTC-8 cells. Mean ± SEM (n = 4). 
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3 Discussion 
Within our collaboration with BRAIN institute, we proposed to investigate the potential cross-
talk that occurs between fat and bitter taste modalities in HTC-8 cells. First, we characterized 
the HTC-8 cell profile. Hochheimer et al. (2014) did not detect GNAT3/α-gustducin and 
PLCβ2 in HTC-8 cells. Thus, they concluded that GNAT2/transducin are also expressed in 
TBC and could partially complement GNAT3/α-gustducin and may participate to the taste 
signal transduction pathway (Kusakabe et al., 2000; McLaughlin et al., 1992). Thus, 
GNAT2/transducin could replace canonical gustatory signalling factors in HTC-8 cells. 
Regarding the absence of PLCβ2 detection, it is likely that PLδ4, a paralog of the PLCβ2 
gene, contributes to the signal transduction as PLCδ4 has been found to be expressed in 
primates TBC (Hevezi et al., 2009). Interestingly, we observed a positive labeling for α-
gustducin, a key factor of the canonical gustatory taste signalling pathway (Kinnamon, 2012) 
as well as PLCβ2. Thus, HTC-8 cells seem to exhibit a type II receptor profile (Chaudhari and 
Roper, 2010). Nevertheless, it is possible that GNAT2/transducin and PLCδ4 contribute to fat 
taste signal transduction. Further studies are needed to explore this assumption. 
Karmous et al. (2018) showed a direct association between orosensory perception of fatty acid 
and PROP. The study sheds light on a possible cross-talk between fat and bitter taste 
involving cellular and molecular interactions.  
Here, we proposed to investigate the likely cross-talk that occurs between fat and bitter tastes. 
To do so, I spent nearly two years to characterize the HTC-8 cell line. We observed that HTC-
8 cells expressed PLCβ2 and α-gustducin among other cell markers and, co-expressed bitter 
and fat taste receptors.  
 Cross-talk between fat and bitter taste modalities 
It is likely that both bitter and fat tastes share a common downstream Ca2+ signalling. We 
proposed to elucidate the underlying mechanisms that occur in taste bud cells. We first 
assessed the expression of bitter and fat taste receptors. We observed that fat taste receptors 
(CD36 and GPR120) and bitter taste receptors (TAS2R38 and TAS2R16) were expressed by 
HTC-8 cells. Moreover, CD36 was co-expressed with TAS2R38 and TAS2R16 in a 
homogenous manner. Therefore, we explored the downstream signal transduction. To do so, 
we selected three bitter agents, PTC known to be a TAS2R38 agonist (Behrens et al., 2013; 
Bufe et al., 2005; Meyerhof et al., 2010), salicin, a TAS2R16 agonist (Maehashi et al., 2008; 
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Meyerhof et al., 2010; Soranzo et al., 2005; Thomas et al., 2017) and sinigrin, a glucosinolate 
to which both TAS2R38 and TAS2R16 respond (Behrens et al., 2013; Meyerhof et al., 2010; 
Thomas et al., 2017). First of all, calcium assays revealed that HTC-8 cells responded to 
endogenous Ca2+ signalling in a dose-dependent manner to bitter and fat tastants (Hochheimer 
et al., 2014; Meyerhof et al., 2010). Then, the diminished Ca2+ signalling responses in absence 
of Ca2+ in the buffer indicated that the signal transduction mobilized Ca2+ from an extra- and 
intacellular pool (Ozdener et al., 2014). It appeared that fatty and bitter taste signalling depend 
on the presence of extracellular Ca2+. The addition of LA and the different bitter taste 
agonists, one after the other, triggered additive responses, suggesting that LA interacted with 
CD36 while bitter agonists activated their cognate receptor, i.e. TAS2R16 and/or TAS2R38. 
Then, we focused on the downstream mechanism. Interestingly, it revealed that downstream 
Ca2+ signalling inhibitors known to be involved in fat taste signal transduction via CD36 also 
inhibited bitter fat taste signalling. Indeed, all of the inhibitors used in the study altered Ca2+ 
signalling after their addition in the medium, strongly supporting the existence of a cross-talk 
bitter the fat taste and the bitter taste modalities. 
The Ca2+ influx that occurs through the opening of stored operated calcium channels (SOC 
channels), such as Orai1 and Orai3, is modulated by phosphorylation, mediated by Src family 
kinases (SFK) (Babnigg et al., 1997). Furthermore, El-Yassimi et al. (2008) showed that 
SFK96365, a selective inhibitor of receptor-mediated Ca2+ entry, significantly reduced the 
LCFA-induced increases in [Ca2+]i in CD36-expressing taste bud cells (TBC) from mice. 
Besides, Stromal interaction molecule 1 (STIM1) is an endoplasmic reticulum (ER) sensor 
whose stimulation results in SOC channels activation. STIM1 has been found to be involved 
in fat taste perception as spontaneous fat preference in Stim1-/- mice was abolished (Dramane 
et al., 2012). Moreover, STIM1 has been shown to regulate LCFA-induced opening of SOC 
channels in CD36-expressing mice TBC (Dramane et al., 2012). Indeed, blockers of SOC 
channels (i.e. SKF96365 and econazole) significantly diminished LA- and bitter agonists-
induced increases in [Ca2+]i. As reported (Ozdener et al., 2014), our study corroborates the 
involvement of STIM1 and SOC channels in Ca2+ responses to LCFA and sheds light on the 
implication of these channels in Ca2+ responses elicited by bitter agents. 
Albeit Hochheimer et al. (2014) failed to detect PLCβ2 in HTC-8 cells, we obtained a PLCβ2-
positive labeling and also found PLCβ2 mRNA. The use of U73122, a PLC inhibitor, 
triggering significant reduced calcium response, indicated that LA as well as bitter agonists 
mobilized Ca2+ via a PLC-dependent mechanism. The concentration used is deliberately low 
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as, it has been shown that U73122 dose-dependently decreases [Ca2+]i responses (Jan et al., 
1998). 
We wonder if fat taste receptors antagonist could disrupt bitter taste signal transduction. As 
expected, Ca2+ signalling evoked by LA was significantly curtailed in presence of sulfo-N-
succinimidyl (SSO) and AH7614 (a GPR120 antagonist) (Ozdener et al., 2014). Surprisingly, 
we observed the same phenomenon with PTC, salicin and, to a lesser extent, sinigrin after a 
20-minute precincubation with SSO and AH7614 suggesting that bitter agonists mobilized 
Ca2+ by interfering with Ca2+ signalling indirectly coupled to fat taste receptors. 
Taken together, these findings suggest that fat and bitter taste share a common pathway. We 
can hypothesize that bitter and fat taste agonists bind to their cognate receptors and activate 
PLCβ2 that triggers IP3 production that would lead to intracellular Ca2+ release, resulting 
ultimately in neurotransmitter release. It also emerged that bitter taste signalling interferes 
with CD36 and GPR120 signalling. Thereby, it appeared that only one pathway seems to exist 
in HTC-8 cells. These findings are contradictory with Hochheimer’s data that indicated two 
signalling pathways coexist, a PLC-dependent and a PLC-independent Ca2+ signalling.  
Anyway, these results highlight the cross-talk between fat and bitter taste signalling 
supporting the concept of “bitter-like fat taste”. Nevertheless, this concept needs to be 
elucidated as it might involve other components. 
HTC-8 cells express the PAV (Proline-Alanine-Valine) haplotype corresponding to the taster 
variant of TAS2R38 (Hochheimer et al., 2014) which has been shown to be associated with 
highest sensitivity to oleic acid and the highest responsiveness to PROP and generally found 
in PROP super-tasters (Melis et al., 2015a). In future, it would be interesting to test and 
compare fat and bitter taste signalling transduction in cells expressing the AVI variant of 
TAS2R38 linked to the lowest capability to orally detect oleic acid and with the lowest 
responsiveness to PROP and corresponding to the PROP non-taste status (Melis et al., 2015a). 
Taken together, these results open new prospects. Indeed, polymorphism has been shown to 
be important in taste perception. Appropriate genetic screening for obesity including 
TAS2R38 SNP, could highlight different options to ameliorate chemosensory alterations 
including addition of simulated flavors to food to compensate for hyposensitization for fat 
taste.  
 
Discussion 
148/214 
Second part: Personal contributions  Modulation of fat preference by bitter agonists 
 Oxytocin involvement in fat taste modulation 
Due to the recent findings of the physiological role of oxytocin in feeding regulation and the 
benefits it presents as a use for the treatment of obesity, we chose to investigate the 
involvement of fat taste stimulation on oxytocin secretion. 
This study also highlighted the important role of oxytocin in food behaviour. Oxytocin is not 
only delivered to taste buds via blood circulation (Sinclair et al., 2010) but is also produced 
locally as revealed by oxytocin released assay in HTC-8 cells. This is supported by the fact 
that oxytocin has been measured in the supernatant of HTC-8 cells. Moreover, we noticed that 
interestingly oxytocin released is more important when linoleic acid is incubated with SSO 
and AH7614 In this way, this phenomen could reveal desensitization to fatty acids at the TBC 
level and that would be responsible for initiating satiety. We can propose the following 
working model based on our results obtained with oxytocin studies (Figure 70). 
 
Figure 70. Proposed model of the involvement of the oxytocin in TBC. 1) LA bind to the lipid 
receptors inducing the downregulation of CD36 via the lipid rafts, 2) this desensitization leads to 
oxytocin release from the TBC in the extracellular environment, 3) the oxytocin released binds to the 
oxytocin receptors located at the cell membrane level of the TBC, 4) the binding induces the 
augmentation of the [Ca2+]i, 5) leading to the satiety perception. LCFA, long-chain fatty-acid; ER, 
endoplasmic reticulum; OXT, oxytocin receptor; OTR, oxytocin. Modified from Gilbertson and Khan 
(2014) including the obtained results on the oxytocin involvement in fat taste perception. 
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These findings identify OXT as an important central and peripheral regulator of energy 
homeostasis linked to lipid-rich food intake. 
Furthermore, bariatric surgery triggers drastic changes in body weight and also drastic 
restoration of postprandial gut peptide release such as GLP-1, PYY and ghrelin (Barja-
Fernández et al., 2015), parameters that are dysregulated in obese subjects (Meyer-Gerspach 
et al., 2014). It, therefore, appeared that influencing the release of hormones might provide a 
pharmacological alternative to invasive surgery. Avau et al. (2015) recently highlighted the 
therapeutic potential of targeting TAS2Rs to reduce body weight. They showed that α-
gustducin-deficient mice (α-gust-/-) mice exhibited lower weights than WT mice when fed a 
high fat diet (HFD). Moreover, white adipose tissue (WAT) mass was lower in α-gust-/- mice 
and correlated to an increase in brown adipose tissue (BAT) thermogenic activity. 
Interestingly, treatment with bitter agonists (denatonium benzoate or quinine) induced an α-
gustducin-dependent decrease in body weight associated with decreased food intake. 
Treatment of pre-adipocytes with TAS2R agonists also decreased differenciation into mature 
adipocytes. Therefore, interfering with the gustatory signalling pathway using TAS2R 
agonists seems to protect against the development of HFD-induced obesity by directly 
affecting adipocyte metabolism.  
Obesity is one major public health issues, and its prevalence is steadily increasing. Over the 
last decades, the role of dietary fatty acids has been largely studied especially their 
involvement as regulators of energy and lipid metabolism and their implication in human 
health. Hence the ability to detect fatty acids and the potential cross-talk between fat and 
bitter tastes remain an important issue to explore as it could constitute new anti-obesity 
strategies. Taken together, these results suggest the following integrative model including the 
the involvement triggered by TAS2R16 and TAS2R38, obtained from our studies on the 
potential cross-talk between fat and bitter taste modalities (Figure 71). 
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It could have application in the pharmaceutical industry (Schiffman, 2018) where numerous 
medicines present a stong bitter taste and are aversive to subjects mostly children and many 
adults. The elucidation of the cross-talk between the bitter and the fat taste could enhance 
drug acceptance and compliance in pediatric populations. 
 
Figure 71. Proposed model of the cross-talk between fat and bitter taste modalities in TBC. LCFA 
and bitter agonists bind to their cognate receptors that triggers the activation of PLCΆ leading to the 
production of IP3. The IP3 triggers the release of intracellular Ca2+ from the ER. The Ca2+ induces the 
release of ATP and 5-HT that constitute the feeding information and transit via the gustatory cranial 
nerves to the brain. LCFA, long-chain fatty-acid; PLCΆ2, phospholipase CΆ2; PIP2, Phosphatidylinositol 
4,5-bisphosphate; IP3, inositol trisphophate; ER,endoplasmic reticulum. Modified from Gilbertson and 
Khan (2014) including the obtained results on TAS2R16 and TAS2R38 and their potential interaction 
with CD36 and GPR120 and the Ca2+ signalling mechanism. 
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4 General discussion and perspectives 
Taken together, these results suggest the following integrative model (Figure 72). 
 
Figure 72. Proposed general hypothesis of the signalling pathway evoked by LCFA and bitter 
agonists in TBC. LCFA, long-chain fatty-acid; PLCΆŘ, phospholipase CΆŘ; PIP2, Phosphatidylinositol 
4,5-bisphosphate; IP3, Inositol trisphosphate; OTR, oxytocin receptor; OXT, oxytocin; ER, endoplasmic 
reticulum. The red signs show the inhibitory effect of CB1R on fat taste signalling. Modified from 
Gilbertson and Khan (2014) including TAS2R16, TAS2R38 and CB1R and their interaction with Ca2+ 
signalling mechanism. 
 
Thus, we can propose the following hypothesis: an activation of the ECS coupled to an 
inhibition of the oxytocin could induce a CD36 upregulating at the cell membrane inducing 
appetite and activating the food intake. Then, LA triggers the downregulation of CD36 and 
the upregulation of GPR120 (Ozdener et al., 2014) that induce the release of GLP-1 and 
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oxytocin from the TBC. The activation of GPR120 and the inhibition of the ECS, i.e., the 
potential internalisation of CB1R via the lipid rafts would lead to the satiaty state. 
In conclusion, both the ECS and the bitter taste status modify the fat taste signalling pathway 
modulating the Ca2+ response that triggers information to the brain and finally leads to food 
intake behaviour. To confirm our results, the same methodology could be performed in mouse 
and human TBC as mouse TBC also respond to linoleic acid, sinigrin, PTC and salicin 
(Figure 73) and HTC-8 cells respond to AEA and ACEA (Figure 74). 
 
Figure 73. LA, sinigrin, PTC and salicin induce increases in [Ca2+]i in mouse fungiform cell line. Ca2+ 
imaging studies were performed in calcium-containing (100% Ca2+) buffer. The changes in free 
intracellular Ca2+ concentrations (ΔF340/F380) were monitored under the Nikon microscope (TiU) by 
using S-fluor 40x oil immersion objectives. The kinetics of the rise in [Ca2+]i levels in mouse fungiform 
cell line following addition of LA (100 µM), sinigrin (1 mM), PTC (10 mM) and salicin (25 mM). Values 
are expressed as mean ± SEM (n=5). 
 
Figure 74. AEA and ACEA induce increases in [Ca2+]i in HTC-8 cells. Ca2+ imaging studies were 
performed in calcium-containing (100% Ca2+) buffer. The changes in free intracellular Ca2+ 
concentrations (ΔF340/F380) were monitored under the Nikon microscope (TiU) by using S-fluor 40x oil 
immersion objectives. The kinetics of the rise in [Ca2+]i levels in mouse fungiform cell line following 
addition of AEA (5 µM) and ACEA (1.5 µM). Values are expressed as mean ± SEM (n=5). 
However, these studies have some limitations. Indeed, regarding the CB1R study, the 
experiment should be repeated on a greater population including female mice and on human 
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subjects. About the cross-talk study, behavioral testes should be assessed on mice to ensure 
the validity of the obtained results. 
Bari et al. (2008) reported that CB1R functions in the context of lipid rafts. Thus, it would be 
interesting to explore the CB1R trafficking during the different phases of the eating behaviour 
considering in the same time the GLP-1 and the oxytocin release variations. Finally, as a 
cross-talk is likely to occur between fat and bitter taste modalities, it would be relevant to 
study the existence of a similar cross-talk between sweet and bitter or salty and bitter as 
suggested by (Khan et al., 2018b). 
These results also clearly strengthen the existence of a cross-talk between two taste 
modalities, here between fat and bitter tastes, that seems to occur at the Ca2+ signalling level. 
It opens the perspective of new anti-obesity strategies such as personalized considering 
sensitivity threshold of overweigh or cancer patients.  
Thus, we could imagine new therapeutic care using molecules modulating the CB1R activity 
and also bitter and fat taste receptors resulting in enhancing or weakening food intake effects 
on the reward circuitry. This therapy could, consequently, trigger the hormone release 
allowing the integration of anorexigenic affects of GLP-1 and the oxytocin.   
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La gustation est une des composantes permettant la perception orosensorielle des aliments et 
de leur composition. Celle-ci joue un rôle crucial dans les choix alimentaires. L’homme 
possède un système du goût très performant lui permettant de distinguer les aliments nutritifs 
des aliments potentiellement toxiques (Jyotaki et al., 2010).   
La perception du goût permet l’apport d’informations sur la qualité de la nourriture ingérée 
par l’organisme. Les signaux générés dans la cavité buccale vont transmettre l’information 
gustative à l’organisme via le système nerveux central. La cavité orale joue donc un rôle 
significatif dans le comportement alimentaire.  
Cinq goûts ont été identifiés : sucré, amer, acide, salé et umami. Pour autant, depuis peu, la 
perception du gras est proposée comme une saveur à part entière (Laugerette et al., 2005 ; 
Khan et Besnard, 2009). Par ailleurs, selon l’Organisation Mondiale de la Santé (OMS), la 
prévalence de l’obésité a pris des proportions telles qu’elle est, désormais, considérée comme 
une épidémie mondiale. Or, il a été démontré un lien entre le risque d’obésité et la 
consommation chronique des graisses alimentaires (Alvheim et al., 2012). C’est donc dans ce 
contexte que comprendre les mécanismes en jeu dans la perception du gras relève d’une 
importance capitale. 
1. Perception gustative 
1.1. Généralités 
La perception gustative relaie l’information déclenchée par les aliments ingérés de la cavité 
buccale au reste de l’organisme. Elle a lieu dans les bourgeons du goût inclus dans les papilles 
et situés, en grande majorité, dans l’épithélium dorsal de la langue. On dénombre 3 grands 
types de papilles : les papilles fongiformes, foliées et circumvallates (ou caliciformes) (Figure 
70). Le bourgeon du goût possède de 30 à 100 cellules gustatives. Il existe principalement 3 
types cellulaires dans les bourgeons du goût : les cellules de type I qui sont qualifiées, de par 
leurs propriétés, de « glial-like cells » ; les cellules de type II, correspondant aux cellules 
réceptrices du goût, qui expriment PLC2 (Phospholipase C 2) et les canaux TRPM5 
(Transient receptor potential cation channel subfamily M member 5), elles sont responsables 
de la libération des neurotransmetteurs, et les cellules de type III qui sont des cellules pré-
synaptiques (Chaudhari et Roper, 2010).  
La liaison d’une molécule sapide avec son récepteur conduit à des changements du potentiel 
membranaire et à une augmentation intracellulaire de la concentration en calcium libre, 
[Ca2+]i. Cette dépolarisation de la cellule gustative déclenche alors la libération de 
neurotransmetteurs (El Yassimi et al., 2008). Les signaux gustatifs de la cavité orale sont alors 
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transmis vers la branche du nerf crânien VII (la chorde du tympan du nerf crânien) et IX (la 
branche linguale du glossopharyngien) jusqu’au noyau du tractus solitaire (NTS) (Gaillard et 
al., 2008). Le NTS, quant à lui, est connecté à différentes zones du cerveau impliquées dans la 
prise alimentaire, la récompense, la mémorisation et le tractus digestif (Besnard et al., 2010). 
Ce mécanisme permet une intégration nerveuse et déclenche une réponse comportementale et 
métabolique (Figure 75).  
 
Figure 75 : Voies nerveuses impliquées dans la perception gustative. D’après Martin et al., 2010. 
VII chorde du tympan, IX nerf glossopharyngien, NTS Noyau du tractus solitaire. 
1.2. Perception orosensorielle des lipides alimentaires  
Des travaux récents ont proposé qu’il existe un 6e goût consacré à la perception des lipides 
(Laugerette et al., 2005 ; Khan et Besnard, 2009). Pour définir une saveur comme un goût 
primaire, il faut que celle-ci réponde à 5 critères : une classe unique de molécules sapides, un 
système de réception spécifique, une implication des voies gustatives, une perception 
gustative d’une sensation unique et une réponse physiologique. Le système de perception des 
lipides semble ainsi répondre à ces conditions (Gilbertson et Khan, 2014). 
1.2.1 Récepteur CD36 
CD36, aussi connu sous le nom de fatty acid translocase (FAT), est une glycoprotéine 
membranaire appartenant à la famille des récepteurs scavengers. Elle est capable de lier 
différents ligands dont les acides gras (Gilbertson et Khan, 2014). En outre, CD36 possède 
une haute affinité, de l’ordre du nanomolaire, pour les acides gras. 
Récemment, Laugerette et al. (2005) ont démontré l’implication de CD36 dans la perception 
des lipides chez la souris. En effet, l’inactivation du gène CD36 abolit complètement la 
Résumé 
158/214 
Second part: Personal contributions Résumé en français 
préférence aux acides gras à longue chaîne (AGLC). Cette observation a été confirmée depuis 
par d’autres équipes (Sclafani et al., 2007). De plus, cet effet serait lipide-spécifique, la 
préférence au sucré et l’aversion à l’amer n’étant pas affectées chez les souris transgéniques 
n’exprimant pas le gène CD36 (Laugerette et al., 2005).  
Le récepteur CD36 est fortement exprimé dans les papilles circumvallates des rongeurs 
(Laugerette et al., 2005). Sa distribution apicale au niveau de l’épithélium lingual est adéquate 
pour la génération d’un signal lipidique par les bourgeons du goût. En effet, CD36 étant situé 
au niveau de ces derniers, il est directement exposé à un microclimat potentiellement riche en 
AGLC (Khan et Besnard, 2009) : les lipases linguales, libérées par les glandes de Von Ebner 
dans la fente des papilles circumvallates, dégradent les triglycérides (qui constituent la 
majorité des lipides d’origine alimentaire) en AGLC, les ligands de CD36 (Figure 76). 
 
Figure 76 : Localisation des glandes de Von Ebner. D'après Khan et Besnard, 2009. 
1.2.2 Récepteur GPR120 
Les G protein-coupled receptors (GPCR) sont une famille de récepteurs qui répondent à des 
ligands variés tels que les photons, les odeurs, les phéromones ou les acides aminés. GPR120, 
un récepteur de la famille GPCR, est capable d’être activé par les AGLC (Gilbertson et Khan, 
2014).  
GPR120, exprimé dans les cellules entéroendocrines, est aussi présent au niveau de 
l’épithélium lingual où il jouerait un rôle dans la détection orale des lipides chez la souris. 
Pour autant, son rôle en tant que récepteur des lipides alimentaires est moins clair. Il a été 
démontré que GPR120 et CD36 possèdent des rôles bien distincts dans la perception 
orogustative des lipides alimentaires et qu’ils sont régulés différemment par l’obésité 
(Ozdener et al., 2014). En effet, CD36 est impliqué dans la perception précoce des lipides 
alimentaires alors que GPR120 serait impliqué dans la perception et la régulation du 
rassasiement.  
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1.3. Mécanisme de signalisation 
La liaison d’AGLC au CD36 linguale 
et/ou au GPR120 déclenche une cascade 
de signalisation. L’activation du récepteur 
conduit à l’activation de la cascade PLC-
IP3 (phospholipase C- inositol 
triphosphate) qui aboutit à la libération de 
Ca2+ par le réticulum endoplasmique (ER). 
L’augmentation de [Ca2+]i va alors activer 
les canaux TRPM5 (Transient receptor 
potential cation channel subfamily M 
member 5), responsables de l’influx 
sodique Na+. Cet influx conduit à 
l’activation des canaux DRK (delayed-
rectifying potassium channel), 
responsables de la repolarisation de la cellule via l’efflux de K+. Ceux-ci seront bloqués par la 
liaison des AGLC à CD36 lors de l’activation soutenue du bourgeon du goût. L’augmentation 
massive de [Ca2+] dans la cellule, via les canaux calciques Orai1 et Orai1/3 dits SOC (store 
operated calcium channels) et les canaux calciques voltage-dépendants (VGCC) activés suite 
au blocage des canaux DRK, va déclencher l’exocytose de neurotransmetteurs (sérotonine) 
qui est responsable de la transmission du signal au cerveau via les fibres nerveuses afférentes 
(Dramane et al., 2012 ; Gilbertson et Khan, 2014) (Figure 77). 
2. Détection orosensorielle des composés amers 
2.1. Agonistes du goût amer 
La capacité de détecter l'amertume est liée à une fonction critique de survie permettant aux 
animaux de distinguer des aliments potentiellement nocifs. Grâce à sa valeur hédonique 
négative innée (Steiner et al., 2001), la perception de l'amertume décourage l'alimentation et 
les différences de sensibilité au goût amer influencent le comportement alimentaire humain. 
La perception du goût amer est contrôlée par la famille de gènes du récepteur du goût 2 
(TAS2R). Il existe 25 gènes TAS2R humains (Drayna, 2005) avec de nombreux 
polymorphismes associés et un large éventail de différences individuelles dans la sensibilité 
au goût amer (Chandrashekar et al., 2000). Cela explique en partie pourquoi des milliers 
Figure 77 : Mécanismes d'action des AGLC via 
CD36 et GPR120 dans une cellule du bourgeon 
du goût. D'après Gilbertson et Khan (2014). 
Résumé 
160/214 
Second part: Personal contributions Résumé en français 
d'agonistes chimiquement dissemblables peuvent déclencher une qualité gustative unique. Les 
récepteurs les plus étudiés sont TAS2R16 et TAS2R38. 
Fox (1932) a découvert fortuitement que la concentration de phénylthiocarbamide (PTC) avait 
un goût extrêmement amer pour certaines personnes et était pratiquement sans goût pour les 
autres. En effet, la sensibilité à la PTC, composé contenant un groupe -N-C = S, est utilisée 
comme marqueur phénotypique pour les sensations orales (Tepper, 2008). 
2.2. Transduction du signal via l’amer dans les cellules des bourgeons 
du goût 
Parmi la famille de gènes TAS2R, le gène TAS2R38 est l'un des plus largement étudiés. 
TAS2R38 code pour un récepteur de sept protéines transmembranaires G (Drayna, 2005). Le 
récepteur est impliqué dans la liaison PTC et 6-n-propylthiouracile (PROP) (Kim et Drayna, 
2005). 
La génération du goût amer commence lorsqu'un composé amer pénètre dans la cavité 
buccale. Le ligand se lie à un récepteur TAS2R exprimé dans la membrane apicale des 
cellules réceptrices des papilles gustatives. Elle déclenche une cascade d'événements de 
signalisation impliquant l'activation de l'α-gustducine, du PLCβ2 et de l'inositol trisphosphate 
(Zhang et al., 2003b), conduisant finalement à la libération de neurotransmetteurs activant une 
fibre nerveuse afférente transmettant le signal via le nerf crânien. au cerveau. Les signaux 
gustatifs traversent le cerveau et transmettent les informations aux circuits impliqués dans 
diverses fonctions, telles que les réflexes physiologiques, la perception discriminatoire et le 
traitement affectif. Ce système illustre la complexité des mécanismes intervenant entre 
l'application du stimulus amer et la génération de la réponse comportementale. 
3. Comportement alimentaire et système endocannabinoïde 
3.1. Système endocannabinoïde 
Le système endocannabinoïde comprend des agonistes endogènes (les endocannabinoïdes) et 
des récepteurs responsables de leurs actions : CB1R et CB2R, ainsi que les systèmes 
enzymatiques qui catalysent leur biosynthèse et dégradation (DiPatrizio et al., 2013).  
L’établissement de ce système fait suite à la découverte du -9-tétrahydrocannabinol 
(9THC) par Raphael Mechoulam en 1964 (Gaoni et Mechoulam, 1964). Le 9THC est le 
composé le plus actif produit par la plante Cannabis sativa. Ainsi, les récepteurs 
cannabinoïdes ont été identifiés : CB1R et CB2R. CB1R est largement exprimé dans le système 
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nerveux central et périphérique surtout au niveau des structures limbiques (hypothalamus) et 
du noyau accumbens (Moldrich et Wenger, 2000). Ils ont aussi été détectés dans les 
bourgeons du goût (Yoshida et al., 2010). CB2R, quant à lui, est essentiellement exprimé dans 
les cellules du système immunitaire. 
L’anandamide et le 2-arachidonylglycerol (2-AG) ont été identifiés comme les deux 
endocannabinoïdes endogènes majeurs agissant sur les récepteurs CB1 et CB2. 
3.2. Cannabinoïdes et prise alimentaire 
Il est connu depuis les années 70 que le cannabis augmente l’appétit et la consommation 
alimentaire, particulièrement des aliments palatables, chez l’homme (Abel, 1975). Plusieurs 
études se sont alors penchées sur les endocannabinoïdes. Il en résulte que l’administration 
exogène de cannabinoïdes (anandamide) induit une hyperphagie et une préférence pour les 
substances palatables (Williams et Kirkham, 1999). Les endocannabinoïdes sont donc des 
médiateurs orexigènes. De plus, l’utilisation d’antagonistes des récepteurs CB1 (tel que le 
rimonabant SR-14716A) réduit la prise alimentaire (Arnone et al., 1997). Les récepteurs CB1 
semblent donc être impliqués dans la prise alimentaire. Les antagonistes des 
endocannabinoïdes ont alors été proposés pour le traitement de l’obésité (Berry et 
Mechoulam, 2002).  
Ces résultats ont mené à l’hypothèse suivant laquelle le système endocannabinoïde endogène 
jouerait un rôle dans la régulation de l’appétit et de la prise alimentaire. De plus, il serait aussi 
impliqué dans le processus de récompense qui provoque la motivation et la valeur hédonique 
des aliments (Kirkham, 2003). En effet, les récepteurs CB1 sont exprimés dans le noyau 
accumbens et dans l’hypothalamus, régions appartenant au circuit de la récompense. 
Le système endocannabinoïde est donc un régulateur clé de la prise alimentaire palatable 
(DiPatrizio et Piomelli, 2012). En effet, les endocannabinoïdes induiraient des modifications 
du comportement alimentaire via la sensation de la palatabilité des composants alimentaires 
(Yoshida et al., 2010). Ainsi, le système endocannabinoïde pourrait être un composant 
critique du mécanisme de feed-back positif requis pour maintenir la prise alimentaire grasse 
(DiPatrizio et al., 2013). 
 
4. Comportement alimentaire et SNP 
Les modalités gustatives pourraient interagir entre elles et avec d'autres sens, et ces 
interactions pourraient être critiques dans l'obésité (Khan et al., 2018). Une relation entre le 
goût gras et amer a été récemment proposée. En effet, certains rapports suggèrent qu'il existe 
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une préférence plus élevée pour les graisses alimentaires chez les perconnes qui ne détectent 
pas PROP (non-tasters) au cours du test PROP (Karmous et al., 2018; Tepper et Nurse, 1997; 
Tepper et al., 2008). De plus, Melis et al. (2015a) ont montré qu'il existe une association entre 
la perception orosensorielle de l'acide oléique, le SNP rs1761667 dans le gène CD36 et le 
statut de « taster » de PROP. Ces études ont également montré que les sujets non-tasters de 
l’amer présentaient également une perception réduite des graisses orales, induisant une 
consommation d'aliments riches en graisses et, par conséquent, un risque élevé d'obésité 
(Keller, 2012). Notre équipe a montré que les génotypes CD36 rs1761667 et TAS2R38 
rs1726866 et rs10246939 étaient associés à des seuils de détection de PROP plus élevés et à 
un IMC plus élevé chez les sujets obèses que les participants de poids normal. Ces 
observations ont révélé l'existence d'une association entre le seuil de détection de PROP et les 
génotypes CD36 et TAS2R38 (Khan et al., 2018). 
Dans le présent rapport, nous avons étudié la relation entre le goût gras et amer en étudiant les 
mécanismes de signalisation en aval dans les cellules fongiformes immortalisées par l'homme, 
HTC-8. Des individus non tasters ont été signalés comme ayant une capacité réduite à 
distinguer la teneur en matières grasses dans les aliments (Hayes et Duffy, 2007). En effet, les 
non-tasters pour l’amer semblaient incapables de distinguer la teneur en graisse des 
vinaigrettes italiennes riches en matières grasses et des acides gras dans les aliments riches en 
graisses (Nasser et al., 2001; Tepper et Nurse, 1998). Par conséquent, ces sujets consomment 
plus de graisses alimentaires et d'aliments riches en énergie que les tasters (Keller et Tepper, 
2004; Tepper et al., 2011). Considérant que les « supertasters » de PROP peuvent éviter les 
aliments riches en graisses en raison de leurs sensations intenses (Duffy et Bartoshuk, 2000),  
Melis et al. (2015a) ont montré pour la première fois une corrélation entre le SNP CD36 et la 
diminution de la perception du goût gras observée chez les sujets non dégustateurs de PROP. 
Il est apparu que les sujets présentaient le phénotype AVI / AVI TAS2R38 homozygote pour 
l'allèle G du rs171667 pour le CD36, la méthode de détection de l'acide oléique étant 11 fois 
plus faible que pour les sujets du génotype AVI / AVI TAS2R38 mais avec un génotype AA 
homozygote polymorphisme. Il est également apparu que les non-dégustateurs de PROP 
avaient la même résistance à l'acide oléique que les super-dégustateurs. Ils ont observé que le 
génotype AA de rs1761667 présentait un IMC accru et une sensibilité réduite à la perception 
des graisses et du goût amer.  
Plusieurs études ont montré que les non-tasters de PROP présentent une densité de papilles 
fongiformes inférieure à celle des tasters de PROP (Melis et al., 2013b; Shahbake et al., 2005; 
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Yeomans et al., 2009). Ebba et al. (2012) ont émis l'hypothèse que la capacité accrue de 
dégustation de l'acide linoléique chez les tasters de PROP, par rapport aux non-tasters, 
pourrait être attribuée à la différence de densité des papilles fongiformes entre ces deux 
groupes. En effet, nos données ont montré une densité plus faible de papilles fongiformes sur 
la partie antérieure de la langue des non-dégustateurs PROP, qui présentent également une 
capacité plus faible à détecter l'acide oléique que les tasters PROP. Cette découverte suggère 
qu'un taux élevé d'expression de CD36 dans les cellules gustatives semble être un facteur 
déterminant pour la détection des graisses alimentaires uniquement chez les sujets ayant une 
faible densité de papilles gustatives (Melis et al., 2015a). Récemment, des enquêtes sur 
l'association du seuil de détection de PROP aux génotypes CD36 et TAS2R38 dans l'obésité 
dans une population tunisienne (Karmous et al., 2018), il est apparu que la méthode de 
détection de PROP était associée à l’IMC. 
Aux niveaux cellulaire et moléculaire, le goût gras, à savoir CD36 et GPR120, et le goût 
amer, à savoir TAS2R16 et TAS2R38, sont exprimés dans les cellules de type II. Ainsi, les 
deux voies pourraient activer l’α-gustducine pour les récepteurs de signalisation en aval 
(Roper et Chaudhari, 2017), puis l'activation de PLCβ2 impliquée dans l'hydrolyse du 
phosphatidylinositol4,5-bisphosphate (PIP2) en inositol trisphosphate (IP3). Ensuite, IP3 se lie 
à son récepteur IP3R sur le RE et déclenche la libération de Ca2+. Ainsi, Khan et al. (2018) ont 
déclaré que le mécanisme commun est la «signalisation du Ca2+» entre la perception du goût 
amer et le goût de la graisse. L’élucidation d’un dialogue entre les modalités du gras et du 
goût amer pourrait trouver des applications dans l’industrie alimentaire, le traitement de 
l’obésité et l’industrie pharmaceutique pour réduire l’amertume des médicaments chez les 
enfants en particulier (Mennella et al., 2013). Keller (2012) a suggéré que les récepteurs de 
graisse et de goût amer pourraient jouer des rôles différents. En effet, TAS2R38 serait 
impliqué dans la perception de la texture des graisses alimentaires en fonction de l’état de du 
test au PROP et le CD36 influencerait la perception chimiosensorielle des AGLC. 
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Hypothèses de travail :  
Implication de CB1R dans la perception des acides gras alimentaires  
Les proportions d'acide linoléique (18: 2) ont considérablement augmenté dans le régime 
alimentaire occidental depuis le vingtième siècle, passant de 1 à 8% de l'apport énergétique 
total. Cette augmentation est corrélée à l'augmentation de la prévalence de l'obésité au cours 
de cette même période (Alvheim et al., 2012). Récemment, l'hypothèse d'une préférence 
spontanée pour les lipides associés au goût des graisses a émergé et pourrait expliquer l'aspect 
comportemental lié à l'obésité. Yoshida et al. (2010) ont testé les préférences alimentaires des 
souris de type sauvage et CB1R-/- traitées avec un agoniste de l'endocannabinoïde, 2-AG. En 
conséquence, seule la consommation de solutions de sucre a été augmentée chez les souris 
sauvages traitées avec 2-AG. La consommation de solutions amères, salées, acides et umami 
n'a pas été affectée par le traitement. Aucun changement de consommation n'a été observé 
chez les souris CB1R-/- (Yoshida et al., 2010). Cette étude démontre une modification de la 
perception de l'appétence par les endocannabinoïdes via les récepteurs CB1R. Étant donné que 
l'excès de prise alimentaire en lipides est associé à l'obésité et que le système 
endocannabinoïde via les récepteurs CB1R améliore la prise alimentaire (perception de la 
douceur en particulier), nous proposons d'étudier le rôle du récepteur CB1 dans la préférence 
des lipides alimentaires. L’implication du système endocannabinoïde dans la perception 
gustative des lipides alimentaires via le CB1R lingual n’a pas encore encore été étudiée. Nous 
proposons d’étudier ce rôle potentiel chez la souris via des tests de comportements, des études 
biochimiques et du signal calcique. Nous émettons l’hypothèse que le système 
endocannabinoïde, via le CB1R lingual, affecte la détection du goût du gras dès la cavité 
buccale. 
Le projet vise à élucider les tâches suivantes: 
1) Etudier les conséquences de la délétion de Cb1r chez les souris invalidées pour le gène 
(CB1R-/-) sur leur perception des lipides alimentaires. 
2) Etudier la conséquence de la délétion du gène sur la régulation des protéines CD36 et 
GPR120. 
3) Etudier les mécanismes de signalisation cellulaire, via les lipides, des récepteurs CD36 
et GPR120 dans les cellules gustatives des souris CB1R-/-. 
4) Etudier les conséquences de la délétion du gène sur la sécrétion de GLP-1. 
Ceci permettrait la synthèse « d’agonistes inverses », agonistes pour CD36 et GPR120 et 
antagoniste de CB1R pouvant alors intervenir dans le traitement de l’obésité. 
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Résultats et Discussion 
Williams et Kirkham (1999) ont démontré que CB1R est responsable de l’augmentation de 
l’apport alimentaire, induite par un agoniste des endocannabinoïdes. Plus tard, Yoshida et al. 
(2010) ont révélé que les endocannabinoïdes amélioraient les réponses gustatives aux goûts 
sucrés via CB1R. En effet, l'activation du système endocannabinoïde (ECS) semble être 
associée à une hyperphagie et à une préférence pour les aliments palatables. Fait intéressant, 
CB1R est également exprimé dans un sous-ensemble de cellules de papilles gustatives 
(Yoshida et al., 2010). Nous rapportons ici que les souris CB1R-/- ne présentaient aucune 
préférence pour les solutions lipidiques par rapport aux souris WT. Le même comportement a 
également été observé lorsque les souris WT ont été traitées avec le rimonabant, un bloqueur 
CB1R, confirmant le rôle de ce récepteur dans la détection des lipides alimentaires. Nous 
avons employé l’acide linoléique (AL) comme candidat pour les acides gras à longue chaîne 
(AGLC), car cet acide gras est abondamment présent dans les aliments occidentaux; 
cependant, il est possible que les acides gras saturés tels que l'acide palmitique (AP) puissent 
également déclencher la même réponse gustative. En effet, nous avons montré précédemment 
que AL et AP provoquaient les mêmes augmentations de [Ca2+]i dans les cellules des papilles 
chez la souris (Gaillard et al., 2008).  
Dans la présente étude, pour les expériences comportementales, nous avons utilisé des souris 
knock-out pour CB1R et il est possible que le système cannabinoïde hypothalamique, via la 
zone dopaminergique, soit impliqué dans la préférence gustative (Melis et al., 2013). 
Néanmoins, nous avons cherché à élucider les mécanismes cellulaires dans la modulation de 
la préférence en matière de graisse. Nous avons tout d'abord testé l'hypothèse d'une altération 
des protéines CD36 et GPR120 dans les TBC de souris CB1R-/-. Dans notre étude, les 
expressions des protéines CD36 et GPR120 n'ont pas été altérées par l'absence de CB1R, ce 
qui suggère que l'absence de préférence pour les solutions lipidiques peut être due à une 
signalisation en aval altérée. De plus, nous avons vérifié la délivrance de l'acide linoléique 
dans les deux conditions et nous avons observé une absorption identique des acides gras 
exogènes. 
Des études antérieures ont indiqué que l'activation de CD36 et GPR120 par un AGLC a 
déclenché la mobilisation de [Ca2+]i à partir du pool intracellulaire de réticulum 
endoplasmique Ca2+ pendant la perception du goût gras (Galindo et al., 2012; Ozdener et al., 
2014). Dans notre étude, nous montrons, pour la première fois, que l’augmentation induite par 
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AL dans [Ca2+]i a été altérée lorsque CB1R a été inactivé par le rimonabant ou par l’absence 
de CB1R. En outre, l'ACEA agoniste CB1R a également augmenté le flux de calcium dans les 
TBC, mais avec une puissance inférieure à celle d’AL. Cependant, l'effet de l'ACEA a été 
maintenu dans les TBC des souris CB1R-/-, augmentant la possibilité que l'augmentation de 
[Ca2+]i puisse être médiée par d'autres récepteurs que CB1R, par exemple TRPV1. En effet, il 
a été montré que l'activation de TRPV1 par les endocannabinoïdes induit la signalisation du 
calcium (Kentish et Page, 2015; Ryskamp et al., 2014). En outre, le blocage de TRPV1 avec 
A784168 a totalement supprimé la réponse [Ca2+]i induite par les ACEA, indiquant que le 
signal calcique résiduel observé dans CB1R-/- TBC avec ACEA pourrait être dû à l'activité 
TRPV1. En outre, il semble que la signalisation en aval couplée à CB1R soit dépendante du 
PLC, conformément aux observations de De Petrocellis et al. (2007). Cependant, il reste à 
élucider si l'anandamide, utilisé dans la présente étude, active la sous-unité Gβδ de CB1R et 
active le PLC via la voie PI-3-kinase. Dans l'ensemble, nos données indiquent que CB1R 
pourrait jouer un rôle crucial dans la perception du goût du gras en modulant la signalisation 
du calcium. 
Comme décrit précédemment, les souris GLP-1-/- ont des réponses gustatives réduites aux 
graisses alimentaires, ce qui suggère que la détection orosensorielle des AGLC pourrait être 
associée à la sécrétion de GLP-1 lingual (Martin et al., 2012). Les données rapportées ici ont 
montré que la sécrétion de GLP-1 active induite par AL est fortement diminuée chez les 
souris CB1R-/-, ce qui suggère l'existence d'un lien entre la signalisation CB1R et la production 
de GLP-1. Par conséquent, l'activation de CB1R peut stimuler la production de proglucagon et 
de GLP-1r et, ainsi, moduler le seuil de perception des AGLC. Des investigations 
supplémentaires sont nécessaires pour explorer la possibilité que la sécrétion de GLP-1 soit 
stimulée par la signalisation [Ca2+]i dans les TBC ou par d'autres mécanismes (Takai et al., 
2015). 
En conclusion, le présent rapport montre que CB1R influence la perception du goût des 
graisses via la régulation de la signalisation calcique dans les TBC. Il est proposé que 
l'activation de CB1R induise une réponse [Ca2+]i qui renforce la perception des lipides, médiée 
par le CD36. L'activation de l'ECS pourrait, de ce fait, augmenter les stimuli sensoriels 
relayant l'appétence des aliments et, en fin de compte, stimuler la prise alimentaire. La 
pertinence physiopathologique d'une telle voie de régulation est étayée par le fait que le tonus 
de l'ECS augmente dans l'obésité. Par conséquent, l'ECS semble émerger comme un 
modulateur clé de la détection orale des sucres et des graisses et pourrait représenter une cible 
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potentielle pour développer de nouvelles stratégies anti-obésité ou, inversement, augmenter la 
prise alimentaire en cas de perte d'appétit dans la cachexie.  
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Hypothèse de travail :  
Communication bidirectionnelle entre les modalités gustatives amères et 
lipidiques dans les cellules gustatives humaines  
L'obésité constitue l'un des principaux problèmes de santé publique en ce début du 21ème 
siècle. Sa prévalence augmente régulièrement, en particulier chez les enfants. Ce constat n'est 
pas anodin car l'obésité est généralement associée à diverses pathologies graves (diabète de 
type 2, hypertension et cancer,…). L'abondance alimentaire contribue grandement à ce 
phénomène. En effet, dans les pays occidentaux, les lipides alimentaires représentent près de 
40% de l'apport calorique quotidien alors que les recommandations nutritionnelles sont 
inférieures de 5 à 10%. Le goût amer est détecté par le récepteur lingual T2R38. Il a été 
proposé que les non-dégustateurs d'acides gras ne soient pas non-tasters du goût amer. En 
outre, le polymorphisme du gène CD36 entraîne une diminution de l'expression des protéines 
et, par conséquent, une diminution de la détection oro-sensorielle du goût des graisses. 
Certains sujets qui expriment le polymorphisme du CD36 présentent également une 
augmentation du seuil de détection de l'amertume. Ainsi, il pourrait exister une interaction 
entre les deux modalités gustatives, à savoir les goûts gras et amers. Par conséquent, la 
capacité à détecter les acides gras et le dialogue possible entre les goûts gras et amer restent 
un sujet important à explorer car cela pourrait constituer de nouvelles stratégies anti-obésité. 
Nous avons émis l’hypothèse que le goût amer et le goût gras partagent un mécanisme de 
signalisation en aval commun. Nous avons étudié la relation entre le goût amer et le gras et le 
gras en étudiant les mécanismes de signalisation en aval dans les cellules fongiformes. 
Le projet vise à élucider les tâches suivantes:  
1) Etude de l'expression des récepteurs gustatifs des lipides alimentaires (CD36 et 
GPR120) et du récepteur de goût amer (TAS2R38) pour déterminer si les 2 récepteurs 
sont co-exprimés par des cellules fongiformes humaines.  
2) Etude de la signalisation cellulaire, en particulier le signal Ca2+, via CD36 / GPR120 et 
T2R38 pour étudier la communication bidirectionnelle entre ces 2 familles de 
récepteurs.  
3) Etude du rôle joué par les agents autocrines / paracrines comme le GLP-1, le CCK… 
qui sont libérés du TBC dans la modulation de deux modalités gustatives.  
Ces tâches seront effectuées sur des cellules fongiformes humaines (HTC-8) immortalisées 
par l'institut BRAIN (Zwingenberg, Allemagne). 
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La mise en évidence du cross-talk entre ces deux modalités gustatives pourrait permettre 
d’établir de nouvelles stratégies alimentaires personnalisées tenant compte des 
polymorphismes des récepteurs gustatifs amers et gras (seuil de sensibilité) pour les patients 
en surpoids ou atteints de cancer. 
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Résultats et discussion 
Dans le cadre de notre collaboration avec l'institut BRAIN, nous avons proposé d'étudier 
l'interaction potentielle entre les modalités du goût du gras et de l’amer dans les cellules HTC-
8. Tout d'abord, nous avons caractérisé le profil des cellules HTC-8. Hochheimer et al. (2014) 
n'ont pas détecté GNAT3/α-gustducine et PLCβ2 dans les cellules HTC-8. Ils ont donc conclu 
que GNAT2/transducine qui est également exprimée dans les cellules des bourgeons du goût, 
pourrait compléter partiellement l’action de GNAT3/α-gustducin et pourrait participer à la 
voie de transduction du signal gustatif (Kusakabe et al., 2000; McLaughlin et al., 1992). 
Ainsi, GNAT2/transducine pourrait remplacer les facteurs de signalisation gustatifs 
canoniques dans les cellules HTC-8. En ce qui concerne l'absence de détection de PLCβ2, il 
est probable que PLδ4, un paralogue du gène PLCβ2, contribue à la transduction du signal, 
car PLCδ4 est exprimé chez les cellules des bourgeons du goût des primates (Hevezi et al., 
2009). Il est intéressant de noter que, dans notre étude, nous avons observé un marquage 
positif pour l'α-gustducine, facteur clé de la voie de signalisation canonique du goût gustatif 
(Kinnamon, 2012), ainsi que pour PLCβ2. Ainsi, les cellules HTC-8 semblent présenter un 
profil de récepteur de type II (Chaudhari et Roper, 2010). Néanmoins, il est possible que 
GNAT2/transducine et PLCδ4 contribuent à la transduction du signal du goût du gras. 
D'autres études sont nécessaires pour explorer cette hypothèse. 
Ici, nous avons proposé d'étudier l'interaction probable entre les goûts gras et amers. Pour ce 
faire, j'ai passé près de deux ans à caractériser la lignée cellulaire HTC-8. Nous avons observé 
que les cellules HTC-8 expriment PLCβ2 et l’α-gustducine parmi d'autres marqueurs 
cellulaires et, principalement, co-expriment les récepteurs du goût amer et du goût du gras. 
Karmous et al. (2018) ont montré une association directe entre l’IMC, la perception 
orosensorielle des acides gras et PROP. L'étude met en lumière un possible croisement entre 
goût gras et amer impliquant des interactions cellulaires et moléculaires. 
Il est probable que les goûts amer et gras partagent une signalisation en aval commune de 
Ca2+. Nous avons proposé d'élucider les mécanismes sous-jacents qui se produisent dans les 
cellules des papilles gustatives. Nous avons d'abord évalué l'expression des récepteurs amers 
et du goût gras. Nous avons observé que les récepteurs du goût gras (CD36 et GPR120) et les 
récepteurs du goût amer (TAS2R38 et TAS2R16) étaient exprimés par les cellules HTC-8. De 
plus, CD36 est co-exprimé avec TAS2R38 et TAS2R16 d'une manière homogène. Pour ce 
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faire, nous avons sélectionné trois agents amers, PTC (phenylthiocarbamide) connu pour être 
un agoniste du TAS2R38 (Behrens et al., 2013; Bufe et al., 2005; Meyerhof et al., 2010), la 
salicine, un agoniste du TAS2R16 (Maehashi et al., 2008; Meyerhof et al., 2010; Soranzo et 
al., 2005; Thomas et al., 2017) et la sinigrine, un glucosinolate auquel TAS2R38 et TAS2R16 
répondent tous deux (Behrens et al., 2013; Meyerhof et al., 2010 ; Thomas et al., 2017). Tout 
d'abord, nous avons montré que cellules HTC-8 réagissaient de manière dose-dépendante à la 
signalisation endogène du Ca2+ pour les saveurs amères et lipidiques (Hochheimer et al., 
2014; Meyerhof et al., 2010). Ensuite, les réponses diminuées du signal en l'absence de Ca2+ 
dans le tampon indiquent que la transduction du signal a mobilisé le calcium  à partir d'un 
pool extracellulaire (Ozdener et al., 2014). Il est apparu que la signalisation du goût du gras et 
amer dépend de la présence de Ca2+ extracellulaire. L'addition d’AL et des différents 
agonistes du goût amer, l'un après l'autre, a déclenché des réponses additives, suggérant que 
l’AL interagissait avec le CD36 tandis que les agonistes amers activaient seulement leur 
récepteur apparenté, à savoir TAS2R16 et / ou TAS2R38. Ensuite, nous nous sommes 
concentrés sur le mécanisme en aval. Il a révélé que les inhibiteurs de la signalisation du Ca2+ 
en aval, connus pour être impliqués dans la transduction du signal du goût du gras via CD36, 
inhibaient également la signalisation de l’amer. En effet, tous les inhibiteurs utilisés dans 
l’étude ont altéré la signalisation du Ca2+ après leur adjonction dans le milieu, ce qui a 
fortement soutenu l’existence d’un croisement amer du goût gras et des modalités de goût 
amer. 
L'influx de Ca2+ qui se produit par l'ouverture des canaux SOC (store operated calcium 
channels), tels que Orai1 et Orai3, est modulé par la phosphorylation, médiée par les kinases 
de la famille Src (Babnigg et al., 1997). El-Yassimi et al. (2008) ont montré que les 
inhibiteurs de SFK réduisaient de manière significative les augmentations de [Ca2+]i induites 
par les AGLC dans les cellules de papilles gustatives (TBC) exprimant CD36 chez la souris. 
En outre, STIM1 (stromal interaction molecule 1) est un capteur de réticulum endoplasmique 
(RE) dont la stimulation entraîne l'activation des canaux SOC. STIM1 s'est avéré impliqué 
dans la perception du goût du gras, car la préférence spontanée vis-à-vis des AGLC chez les 
souris STIM1-/- a été supprimée (Dramane et al., 2012). De plus, il a été démontré que STIM1 
régule l'ouverture des canaux SOC induite par les AGLC chez des souris exprimant CD36 
(Dramane et al., 2012). En effet, les bloqueurs des canaux SOC (c.-à-d. SKF96365 et 
econazole) ont diminué de manière significative les augmentations induites par les agonistes 
amers et amers de [Ca2+]i. Comme indiqué (Ozdener et al., 2014), notre étude corrobore 
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l'implication des canaux SOC dans les réponses au Ca2+ au LCFA et met en évidence 
l'implication de ces canaux dans les réponses au Ca2+ provoquées par les agents amers.  
Bien que Hochheimer et al. (2014) n'aient pas réussi à détecter PLCβ2 dans les cellules HTC-
8, nous avons obtenu un marquage PLCβ2 positif et avons également trouvé l'ARNm de 
PLCβ2. L'utilisation de l’U73122, un inhibiteur des PLC, déclenchant une réponse calcique 
réduite significative, a indiqué que les agonistes du goût du gras  et les agonistes amers ont 
mobilisé le Ca2+ via un mécanisme dépendant du PLC. La concentration utilisée est 
délibérément faible, car il a été démontré que le U73122 diminuait de manière dose-
dépendante les réponses [Ca2+]i (Jan et al., 1998). 
Nous nous demandons si un antagoniste des récepteurs du goût gras pourrait perturber la 
transduction du signal de goût amer. Comme prévu, la signalisation de Ca2+ évoquée par AL a 
été significativement réduite en présence de sulfo-N-succinimidyle (SSO) et AH7614 (un 
antagoniste de GPR120) (Ozdener et al., 2014). Fait intéressant, nous avons observé le même 
phénomène avec PTC, la salicine et, dans une moindre mesure, la sinigrine après 20 minutes 
de pré-incubation avec SSO et AH7614, suggérant que les agonistes amers ont mobilisé le 
Ca2+ en interférant avec la signalisation indirecte. 
Pris ensemble, ces résultats suggèrent que le goût du gras et de l’amer partagent une voie 
commune. Nous pouvons supposer que les agonistes de goût amer et gras se lient à leurs 
récepteurs apparentés et activent PLCβ2 qui déclenche la production d'IP3 qui conduirait à la 
libération intracellulaire de Ca2+, aboutissant finalement à la libération de neurotransmetteurs. 
Il est également apparu que la signalisation de goût amer interfère avec la signalisation CD36 
et GPR120. Ainsi, il semble qu'une seule voie existe dans les cellules HTC-8. Ces résultats 
sont contradictoires avec les données d’Hochheimer et al. (2014), qui indiquent que deux 
voies de signalisation coexistent, une signalisation dépendante du PLC et une signalisation du 
Ca2+ indépendante du PLC. Cela signifie que l'influx de Ca2+ extracellulaire et intracellulaire 
est impliqué dans la signalisation en aval, à la fois amère et lipidique. Quoi qu’il en soit, ces 
résultats mettent en évidence le croisement entre le goût gras et le goût amer qui confirme le 
concept de «goût gras amer». Néanmoins, ce concept doit être élucidé car il pourrait 
impliquer d'autres composants.  
Les cellules HTC-8 expriment l'haplotype PAV (Proline-Alanine-Valine) correspondant à la 
variante « taster » de TAS2R38 (Hochheimer et al., 2014) et associée à la plus haute 
sensibilité à l'acide oléique et PROP (Melis et al., 2015). À l’avenir, il serait intéressant de 
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tester et de comparer la transduction de signalisation du gras et du goût amer dans les cellules 
exprimant la variante de test AVI du TAS2R38 liée à la capacité la plus faible de détecter 
l’acide oléique (Melis et al., 2015).  
En raison des découvertes récentes sur le rôle physiologique de l'ocytocine dans la régulation 
de l'alimentation et des avantages qu'elle présente pour le traitement de l'obésité, nous avons 
étudié l'implication de la stimulation du goût du gras dans la sécrétion de l'ocytocine. 
L'ocytocine n'est pas seulement administrée aux papilles via la circulation sanguine 
contrairement à Sinclair et al. (2010), mais est également produite localement, comme l'a 
révélé le dosage libéré par l'ocytocine dans les cellules HTC-8. Ceci est étayé par le fait que 
l’ocytocine a été mesurée dans le surnageant des cellules HTC-8. De plus, il est intéressant de 
noter que la libération d’ocytocine est plus importante lorsque l’acide linoléique est incubé 
avec la SSO et l’AH7614. Ce phénomène pourrait révéler une désensibilisation aux acides 
gras au niveau des TBC et initier la satiété. 
Ces résultats renforcent l’importance du rôle anorexigène de l’ocytocine et révèlent que sa 
sécrétion est modulée par les récepteurs du goût du gras, i.e., CD36 et GPR120. Ainsi, il 
semble que l’ocytocine influence la satiété liée à la détection du goût du gras.  
La chirurgie bariatrique entraîne des modifications drastiques du poids corporel et une 
restauration drastique de la libération peptidique intestinale postprandiale, telles que GLP-1, 
PYY et la ghréline (Barja-Fernández et al., 2015), des paramètres qui sont dérégulés chez les 
sujets obèses (Meyer-Gerspach et al., 2014). Il est donc apparu qu'influencer la libération 
d'hormones pouvait constituer une alternative pharmacologique à la chirurgie invasive. Avau 
et al. (2015) ont récemment souligné le potentiel thérapeutique du ciblage des TAS2R pour 
réduire le poids corporel. Ils ont montré que les souris déficientes en α-gustducine (les souris 
α-gust-/-) présentaient un poids inférieur à celui des souris WT lorsqu'elles recevaient un 
régime riche en graisses (HFD). De plus, la masse du tissu adipeux blanc (WAT) était plus 
faible chez les souris α-gust-/- et était corrélée à une augmentation de l’activité thermogénique 
du tissu adipeux brun (BAT). Fait intéressant, le traitement avec des agonistes amers 
(benzoate de dénatonium ou quinine) induit une diminution du poids corporel dépendante de 
l’α-gustducine, associée à une diminution de la prise alimentaire. Le traitement des pré-
adipocytes avec des agonistes de TAS2R a également diminué la différenciation en 
adipocytes matures. Par conséquent, interférer avec la voie de signalisation gustative avec les 
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agonistes de TAS2R semble protéger contre le développement de l'obésité induite par un 
régime riche en graisses en affectant directement le métabolisme des adipocytes. 
L'obésité est l'un des principaux problèmes de santé publique et sa prévalence ne cesse 
d'augmenter partout dans le monde. Au cours de la dernière décennie, le rôle des acides gras 
alimentaires a été largement étudié, en particulier leur implication en tant que régulateurs du 
métabolisme énergétique et lipidique et leur implication dans la santé humaine. Par 
conséquent, la capacité à détecter les acides gras et l'interaction potentielle entre les saveurs 
de gras et les goûts amers reste une question importante à explorer car elle pourrait constituer 
de nouvelles stratégies anti-obésité. 
Un dépistage génétique approprié de l'obésité, y compris le SNP TAS2R38, pourrait mettre en 
évidence différentes options pour améliorer les altérations chimiosensorielles, notamment 
l'ajout d'arômes simulés aux aliments pour compenser l'hyposensibilisation au goût gras. 
Il pourrait également avoir une application dans l'industrie pharmaceutique (Schiffman, 2018) 
où de nombreux médicaments présentent un goût amer important et sont aversifs pour la 
plupart des enfants et de nombreux adultes. L’élucidation de l’interaction entre le goût amer et 
le goût de graisse pourrait améliorer l’acceptation et l’observance du médicament chez les 
populations pédiatriques 
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Pris ensemble, ces résultats suggèrent le modèle intégratif suivant (Figure 78). 
 
Figure 78. Hypothèse proposée de la voie de signalisation induite par les AGLC et par les agonistes 
amers dans les cellules des bourgeons du goût. AGLC, acide gras à longue chaîne; PLCΆ2, 
phospholipase CΆ2; PIP2, Phosphatidylinositol4,5-bisphosphate; IP3, Inositol trisphosphate; OTR, 
récepteur de l’ocytocine ; OXT, ocytocine ; RE, reticulum endosplasmique. D’après Gilbertson et Khan 
(2014). 
Ainsi, nous pouvons proposer l'hypothèse suivante: une levée d’inhibition de l'ECS couplée à 
une inhibition de l'ocytocine pourrait induire une régulation positive de la CD36 au niveau de 
la membrane cellulaire en induisant l'appétit et en activant la prise alimentaire. Ensuite, LA 
déclenche la régulation négative de CD36 et la régulation positive de GPR120 (Ozdener et al., 
2014) qui induisent la libération de GLP-1 et d'ocytocine à partir des TBC. L'activation de 
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GPR120 et l'inhibition de l'ECS, c'est-à-dire l'internalisation potentielle de CB1R via les 
radeaux lipidiques conduiraient à l'état de satiété. 
En conclusion, l'ECS et le statut amer du goût modifient la voie de signalisation du goût gras 
modulant la réponse au Ca2+ qui déclenche l'information au cerveau et conduit finalement au 
comportement alimentaire. Pour confirmer nos résultats, la même méthodologie pourrait être 
utilisée chez les souris et les humains, le TBC chez la souris réagissant également à l'acide 
linoléique, à la sinigrine, au PTC et à la salicine. Les cellules HTC-8 répondent à l'AEA et à 
l'ACEA. 
Enfin, Bari et al. (2008) ont signalé que CB1R fonctionne dans le contexte des radeaux 
lipidiques. Ainsi, il serait intéressant d’explorer le trafic de CB1R au cours des différentes 
phases du comportement prandial en tenant compte en même temps des variations de la 
libération du GLP-1 et de l’ocytocine. Enfin, étant donné qu’un cross-talk est susceptible de 
se produire entre les modalités du goût du gras et de l’amer, il serait pertinent d’étudier 
l’existence d’un dialogue similaire entre le sucré et l’amer ou le salé et l’amer, comme le 
suggère (Khan et al., 2018b). 
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